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Abstract 
Rhynchosporium secalis is a major fungal pathogen of barley. Fungicides, including triazoles 
and Qols, play an important part in R. secalis control programmes, but can select for 
resistance. Reduced triazole sensitivity had been reported in R. secalis, but the mechanism 
was not known. Qol resistance had not been reported in R. secalis until 2008, when the 
G143A substitution in cytochrome b was reported in two R. secalis isolates from France. 
A high-throughput fungicide sensitivity assay was developed for R. secalis, and isolates were 
screened for Quinone outside Inhibitor (QoI) and triazole sensitivity. Qol sensitivity was 
reduced by over 100-fold in the isolates with G143A. This was not found in any UK isolates, 
but smaller sensitivity shifts were detected. These sensitivity shifts were mostly reversed by 
alternative oxidase (AOX) inhibitors, and there is preliminary evidence of AOXupregulation 
following exposure to azoxystrobin. 
Shifts in triazole sensitivity were not correlated with point mutations or constitutive over- 
expression of the target site encoding gene, CYP51, or reversed by putative efflux inhibitors. 
However, a second CYP51 paralogue, CYPSIA, was sequenced from less-sensitive isolates 
but absent from sensitive isolates. CYP51A was upregulated more than CYP51B following 
exposure to tebuconazole. Pyrosequencing analysis of the Hoosfield archive showed that 
levels of CYP51A were low until 1998, then rapidly increased. Phylogenetic analysis suggests 
a CYP51 gene duplication event basal to the filamentous ascomycetes, followed by multiple 
losses of CYP51A. Therefore it appears that CYP51A was almost lost from the R. secalis 
population, but re-emerged due to selection by triazoles. 
This project has identified the mechanism responsible for an initial shift in R. secalis 
sensitivity that compromised the effectiveness of some older triazoles, and reported further 
variation in sensitivity to newer triazoles that currently provide control in the field. 
Furthermore, the G143A cytochrome b substitution can confer QoI resistance in R. secalis. 
Therefore resistance management is important for sustainable R. secalis control. 
Acknowledgements 
I would like to thank my supervisors: Bart Fraaije and Hans Cools at Rothamsted, for all their 
help and support and everything they have taught me over the last four years, and Michael 
Shaw at Reading and Helge Sierotzki at Syngenta, for all their useful suggestions and 
feedback. 
I am grateful to James Fountaine at Rothamsted and then the Scottish Agricultural College, 
Helge Sierotzki and Regula Frey at Syngenta, and Gerd Stammler at BASF, for providing 
fungal isolates; Jason Rudd and Juliet Motteram for assistance with Southern blots; Tony 
Holton for all the autoclaving; the Rothamsted Farm staff for their work on my field trials; 
my fellow members of the Fungicide Resistance Group, past and present, for being generally 
helpful; David Ranner, our Syngenta contact in the UK and a useful contributor to project 
meetings; and Anna Avrova at the James Hutton Institute for pre-release access to the 
Rhynchosporium genome. 
I also gratefully acknowledge the UK Biotechnology and Biological Sciences Research 
Council (BBSRC), and Syngenta Crop Protection, for funding this project through a CASE 
studentship, and the British Society for Plant Pathology for conference travel funding. 
I am thankful for my friends at Rothamsted: lab and office-mates, Tea Club members and 
other PPM folks, fellow students, Music Society members, and Pavilion regulars, who have 
made my time at Rothamsted so memorable and enjoyable, and who I'm sure would rather be 
thanked with a cake in the tea-room or a pint in the Pavilion than their name in my thesis. 
Also my dance classes, the Wild Flower Society and my friends back in Kent and elsewhere, 
for providing occasional escapes from the Rothamsted bubble, with apologies to friends for 
whom my visits became a bit too occasional; and thanks to various folk-rock musicians and 
jelly sweet manufacturers for getting me through my thesis writing! 
Perhaps surprisingly, I would actually like to thank my Rhynchosporium, too. It put up a 
tough fight, but eventually told some interesting stories. 
Finally, I would like to thank my family, and especially my parents, for their constant love 
and support, and their patience through another four years of me not getting a proper job! 
ii 
Abbreviations 
ABA Abscisic acid 
ABC ATP-binding cassette 
AOX Alternative oxidase 
CDM Czapek Dox medium with Mycological peptone 
CYP Cytochrome P450 
DMI (Sterol) Demethylation inhibitor 
EC5o Fifty per cent effective concentration 
MBC Methyl Benzimidazole Carbamate 
MDR Multi-Drug Resistance 
MFS Major Facilitator Superfamily 
MIC Minimum Inhibitory Concentration 
PC Principal Component 
PCA Principal Components Analysis 
PDA Potato dextrose agar 
PDR Pleiotropic Drug Resistance 
QiI Quinone inside Inhibitor 
Qo Quinone outside (redox site) 
QoI Quinone outside Inhibitor 
RFLP Restriction Fragment Length Polymorphism 
SBI Sterol Biosynthesis Inhibitor 
SDHI Succinate Dehydrogenase Inhibitor 
SHAM Salicylhyroxamic acid 
S. I. sensu lato 
YPD Yeast peptone dextrose 
iii 
Contents 
Abstract ....................................................................................................................................... i 
Acknowledgements .................................................................................................................... ii 
Abbreviations ........................................................................................................................... iii 
Chapter 1 Introduction 
............................................................................................................... 1 
1.1 Rhynchosporium secalis ................................................................................................. .. I 
1.1.1 Infection process ..................................................................................................... .. 2 
1.1.2 Epidemiology .......................................................................................................... .. 5 
1.1.3 Control ......................................................... 7 ........................................................... .. 
1.1.4 Chemical control ..................................................................................................... .. 9 
1.2 Fungicides and resistance .............................................................................................. 11 
1.2.1 Fungicide resistance ................................................................................................ 11 
1.2.2 Fungicide classes used against R. secalis ............................................................... 13 
1.2.3 Benzimidazoles 
....................................... . 17 .... ........................................................... 
1.3 Qol fungicides ................................................................................................................ 20 
1.3.1 Target-site resistance .............................................................................................. 21 
1.3.2 Alternative oxidase ................................................................................................. 24 
1.4 Triazoles ......................................................................................................................... 28 
1.4.1 Mode of action ........................................................................................................ 30 
1.4.2 Target-site mutations .............................................................................................. 33 
1.4.3 Target-site over-expression ..................................................................................... 34 
1.4.4 Enhanced efflux ...................................................................................................... 36 
1.4.5 Altered sterol biosynthesis ...................................................................................... 38 
1.4.6 Resistance in R. secalis ........................................................................................... 39 
1.5 Aims of current work ..................................................................................................... 43 
iv 
Chapter 2 Method development: R. secalis culture conditions and fungicide sensitivity assay 
.................................................................................................................................................. 44 
2.1 Introduction .................................................................................................................... 
44 
2.2 Materials and Methods ................................................................................................... 
47 
2.2.1 Culture conditions ................................................................................................... 
47 
2.2.1.1 Medium ............................................................................................................ 
47 
2.2.1.2 Temperature ..................................................................................................... 
50 
2.2.1.3 Inoculum density .............................................................................................. 
50 
2.2.2 Assay method .......................................................................................................... 
50 
2.2.2.1 Medium ............................................................................................................ 
50 
2.2.2.2 Incubation Temperature and Time ................................................................... 
51 
2.2.2.3 Inoculum density .............................................................................................. 
51 
2.2.2.4 Growth Heterogeneity: Gelatin ........................................................................ 51 
2.2.2.5 Growth Heterogeneity: Shaking ...................................................................... 51 
2.2.2.6 Growth Heterogeneity: Fluorescence-Based Assays ....................................... 
51 
2.2.2.7 Growth Heterogeneity: Reader Settings .......................................................... 52 
2.2.3 Growth curve .......................................................................................................... 52 
2.3 Results ............................................................................................................................ 52 
2.3.1 Culture conditions ................................................................................................... 
52 
2.3.1.1 Medium ............................................................................................................ 52 
2.3.1.2 Temperature and Time ..................................................................................... 53 
2.3.1.3 Inoculum density .............................................................................................. 
53 
2.3.2 Assay method .......................................................................................................... 54 
2.3.2.1 Medium ............................................................................................................ 
54 
2.3.2.2 Temperature and Time ..................................................................................... 57 
2.3.2.3 Inoculum density .............................................................................................. 
59 
2.3.2.4 Growth Heterogeneity: Gelatin ........................................................................ 59 
V 
2.3.2.5 Growth Heterogeneity: Shaking ...................................................................... 61 
2.3.2.6 Fluorescence-Based Assays ............................................................................. 
64 
2.3.2.7 Growth Heterogeneity: Reader Settings .......................................................... 
66 
2.3.3 Growth curve .......................................................................................................... 
74 
2.4 Discussion ...................................................................................................................... 
74 
2.4.1 Culture conditions ................................................................................................... 
74 
2.4.2 Assay method .......................................................................................................... 
76 
2.4.3 Growth curve .......................................................................................................... 
79 
Chapter 3 Qol fungicide sensitivity in R. secalis ..................................................................... 
80 
3.1 Introduction .................................................................................................................... 
80 
3.2 Materials and Methods ................................................................................................... 
81 
3.2.1 Sensitivity testing .................................................................................................... 
81 
3.2.2 SHAM matrix assays .............................................................................................. 
82 
3.2.3 DNA extraction ....................................................................................................... 83 
3.2.4 Target site sequence analysis .................................................................................. 
83 
3.2.5 AOX sequence analysis ........................................................................................... 
85 
3.2.6 AOX expression analysis ......................................................................................... 86 
3.3 Results ............................................................................................................................ 88 
3.3.1 Sensitivity testing .................................................................................................... 88 
3.3.2 SHAM matrix assays .............................................................................................. 
89 
3.3.3 Target site sequence analysis .................................................................................. 
92 
3.3.4 AOX sequence analysis ........................................................................................... 
95 
3.3.5 AOX expression analysis ....................................................................................... 103 
3.4 Discussion .................................................................................................................... 
106 
Chapter 4 Triazole sensitivity in R. secalis ............................................................................ 114 
4.1 Introduction .................................................................................................................. 
114 
4.2 Materials and Methods ................................................................................................. 
116 
vi 
4.2.1 Triazole sensitivity testing .................................................................................... 116 
4.2.2 Field conditions and R. secalis isolation ............................................................... 117 
4.2.3 Sequencing of R. secalis CYP51A by genome-walking ........................................ 117 
4.2.4 Sequencing of CYP51 genes from R. secalis isolates ........................................... 119 
4.2.5 Efflux inhibitor assay ............................................................................................ 120 
4.3 Results .......................................................................................................................... 121 
4.3.1 Triazole sensitivity testing .................................................................................... 121 
4.3.2 Rothamsted field isolates 
...................................................................................... 127 
4.3.3 CYP51 sequence analysis ...................................................................................... 128 
4.3.4 Efflux inhibitor assays .......................................................................................... 131 
4.4 Discussion 
.................................................................................................................... 13 3 
4.4.1 Triazole sensitivity testing .................................................................................... 133 
4.4.2 CYP51 sequence analysis ...................................................................................... 135 
4.4.3 Efflux inhibitor assays .......................................................................................... 136 
Chapter 5 CYP51 paralogues and triazole sensitivity ............................................................ 138 
5.1 Introduction 
.................................................................................................................. 13 8 
5.2 Materials and Methods ................................................................................................. 139 
5.2.1 Analysis of CYPSI paralogues in fungal genomes ............................................... 139 
5.2.2 PCR-RFLP Assay 
................................................................................................. 141 
5.2.3 Southern Blot ........................................................................................................ 142 
5.2.4 Yeast Complementation 
........................................................................................ 144 
5.2.5 CYP51 Expression Analysis: Constitutive Expression 
......................................... 146 
5.2.6 CYP51 Expression Analysis: Induced Expression ................................................ 147 
5.2.7 Pyrosequencing Assay .......................................................................................... 147 
5.3 Results .......................................................................................................................... 148 
5.3.1 Analysis of CYP51 paralogues in fungal genomes ............................................... 148 
5.3.1.1 Protein localisation prediction ....................................................................... 163 
vii 
5.3.2 PCR-RFLP Assay ................................................................................................. 169 
5.3.3 Southern Blot ........................................................................................................ 169 
5.3.4 Yeast Complementation ........................................................................................ 
172 
5.3.5 CYP51 Expression Analysis: Constitutive Expression ......................................... 172 
5.3.6 CYP51 Expression Analysis: Induced Expression ................................................ 174 
5.3.7 Pyrosequencing Assay .......................................................................................... 
177 
5.4 Discussion .................................................................................................................... 
179 
5.4.1 CYP51 paralogues in fungal genomes .................................................................. 
179 
5.4.2 CYP51 paralogues and azole sensitivity in R. secalis ........................................... 
183 
Chapter 6 General discussion ................................................................................................. 190 
6.1 Key findings 
............................................................................................................ 
190 
6.1.1 A high-throughput fungicide sensitivity bioassay can be used for R. secalis if 
multiple readings are taken to allow for heterogeneous growth .................................... 
190 
6.1.2 Qol sensitivity in R. secalis may be reduced by a target-site mutation encoding 
G143A, or by increased induced expression of AOX, but target-site resistance has not yet 
spread ............................................................................................................................. 190 
6.1.3 Triazole sensitivity in R. secalis has declined over the last twenty years, but 
sensitivity differences are not associated with point mutations or constitutive over- 
expression of CYP51 ...................................................................................................... 191 
6.1.4 Rhynchosporium secalis isolates with reduced triazole sensitivity have a second 
CYP51 paralogue ........................................................................................................... 192 
6.1.5 The two CYP51 paralogues in R. secalis result from a gene duplication basal to the 
filamentous ascomycetes ............................................................................................... 192 
6.1.6 The filamentous ascomycete CYP51A paralogue is upregulated in response to the 
effects of triazole fungicides .......................................................................................... 
192 
6.2 Practical implications for R. secalis control and resistance management ................... 193 
6.2.1 QoIs ....................................................................................................................... 
193 
6.2.2 Triazoles ................................................................................................................ 
194 
6.2.3 Other fungicide groups ......................................................................................... 
195 
viii 
6.3 Emergence and spread of mutations conferring fungicide resistance in R. secalis ..... 195 
6.4 Role of multiple CYP51 paralogues in filamentous ascomycetes ............................... 196 
6.5 Constraints and contingency in molecular evolution ................................................... 
199 
6.5.1 Predictability in molecular evolution: the debate so far ....................................... 
200 
6.5.2 Predictability in evolution of fungicide resistance ................................................ 
202 
6.6 Future research directions ............................................................................................ 
203 
References .............................................................................................................................. 
205 
Appendices ............................................................................................................................. 
206 
ix 
Chapter 1 
Introduction 
1.1 Rhynchosporium secalis 
Rhynchosporium secalis (Oud. ) Davis sensu lato (s. L) is a phytopathogenic fungus, causing 
barley leaf blotch or scald. This foliar disease can cause serious reductions in grain yield. If 
untreated, yield losses within affected crops may be as high as 30% (Mayfield and Clare 
1991). Rhynchosporium secalis infection can also reduce grain quality characters such as 
specific weight and protein content (Khan and Crosbie 1988). 
Rhynchosporium secalis is found in barley-growing areas worldwide. When the last 
Commonwealth Mycological Institute Disease Distribution Map for R. secalis was published 
in 1986, it had been reported in over 50 countries, including across Europe, the Middle East 
and North America, Northern and Eastern coastal parts of Africa, North-western and South- 
eastern areas of South America, New Zealand and Southern coastal regions of Australia, the 
West coast of India and across South East Asia (CMI 1986). 
In the U. K., R. secalis is especially problematic on winter barley. The Defra 2003 Cereal 
Disease Database Report estimated that of £4.95 million in yield losses caused by foliar 
pathogens, £2.57 million was due to R. secalis, making it the most economically-damaging 
foliar pathogen of barley. This represents a total yield loss of 1.39% nationally, even with 
£24.8 million, an average of £55/ha, spent on fungicide use, and 96.4% of crops receiving at 
least one spray (DEFRA 2003). Data after 2003 are more limited, but 2005 figures estimate 
that with increased grain prices, yield losses amounted to £4.8 million (Blake et al. 2011). 
Rhynchosporium secalis s. l. also affects rye and various wild grass species (Caldwell 1937). 
While some early studies claimed isolates were able to cross-infect the full range of hosts 
(Bartels 1928), subsequent work has found isolates to be predominantly host-specialised. 
Caldwell (1937) described six different host groups, comprising barley (Hordeum vulgare), 
rye (Secale cereale), Agropyron repens, Bromus inermis, Elymus canadensis and Hordeum 
jubatum. Several later studies have found barley and rye isolates to be unable to cross-infect 
(Müller 1953; Owen 1958; Dodov, 1963; Kajiwara 1968; Lebedeva and Tvaruzek 2006). 
Müller (1953) and Owen (1958) both proposed designating the barley-infecting and rye- 
infecting races as formae specialis, R. secalis £sp. hordeum and R. secalis Esp. secalis, but 
these names have not entered common usage. Kajiwara and Iwata (1963) also found host- 
specialised races infecting the grass species Agropyron semicostatum and Phalaris 
arundinacea (now under investigation as a potential energy crop), which they named R. 
secalis f. sp. agropyri and R. secalis f. sp. phalaridis. Zaffarano et al. (2008) found host- 
specialised races infecting rye, barley or Agropyron spp. and constructed a molecular 
phylogeny based on ITS sequences, which showed these three host-specialised lineages to be 
monophyletic, and it was concluded that they are three separate species. However, for the 
purpose of this thesis, R. secalis refers to R. secalis s. l., including the barley-infecting lineage 
to which this study predominantly relates. 
The genus Rhynchosporium also contains the morphologically distinct R. orthosporum 
Caldwell which infects the grass Dactylis glomerata (Caldwell 1937) and may cause reduced 
yield (Isawa 1983; Welty 1991) and some reduction in nutritional value (Isawa 1983) in this 
popular forage grass. A species sometimes referred to as R. alismatis was excluded from the 
genus Rhynchosporium by Caldwell (1937) on morphological grounds, and reclassified as 
Plectosporium alismatis (Oudem. ) W. M. Pitt, W. Gams and U. Braun, by Pitt et al. (2004) 
based on molecular analysis. Molecular phylogenetic analyses have placed R. secalis and R. 
orthosporum close to Oculimacula in the Leotiomycetes (Goodwin 2002), whereas P. 
alismatis was placed close to Verticillium in the Sordariomycetes (Pitt et al. 2004). A species 
initially described as R. oryzae, causing a scald-like disease of rice, placed in 
Rhynchosporium based on a superficial similarity in the conidia which are sometimes two- 
celled and curved, has since been reclassified as Gerlachia oryzae (Hashioka & Yokogi) 
Gams (Gams and Muller 1980), and then Microdochium oryzae (Hashioka & Yokogi) 
Samuels & I. C. Hallet (Samuels and Hallett 1983), following more detailed morphological 
studies. 
1.1.1 Infection process 
Rhynchosporium secalis is a foliar pathogen, mainly producing symptoms on the leaf blades 
and sheaths. Spores landing on barley leaves germinate in response to nutrients or other 
substances exuded at the leaf surface (Ayres and Owen 1969). An early study by Bartels 
(1928) claimed that the fungus enters the leaf through stomata, but subsequent studies have 
repeatedly shown direct entry through the epidermis by forming appressoria (Caldwell 1937; 
Ayesu-Offei and Clare 1970; Jones and Ayres 1974). 
2 
There is an initial symptomless phase in which the fungus produces subcuticular hyphae, 
growing through the pectic layer between the cuticle and the epidermal cell walls (Ryan and 
Grivell 1974). The fungus penetrates the epidermal cells, causing epidermal cell collapse. At 
this stage bluish-grey, `lenticular' (lens-shaped) lesions, with a water-soaked appearance, 
become visible (Caldwell 1937). Fungal hyphae then grow down into the mesophyll, causing 
mesophyll cell collapse. The centre of the lesion then dries, leaving a light brown or grey 
necrotic lesion with a characteristic dark margin (Bartels 1928) (Figure 1.1). Lesions may 
spread outwards to form concentric rings, and in heavily-infected leaves they may coalesce to 
cover a large proportion of the leaf area. The two-celled conidia, with a beaked shape that 
gives the genus its name, form directly from hyphae, on one side of the leaf only, mostly in 
the centre of the lesion where hyphal growth is most dense, dislodging the cuticle so the 
spores are exposed (Caldwell 1937). 
Subsequent investigations using electron microscopy (Jones and Ayres 1974; Hosemans and 
Branchard 1985), GFP-transformed strains (Newton et al. 2010) and qPCR detection 
(Fountaine et al. 2007) of R. secalis have shown the symptomless phase to be more extensive. 
The fungus does not produce haustoria, but during the symptomless phase it may increase the 
permeability of plant cell membranes, increasing the availability of sugars and amino acids 
from plant cells to the fungus in the subcuticular space (Jones and Ayres 1972). The 
symptomless phase can persist for months (Fountaine et al. 2010), and the fungus can 
produce conidia through the cuticle (Howlett and Cooke 1987). 
The formation of necrotic lesions causes a reduction in photosynthetic area, reducing 
photosynthetic productivity and ultimately grain yield. James et al. (1968) found a clear 
correlation between the percentage of the flag leaf and leaf two visibly infected after ear 
emergence and the percentage yield lost, suggesting that loss of photosynthetic area during 
grain filling is especially damaging to yields. However, such studies have correlated yield 
loss with visibly-infected lead area, and so do not take account of asymptomatic infection. 
While there is experimental evidence that photosynthetic rate, measured by carbon dioxide 
uptake, only decreases from mesophyll cell collapse, the fungus is already taking up 
photosynthetic products from the plant during subcuticular growth (Jones and Ayres 1972). 
Mayfield and Clare (1991) studied plants grown in controlled environment, artificially 
inoculated with R. secalis at different growth stage. They found that reductions in yield were 
mainly due to fewer ears being produced per plant, and fewer grains per head, but still found 
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that infection later in the growing season was most damaging to grain yields. However, the 
plants were grown in controlled environment chambers, with water provided directly into the 
pots. Therefore in the absence of rainfall to cause splash-dispersal, this experiment did not 
account for the importance of earlier infection for the build-up of secondary inoculum that 
can cause later-season infection in the field. Taggart et al. (1998) found that control failure of 
R. secalis resulted in reduced grain weight. 
(n) 
Figure 1.1. Rhynchosporium secalis lesions on barley (a) in the field, (b) on leaf blades and leaf sheath. 
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1.1.2 Epidemiology 
Leaf scald is a polycyclic disease. Within a growing season, the primary inoculum source is 
infected seed or plant debris, followed by secondary spread by splash-dispersal of conidia 
(Habgood 1971; Shipton et al. 1974). 
Bartels (1928) describes R. secalis as overwintering on crop debris and in the soil as hyphae 
and conidia, sometimes forming sclerotia-like bodies of tightly-packed hyphae. Polley (1971) 
reports similar findings: lesions on dead leaves no longer sporulated, but conidia germinated 
on crop debris and grew saprophytically as dense hyphal masses that later produced conidia, 
forming the primary inoculum to infect the next crop. Ayesu-Offei and Carter (1971) used 
infected barley straw as an experimental inoculum source at the centre of a field, and 
observed the initial spread of symptomatic infection out through the crop. Evans (1969) 
observed higher disease incidence on farms where large amounts of barley stubble had been 
left in fields, and confirmed with glasshouse tests that a layer of debris, if wet, on top of the 
soil can infect growing plants. 
Another major primary inoculum is infected seed. Skoropad (1959) showed that R. secalis 
infection could spread from the leaves to the ear, infecting the inner surface of the lemma and 
then the pericarp of the grain itself. When seeds germinated in such a position that the 
emerging seedling came into contact with the infecting area of the seed-coat, symptoms 
appeared on the emerging shoot within a week. Habgood (1971) found that seed from an 
infected crop could produce infected seedlings, even where the seed lacked visible symptoms. 
Fountaine et al. (2010) measured significantly higher rates of infection from infected than 
from clean seed in field trials, and detected systemic symptomless infection in plants grown 
from infected seed, whereas previous studies had only measured visible symptoms in 
seedlings. 
Barley volunteers may act as a disease reservoir between barley crops (Stapel 1960), although 
this is less important than for obligate biotrophic pathogens (Yarham and Gladders 1993), as 
R. secalis can also survive saprophytically, and removal of volunteer plants may only reduce 
disease levels if crop debris is also removed (Evans 1969). It has also been suggested that 
wild grasses at field margins may act as reservoirs for the disease, but current knowledge of 
host-specialisation in R. secalis suggests this only applies to a limited range of grass species, 
such as wall barley, Hordeum murinum (Zaffarano et al. 2008). 
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Secondary dispersal by rain-splashed conidia allows the fungus to infect higher leaves, 
reaching epidemic levels in suitable conditions. In glasshouse tests, Polley (1971) found that 
epidemic levels of R. secalis infection occurred after periods of at least twelve hours with 
relative humidity over 90% and rainfall at least nine hours before the end. In the field, Ayesu- 
Offei and Carter (1971) detected conidia in spore-traps only after rainfall or spray-irrigation. 
Fitt et al. (1986) used simulated rainfall to show that more spores were collected in spore 
traps following heavier rain, with a minimum rainfall rate of 0.2mm/hour required for conidia 
to be detected. Occasionally spores were detected in windy conditions immediately following 
rainfall, but none were detected from dry leaves in wind-tunnel experiments. This 
corresponds with historical (Priestley and Bayles 1979) and geographical (Khan et al. 1968; 
Priestley and Bayles 1979) studies, which show that R. secalis epidemics are more frequent in 
seasons with high rainfall in May to July, and in regions with higher annual rainfall. 
Rhynchosporium secalis is an imperfect fungus, with no known sexual stage. 
Phylogenetically, however, it is a member of the Ascomycota, thought to be related to 
discomycete fungi in the Leotiales (Goodwin 2002; Crous et al. 2003), including the related 
species Oculimacula yallundae and Pyrenopeziza brassicae, which produce airborne 
ascospores from apothecia on crop debris (Wallwork 1987; McCartney and Lacey 1989; Dyer 
et al. 2001). 
There is some evidence of genetic recombination in R. secalis populations (Burdon et al. 
1994), but it is not yet clear whether this is due to an as yet undiscovered sexual stage, 
perhaps occurring on different host species (Zaffarano et al. 2006), or somatic recombination 
(Bo et al. 1994; Salamati et al. 2000). Spore trapping has repeatedly found only conidia of R. 
secalis (e. g. Skoropad 1959; Ayesu-Offei and Carter 1971), and very low levels of DNA 
(Fountaine et al. 2010), consistent with occasional capture of splash-dispersed spores rather 
than common wind-dispersed ascospores. 
Bartels (1928) described the formation in culture of gemmae, vegetative fragments that 
subsequently germinate, but there have been no reports of such propagules being produced in 
planta or dispersed in the field. Jones and Ayres (1974) found that when plants were 
inoculated with a mixture of hyphal fragments and spores, some hyphal fragments grew over 
the leaf surface, but were not able to penetrate the cuticle and infect the leaf. Microconidia 
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have also been reported in culture (Skoropad and Grinchenko 1957), but they did not 
germinate and have not been found in the field. 
1.1.3 Control 
Effective control relies on the combined use of more resistant barley varieties and fungicide 
applications (Zhan et al. 2008; Blake et al. 2011). Crop rotation, tillage to reduce surface 
crop debris and removal of volunteer plants have a limited effect in reducing those inoculum 
sources (Oxley 2010), but no effect on seed-borne infection. Work is underway to evaluate 
seed treatments for R. secalis control, but so far, effective control has not been achieved 
(Oxley and Burnett 2010). Later sowing date reduces infection levels, but also causes direct 
yield reduction (Cooke and Oxley 2000; Kavak 2004). 
Cultivar resistance includes major-gene-mediated and partial (or polygenic) resistance. In 
major-gene-mediated resistance, a single host gene enables recognition of pathogen strains 
with the corresponding avirulence gene, eliciting a defence response that prevents lesion- 
forming infection (Zhan et al. 2008). For example, the Rrsl resistance allele in barley gives 
resistance to R. secalis isolates with the corresponding avirulence allele, AvrRrsl. The 
resistance elicitor for AvrRrsl has now been identified as the protein NIP 1, a necrosis- 
inducing protein produced by R. secalis at the mesophyll-collapse, lesion-forming stage of 
infection (Rohe et al. 1995). So far, 17 resistance genes have been described (Wagner et al. 
2008), although some of these map to the same chromosome location and may represent 
multiple alleles rather than separate loci (Genger et al. 2005). 
The effect of major-gene-mediated resistance on asymptomatic infection has proven less 
tractable. Jones and Ayres (1972) found some subcuticular growth in a susceptible and a 
resistant variety, but in the resistant variety the levels of nutrients from the plants cells 
available to the fungus in the intercellular space were lower, and mycelial growth was less 
than in the susceptible variety. Lehnackers and Knogge (1990) observed some differences in 
spore germination rates and subcuticular hyphal growth levels, and in some cases host cell 
wall alterations blocking epidermal penetration, but these were not correlated with the 
presence of Rrsl/NIPJ. Subcuticular hyphal growth was less dense in the resistant 
interaction, but some sporulation still took place. Steiner-Lange et al. (2003) found that 
defence responses in resistant plants were triggered within 24 hours post inoculation, just 
after the fungus penetrated the cuticle. One of the Rrsl AvrRrsl-specific pathogenesis-related 
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proteins was expressed specifically in the epidermis, but three were expressed specifically or 
most highly in the mesophyll. Microscopy studies with a GFP-labelled R. secalis 
transformant on one susceptible barley cultivar and a near-isogenic resistant cultivar found 
that spore germination and mycelial growth rate were reduced on the resistant cultivar, with 
the hyphal network mostly limited to subcuticular growth parallel to the leaf surface rather 
than growing deeper into the leaf tissue. However, some sporulation did take place 
(Thirugnanasambandam et al. 2010). 
Major-gene-mediated resistance is vulnerable to resistance-breaking pathogen strains. 
Schurch et al. (2004) tested R. secalis isolates from a range of locations and found the NIP] 
gene had been deleted in 45% of isolates, resulting in virulence on Rrsl barley varieties. Of 
the remaining isolates, 10% of those sequenced had mutations in N1P1 associated with 
virulence on Rrsl barley varieties. Lehnackers and Knogge (1990) describe several R. secalis 
field isolates virulent on Rrs2 cultivars. Such gene-for-gene interactions provide the basis for 
the `physiologic races' of R. secalis on barley described in earlier literature (Shipton et al. 
1974). Rhynchosporium secalis populations contain a range of pathogenicity types (Burdon et 
al. 1994; Newton et al. 2001), and are able to evolve quickly to different barley cultivars as 
virulent strains are selected (Xi et al. 2003). 
Polygenic resistance, whereby multiple loci contribute to quantitative resistance, is thought to 
be more durable, but only provides partial resistance. In a cultivar with partial resistance, 
visible lesions will appear, but they may be smaller, fewer, develop later or have lower spore 
production (Habgood 1977; Kari and Griffiths 1993). Partial resistance is sometimes referred 
to as adult resistance, and major-gene-resistance as seedling resistance. Studies in R. secalis 
have shown that some, but not the majority, of partial resistance to R. secalis in barley is 
effective only in adult plants (Xue and Hall 1995). Recently, some components of polygenic 
resistance have been genetically analysed as QTLs and mapped to chromosomes (Wagner et 
al. 2008), but comparison of analyses is hampered by strong genotype x environment 
interactions (Kari and Griffiths 1993). 
Therefore a more durable resistance strategy would involve a combination of partial 
resistance, and multiple major resistance genes, combined in one cultivar by `pyramiding' 
(Jefferies et al. 2000), or in a cultivar mixture (Oxley and Burnett 2010). There has also been 
some interest in disease escape, whereby aspects of crop growth, such as earlier stem 
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elongation, lower canopy density, or more horizontal leaf surfaces, reduce secondary spread 
(Zhan et al. 2008). However, there may be associated yield penalties, such as increased 
shading of lower leaves. It has also been suggested that disease tolerance could be improved, 
so yield loss is lower for a given disease level, although it is not yet clear whether this would 
be possible without reducing the disease-free yield (Bingham et al. 2009). 
Blake et al. (2011) suggest that net blotch, Pyrenophora teres, overtook R. secalis as the most 
damaging foliar pathogen of winter barley in the UK in 2005 due to the introduction of barley 
varieties with higher resistance to R. secalis, although Oxley and Burnett (2010) list R. 
secalis as the most damaging foliar disease of barley in the UK. However, barley varieties 
still only provide moderate levels of resistance to R. secalis (Wagner et al. 2008) and 
fungicides remain a key part of disease control. HGCA Recommended List Varieties in 2010 
trials gave yields 8%-23% lower without fungicides than with standard treatment 
programmes, with a median yield difference of 17% (HGCA 2010). 
1.1.4 Chemical control 
Current UK recommendations for R. secalis control in winter barley include a Ti spray, at 
growth stage 31-32 for winter barley or growth stage 25-30 for spring barley, containing a 
triazole with a Qol (Quinone outside inhibitor) or SDHI (Succinate dehydrogenase inhibitor), 
or a morpholine if eradicant activity is needed; followed in wet summers by a T2 spray, at 
growth stage 39-49, containing a triazole with a different mixing partner such as cyprodinil or 
an SDHI if not used at Ti. An earlier spray, before GS30, containing morpholines and 
cyprodinil, may be applied on winter barley if early disease levels are high (Blake et al. 
2011). The UK Pesticide Usage Survey Report in 2008 showed that these recommendations 
were widely followed, with most fungicides applied in a two-way mixture and the most 
common mixtures containing a triazole with a QoI or morpholine (Figure 1.2) (Garthwaite et 
al. 2008). The modes of action and resistance mechanisms for these fungicide groups are 
discussed in Secion 1.2. 
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Figure 1.2. Pie chart showing fungicide use on barley in the UK in 2008 by proportion of active substance 
treated area. Series 1 (inner circle): proportion of total fungicides used. Series 2: mixing partners used 
with the fungicide groups shown in series 1. Series 3: additional mixing partners used with the fungicide 
combinations shown in series 2. Red: anilinopyrimidines; orange: imidazoles; yellow: benzimidazoles; 
light green: mildewicides; dark green: morpholines; light blue: multi-site inhibitors; dark blue: QoIs; 
light purple: SDHIs; dark purple: triazoles. Grey: no additional mixing partner. 
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1.2 Fungicides and resistance 
Fungicides are a key part of control programmes for R. secalis. The Defra 2003 Cereal 
Disease Database Report estimated that £24.8 million, an average of £55/ha, was spent on 
fungicide use on winter barley in the UK, with 96.4% of crops receiving at least one spray 
(DEFRA 2003). 
There are currently 408 fungicide products approved for use on barley in the U. K., 
comprising 379 field fungicides and 29 seed treatments (Chemicals Regulation Directorate 
2010). However, the 379 field fungicides contain only 35 different active ingredients, with 
just 11 different modes of action (FRAC 2010a), three of which are mildew-specific. 
Bringing a new compound to market takes over ten years (Morton and Staub 2008) and costs 
up to £200 million (Case 2010). Therefore the monitoring and management of fungicide 
resistance is essential, to prolong the effective life of the available products. 
1.2.1 Fungicide resistance 
Fungicide resistance has been defined as "stable, inheritable adjustment by a fungus to a 
fungicide, resulting in less than normal sensitivity to that fungicide... for strains of a sensitive 
species that have changed, usually by mutation, to be significantly less sensitive" (European 
and Mediterranean Plant Protection Organization 1988). This definition specifies acquired 
resistance, as opposed to intrinsic differences between species. In some cases, resistance has 
been defined as having occurred only when the frequency of such strains in field populations 
results in the failure of disease control (HGCA 2000), a situation which may be referred to as 
"practical resistance" (European and Mediterranean Plant Protection Organization 1988). 
Fungicide resistance develops when naturally-occurring genetic variation in a pathogen 
population includes mutations conferring reduced fungicide sensitivity, and fungicide use 
exerts a selective pressure that favours such mutations. Both of these stages, emergence and 
selection, have implications for resistance risk and management (Georgopoulos and 
Skylakakis 1986). Therefore detection of less-sensitive fungal isolates, before they reach 
sufficient frequency in the population to result in loss of control in the field, is vital in order 
to assess the risk of field resistance occurring and give appropriate management guidelines. 
The continued efficacy of most broad-spectrum fungicides relates to their multi-site mode of 
action, since mutations affecting a single target site will not confer resistance. Hence only 
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isolated cases of resistance have been reported, which are non-target-site based (e. g. Barak 
and Edgington 1984). In contrast, for many fungicides with a site-specific mode of action, a 
single mutation can confer high levels of resistance. Consequently in many cases resistance 
has developed rapidly, with resistance to benzimidazoles and strobilurins reported in some 
pathogens within two years of their introduction (Brent and Hollomon 2007b). 
When mutations conferring reduced sensitivity do arise, their persistence and spread will 
depend upon population genetic factors such as ploidy level and recombination frequency 
(Milgroom et al. 1989); biological factors relating to the level of selective advantage given by 
the mutation, a product of the resistance factor balanced against any fitness penalties resulting 
from reduced target-site efficiency or energy expenditure on over-expression or efflux; and 
agronomic factors relating to the level of selective pressure exerted by the fungicide class in 
question. 
Therefore fungicide risk can be broken down into fungicide-related factors, pathogen-related 
factors and agronomic factors (Brent and Hollomon 2007b). Where fungicide and pathogen 
risk are moderate to high, agronomic risk must be reduced through resistance management 
practices. These involve limiting the selective advantage conferred by resistance to a 
fungicide class by reducing exposure of pathogen populations to selection by those 
fungicides. This can be achieved by reducing the pathogen population under selection by the 
fungicide by utilising other control methods including resistant varieties and cultural control 
(HGCA 2000). Initially, cases where resistance emerged first in high disease pressure areas 
were given as anecdotal evidence that reducing pathogen populations by other means could 
prove useful in resistance management (Staub 1991). More recently field experiments have 
shown a lower shift in R. secalis sensitivity to epoxiconazole over a growing season on less 
sensitive barley cultivars (Oxley et al. 2003). Conversely, the use of fungicides alongside 
resistant cultivars can reduce the pathogen population under selection for virulence, 
prolonging the useful life of resistance genes (Staub 1991). 
Reducing the exposure of the pathogen population to a fungicide may be achieved by limiting 
the number of applications per season (Brent and Hollomon 2007a). This means using 
fungicides only when warranted by the presence or risk of disease (HGCA 2000). However, 
waiting for an epidemic to develop and then attempting eradicant use of fungicides results in 
a large pathogen population under selection by the fungicide, increasing resistance risk 
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(Staub 1991). Therefore disease forecasting and early detection are key. The number of 
applications of a single group of fungicides to a single crop during a growing season should 
also be limited, but here some compromise may be necessary between resistance 
management and disease control. The selection imposed by any one fungicide can be reduced 
by mixing or alternating fungicides from different cross-resistance groups (HGCA 2000), 
although experimental data regarding the effectiveness of using fungicide mixtures are 
limited and conflicting. Mixing or alternating with different fungicide groups delayed the 
selection of Qol and triazole resistance in Sphaerothecafuligenea (Wyenandt et al. 2008) and 
QoI resistance in Blumeria graminis f. sp. hordei (Fraaije et al. 2006), and reduced sensitivity 
shifts of R. secalis against epoxiconazole and prothioconazole within individual sites over a 
single season (Oxley et al. 2008). However, QoI resistance in M graminicola was rapidly 
selected even when QoI fungicides were only used once, in mixtures and alternations (Fraaije 
et al. 2006). In Plasmopara viticola, the benefit of a mixing partner in delaying the selection 
of Qol resistance depended on the mixing partner used and the dose rate of Qol and mixing 
partner (Genet et al. 2006). In R. secalis, the frequency of MBC resistance in populations 
proved too erratic between years and sites to determine the effect of fungicide mixtures on 
the frequency of resistant isolates (Holloman 1997). 
Fungicides used in mixtures or alternations should belong to different groups which are not 
cross-resistant. Positive cross-resistance occurs when different fungicides share a mode of 
action, and a single resistance mechanism confers resistance to both, whereas multiple 
resistance is the occurrence of separate mechanisms conferring resistance to different 
fungicides in the same pathogen. Fungicides have been classified into cross-resistance 
groups, each sharing a mode of action and affected (or potentially affected) by a common 
resistance mechanism (FRAC 2010a). Groups currently authorised for use on barley in the 
UK are the amines (morpholines), carboxamides, anilinopyrimidines, MBCs, QoIs, DMIs 
(demethylation inhibitors) and multi-site inhibitors, along with some specific mildewicides 
(Chemicals Regulation Directorate 2010). 
1.2.2 Fungicide classes used against R. secalis 
The amines, sometimes referred to as morpholines but also including piperadines and 
spiroxamine (FRAC 201 Oa), are a class of sterol biosynthesis inhibitors (SBIs) (Leroux and 
Gredt 1978), inhibiting sterol Og-07 isomerase (Kato et al. 1980) and A 14 -reductase 
(Kerkenaar et al. 1981). They are in a separate cross-resistance group from the DMIs 
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(Hollomon 1994; Godet and Limpert 1998), which inhibit a different step in sterol 
biosynthesis. Their inhibition of two different enzymes is thought to make target-site 
resistance unlikely to evolve, since appropriate mutations in both target site encoding genes 
would be required (Hollomon 1994). The only reports of resistance so far are of a quantitative 
shift in B. graminis (f. sp. tritici and hordei) which was significant but smaller than that for 
DMIs (Godet and Limpert 1998; Napier et al. 2000), and laboratory mutants of Ustilago 
maydis (Markoglou and Ziogas 2001) and Nectria haematococca, the latter due to altered 
sterol metabolism, and possibly mutation or over-expression of one of the two target sites, 
sterol 014-reductase (Lasseron-De Falandre et al. 1999). Whilst the amines are not the most 
effective fungicides against R. secalis when used alone, their use in mixtures can improve 
results relative to use of another fungicide alone (Phillips and Frost 1975), including use as a 
mixing partner for triazoles (Taggart et al. 1998). The eradicant activity of amine fungicides 
means they can be used against established R. secalis infections, although their use is not 
recommended after canopy expansion as they can cause leaf die-back (Oxley and Burnett 
2010). In the UK in 2008, amines accounted for 17% of fungicide applications by active 
substance treatment area on barley (Garthwaite et al. 2008) (Figure 1.2) and nearly 10% of 
fungicide applications by treatment area on all cereals (FERA 2010) (Figure 1.3). 
The carboxamides, or SDHIs, inhibit succinate dehydrogenase of respiratory complex II 
(White 1971). Complex II comprises sdhA, or sdhFp, the flavoprotein subunit; sdhB, or 
sdhlp, the iron-sulphur protein subunit; and the membrane anchor, in fungi consisting of two 
subunits, sdhC and sdhD (Ackrell 2000). The first SDHI fungicides, such as carboxin, were 
introduced in the late 1960s for use against rusts and other basidiomycetes (Avenot and 
Michailides 2010). Field resistance to carboxin and fenfuram was detected in Ustilago nuda 
in 1986 (Leroux and Berthier 1988). Studies of carboxin-resistant laboratory mutants of U 
maydis (Broomfield and Hargreaves 1992) and M graminicola (Skinner et al. 1998) found 
single-site substitutions substitutions L257K and H267 Y/L, respectively, in the third 
cysteine-rich cluster of the iron-sulphur redox centre in sdhB. However, studies of resistant 
laboratory mutants of Coprinopsis cinerea found a single-site substitution (N80K) in sdhC 
(Ito et al. 2004). Mutations in sdhB and sdhD have been found in phytopathogenic bacteria 
(Matsson et al. 1998; Li et al. 2006), and mutations in sdhB, sdhC and sdhD have been found 
in carboxin-resistant laboratory mutants of Aspergillus oryzae, with each mutation 
independently conferring carboxin resistance (Shima et al. 2009). 
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Since 2002, a new generation of SDHI fungicides, effective against ascomycete pathogens, 
has been introduced (Ammermann et al. 2002). The first such compound was boscalid, 
released for use on cereals in 2005, followed by isopyrazam and bixafen in 2010 and 2011, 
with further compounds including penthiopyrad yet to be released (Avenot and Michailides 
2010; Chemicals Regulation Directorate 2010; FRAC 2010a; Oxley and Burnett 2010). By 
2008, boscalid accounted for 3.6% of fungicide applications on cereals in the UK by active 
substance treated area (FERA 2010), and whilst SDHIs accounted for only 0.28% of 
fungicide applications on barley in 2008 (Garthwaite et al. 2008), this is likely to increase as 
more products are introduced. In 2006, boscalid-resistant field isolates of Botrytis cinerea 
were found, with substitutions in sdhB (Stammler et al. 2007). Resistance to boscalid has also 
recently been reported in field isolates of Alternaria alternata carrying mutations in sdhB 
(Avenot et al. 2008), sdhC or sdhD (Avenot et al. 2009), with any one mutation conferring a 
resistance factor of over 900 against boscalid but lower resistance factors against carboxin. 
Resistance has also been reported in B. cinerea (Stammler et al. 2007), Sclerotinia 
sclerotiorum and some diseases of horticultural crops (Avenot and Michailides 2010), but so 
far there have been no reported cases of field resistance to the newer SDHIs in cereal 
pathogens (FRAC 201 Ob). Products currently registered for use on barley in the UK contain 
either boscalid in mixture with epoxiconazole, bixafen with prothioconazole or isopyrazam 
with cyprodinil (Chemicals Regulation Directorate 2010). 
The anilinopyrimidines were introduced in the 1990s. The mode of action has not yet been 
fully elucidated, but sensitivity is reduced in vitro in rich media and so the mode of action is 
believed to be linked to extracellular secretion of hydrolytic enzymes (Miura et al. 1994), or 
to methionine biosynthesis (Masner et al. 1994), although cystathionine ß-lyase appears not 
to be the target site (Fritz et al. 2003). Field resistance was detected in B. cinerea in 1993 
(Leroux and Gredt 1978), and subsequently in Venturia inaequalis (Kung et al. 1999) and the 
post-harvest pathogen Penicillium expansum (Li and Xiao 2008), and shifts were seen in 
Oculimacula spp. in field experiments (Babij et al. 2000). The anilinopyrimidine cyprodinil 
is effective against R. secalis (Heye et al. 1994), including as a mixing partner for triazoles 
(Cooke et al. 2004) or isopyrazam (Blake et al. 2011), but it accounts for under 5% of UK 
fungicide treatments on barley (Figure 1.2) and less than 1% of UK fungicide treatments on 
cereals (Figure 1.3), and some formulations cannot be used at T2 where certain plant growth 
regulators are used (Oxley and Burnett 2010). 
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The main multi-site inhibitor currently in use against R. secalis is chlorothalonil, which reacts 
with thiols such as glutathione so various thiol-dependent enzymes cannot function (Tillman 
et al. 1973). Generally multi-site inhibitors have very low risk of resistance, although B. 
cinerea isolates with cross-resistance to chlorothalonil and five other multi-site inhibitors 
were reported, suggesting that a non-target-site mechanism is involved, such as thiol over- 
production (Barak and Edgington 1984). Chlorothalonil shows good protectant activity 
against R. secalis, but lacks systemicity and curative action (Oxley and Burnett 2010). 
Therefore, it is often used in mixtures with systemic but higher resistance risk fungicides, and 
accounted for 16% of fungicide applications on cereals in the UK by active substance treated 
area in 2008 (FERA 2010) (Figure 1.3). 
1.2.3 Benzimidazoles 
Benzimidazoles, introduced in the late 1960s, were among the first selective, site-specific 
fungicides (Morton and Staub 2008). Benzimidazoles bind to ß-tubulin, preventing 
microtubule assembly (Davidse and Flach 1977), causing mitotic failure as pairs of 
chromatids cannot be separated (Hammerschlag and Sisler 1973). The thiophanate fungicides 
are converted by fungi to the benzimidazole carbendazim (Uesugi 1998), so the thiophanates 
and benzimidazoles are grouped together as methyl benzimidazole carbamates (MBCs) 
(FRAC 2010a). 
Field resistance was first reported in S. fuliginea in 1971, followed rapidly by many other 
pathogens of horticultural crops, and by B. graminis on the grass Poa pratensis in 1973 
(FRAC 201 Ob). MBCs were used on cereals from the mid-1970s. Field resistance was 
reported in Oculimacula spp. in 1982, Microdochium nivale in 1983 (FRAC 2010b), and M. 
graminicola in 1985 (Fisher and Griffin 1984). The Fungicide Resistance Action Committee 
now lists 120 plant pathogens that have developed benzimidazole resistance (FRAC 201 Ob). 
In 1990, benzimidazoles accounted for 16% of fungicide treatments on cereals in the UK by 
active substance treated area. By 2008, this had fallen to 0.15% (FERA 2010) (Figure 1.2). 
The ß-tubulin of MBC-resistant fungal strains has a greatly reduced binding affinity to MBCs 
(Davidse and Flach 1977), resulting from single-site mutations, predominantly at codons 198 
or 200 (Koenraadt et al. 1992). Substitutions include E198G, E198K, E198A and F200Y in 
V. inaequalis, with the same mutations in Monilinia fructicola, Sclerotinia homoeocarpa and 
various Penicllium species, as well as E198V in P. expansum (Koenraadt et al. 1992); the 
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same mutations have been found in other species in subsequent studies (e. g. Wong et al. 
2005; Ziogas et al. 2009), along with E198Q and L240F in O. yallundae (Albertini et al. 
1999) and F 167Y in Fusarium graminearum (Chen et al. 2009). Y200 corresponds to the 
wild-type sequence in some intrinsically insensitive species, including humans (Davidse and 
Ishii 1995). Further substitutions have been found in laboratory mutants but have not in field 
isolates, possibly due to fitness costs resulting from impaired tubulin-tubulin binding in 
microtubule formation making microtubule structure less stable and more temperature- 
sensitive (Davidse and Ishii 1995). Alternatively, some laboratory mutants of Oculimacula 
spp. had changes at multiple residues, or amino acid substitutions resulting from a two-base- 
pair mutation, which may not have been found in the field because these multiple changes 
have not occurred at natural mutation rates (Albertini et al. 1999). Benzimidazoles are also 
used as nematicides, and the substitutions E 198A, F200Y and F 167Y have been found in 
benzimidazole-resistant nematodes (Skuce et al. 2010). Furthermore, some mutations only 
reported in resistant laboratory mutants in fungi correspond to wild-type sequences found in 
intrinsically insensitive organisms (Davidse and Ishii 1995). This suggests that any fitness 
penalty depends on the genetic background. 
Substitutions E198A and E198G conferred negative cross-resistance to N-phenylcarbamate 
fungicides, such as diethofencarb: wild-type isolates are insensitive to these fungicides, but 
isolates with these substitutions are sensitive. Therefore fungicide mixtures of carbendazim 
and diethofencarb were introduced to control mixed populations of carbendazim sensitive and 
resistant isolates of Cercospora beticola (Kato et al. 1984). However, the F200Y and L240F 
substitutions confer resistance to the MBCs while retaining insensitivity to the N- 
phenylcarbamates, and E198K, E198Q and E198V confer resistance to MBCs, with negative 
cross-resistance to methyl N-(3,5-dichlorophenyl)-carbamate (MDPC) but retaining 
insensitivity to diethofencarb (Koenraadt et al. 1992). Therefore attempts to exploit the 
negative cross-resistance for resistance management by combining carbendazim and 
diethofencarb resulted in the selection of genotypes resistant to both compounds (Faretra et 
al: 1989; Katan et al. 1989; Ziogas et al. 2009). 
MBC fungicides were introduced for use on barley in the UK in 1975, but resistance in R. 
secalis was not reported until 1989 in Northern Ireland (Hollomon 1992) and 1990 on the UK 
mainland (Wheeler et al. 1995b). The ß-tubulin of resistant isolates bound radio-labelled 
carbendazim less strongly than that the ß-tubulin of sensitive isolates (Kendall et al. 1994). 
18 
All resistant field isolates of R. secalis sequenced have the ß-tubulin substitutions El98G 
(Wheeler et al. 1995a) or F200Y (Butters and Hollomon 1999). Substitution E198K has been 
found in a benzimidazole-resistant laboratory mutant of R. secalis (Wheeler et al. 1995a). 
This laboratory mutants had lost pathogenicity, whereas field isolates with E198G or F200Y 
had not (Wheeler et al. 1995b). However, it is not clear whether El 98K itself has fitness 
costs in planta, or whether the loss of pathogenicity resulted from co-incidental mutations or 
growth in culture. The E198G substitution, but not the F200Y substitution, confers negative 
cross-resistance to the N-phenylcarbamate fungicide, diethofencarb (Wheeler et al. 1995a). 
The spread of MBC-resistant genotypes in R. secalis populations has been described as 
"erratic". Ten years after the first report of resistance, the occurrence was still sporadic in the 
UK mainland, with farmers advised that carbendazim-containing mixtures still "may be 
useful" in some cases. In contrast, in Northern Ireland, resistance became "common and 
widespread" within three years (HGCA 2000). A survey in 1993 found 39% of isolates from 
Northern Ireland were carbendazim-resistant (Taggart et al. 1994), compared to 16.6% of 
isolates, with no resistant isolates obtained from over half of crops surveyed, in England and 
Wales in the same year (Locke and Phillips 1995). However, the apparent division between 
Northern Ireland and mainland Britain may be misleading, since resistant isolates were also 
found at higher frequencies in wetter regions of England and Wales, where higher rainfall 
results in higher disease pressure. For example, 12 out of 35 Welsh isolates were resistant to 
carbendazim, compared to none of 54 isolates from Suffolk and Essex (Locke and Phillips 
1995). Differences between Northern Ireland and Wales were not significant (Taggart et al. 
1999), and there was considerable variation between sites in Northern Ireland, with the 
proportion of resistant isolates ranging from 7.6% to 85.7%, and carbendazim still giving 
disease control at sites with the lowest frequency of resistance (Taggart et al. 1994). From 
1993 to 1995, overall resistance frequency in Northern Ireland stabilised at around 40%, but 
remained highly variable between sites (Taggart et al. 1999). Differences in resistance 
frequency between sites were not correlated with carbendazim use within each growing 
season, as large differences in the initial frequency of resistant isolates prior to fungicide 
treatment had a greater impact on the final frequency of resistant isolates (Taggart et al. 
1999). However, within sites the frequency of resistant isolates was higher after carbendazim 
treatment (Taggart et al. 1998). However, frequency of resistance was negatively correlated 
with disease control (Taggart et al. 1999), and by 2002, resistance was sufficiently 
widespread that MBCs were no longer considered useful for R. secalis control in the UK. 
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Morpholines and the newer anilinopyrimidine and Qol fungicides were recommended instead 
alongside DMIs (Cooke and Locke 2002). 
1.3 QoI fungicides 
The Quinone-outside inhibitors (QoIs) (Figure 1.4) effect reversible competitive inhibition of 
the quinone outside redox site (Q0) of cytochrome b of the cytochrome be j complex in 
respiration (Becker et al. 1981; Brandt et al. 1988) (Figure 1.5), a mitochondrially-encoded 
target site. This group includes the strobilurins, based on natural products of various 
basidiomycete fungi. The antifungal activity of strobilurins A and B, from Strobilurus 
tenacellus, was first reported in 1977, but extensive chemical modification was necessary to 
develop fungicides with sufficient stability and photo-stability to be useful in the field (Sauter 
et al. 1995). The first commercial strobilurin fungicides were released in 1996 and 1997 
(Joshi and Sternberg 1996; Bartlett et al. 2002). They now account for 21.4% of fungicide 
applications by active substance treated area on cereals in the UK (Chemicals Regulation 
Directorate 2010) (Figure 1.3), and 19.5% of applications on barley (Garthwaite et al. 2008) 
(Figure 1.2). 
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Figure 1.4. Structures of two QoI fungicides: (a) Azoxystrobin, (b) Pyraclostrobin. 
Resistance was first found in P. viticola in a field trial in 1997 (Heaney et al. 2000). These 
isolates were cross-resistant to strobilurins (azoxystrobin, kresoxim-methyl and 
trifloxystrobin were tested), fenamidone and famoxadone. These fungicides, therefore, were 
placed in the QoI-STAR (Strobilurin Type Action and Resistance) cross-resistance group 
(Heaney et al. 2000), which now includes a further eight strobilurins and the 
benzylcarbamate pyribencarb (FRAC 2010a). Kataoka et al. (2010) suggested that 
pyribencarb may interact with different Qo site domains from other QoIs due to its higher 
activity against B. cinerea strains with target-site resistance to other QoIs, but the resistant 
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isolates still had a resistance factor of 65, and higher EC50 values than most non-target 
organisms. The quinone inside inhibitors (Qils), such as cyazofamid and amisulbrom (FRAC 
201 Oa), inhibit a different region of cytochrome b, and are in a different cross-resistance 
group from the Qols (di Rago et al. 1989). The Qils are used for the control of oomycetes, 
and at present in the UK, they are only registered for use on potatoes (Chemicals Regulation 
Directorate 2010). 
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Figure 1.5. Schematic diagram of the mitochondrial electron transfer chain, including the Quinone 
outside (Qo) site, target site of the Qol fungicides. 
1.3.1 Target-site resistance 
The ability of target-site mutations to confer Qol resistance was shown by di Rago et al. 
(1989), who generated laboratory mutants of Saccharomyces cerevisiae with amino acid 
substitutions including F 129L and G 137R, as well as N256Y and three different substitutions 
at residue 275. Studies of naturally-resistant strobilurin-producing basidiomycetes revealed 
further amino acid changes associated with resistance, including A143 (Kraiczy et al. 1996). 
The G143A substitution, with a change from glycine to alanine encoded by a single 
nucleotide mutation from GGN to GCN at codon 143, was found in a field isolate of B. 
graminis f. sp. tritici collected in 1998, with around a 200-fold reduction in sensitivity to 
strobilurins (Sierotzki et al. 2000b). A study of field isolates of Magnaporthe oryzae found 
some with the G143A substitution, and some with F129L, with G143A conferring around ten 
times the level of resistance conferred by F 129L (Farman 2001). In field populations of 
Pyrenophora tritici-repentis, G143A, F129L and G137R have all been found, with G143A 
21 
conferring the highest level of resistance, and G137R similar to F129L (Sierotzki et al. 2007). 
In P. teres only F 129L has been found so far, and control is still possible using Qols with 
higher activity, such as pyraclostrobin and picoxystrobin (Oxley and Burnett 2010). As of 
January 2010, resistance to Qols had been reported in 39 phytopathogenic fungi and 
oomycetes, including Mycosphaerella graminicola, B. graminis f. spp. hordei and Ramularia 
collo-cygni (FRAC 2010b). 
Target-site resistance emerged rapidly in some pathogens, but has yet to be reported in others, 
raising questions as to why this is the case. Grasso et al. (2006) describe a type I intron 
immediately after codon 143, with the GT of the glycine-encoding GGT codon forming part 
of the splice site, in several rust species and in Alternaria solani. A mutation from GGT to 
the alanine-encoding GCT codon would prevent the intron from self-splicing, making the 
gene non-functional. The G143A substitution has not been found in taxa with this intron. The 
cytochrome b gene of P. teres also contains an intron at this position, whereas P. tritici- 
repentis does not. Accordingly, G143A has emerged in P. tritici-repentis, whereas only the 
F129L substitution has been reported in P. teres (Sierotzki et al. 2007). Monilinia laxa and 
M fructicola also possess this intron, whereas M fructigena does not (Miessner and 
Stammler 2010). In B. cinerea, some isolates have an intron after codon 143, but the G143A 
substitution is found only in isolates lacking this intron (Banno et al. 2009). Possible 
compensatory mutations restoring cytochrome b function in the presence of G143A and an 
intron at codon 143 have recently been reported in laboratory mutants of S. cerevisiae 
(Vallieres et al. 2011). A mutation to restore correct base pairing for intron formation would 
have to take place simultaneously with G143A as either mutation alone would prevent 
splicing, and overexpression of mitochondrial metal ion carriers resulted in other fitness 
penalties, so these mutations are unlikely to emerge in the field, but loss of the intron may be 
possible in the field. 
In species without an intron after codon 143, there may be fitness penalties associated with 
cytochrome b substitutions, due to effects on the structure or function of cytochrome b, such 
as steric hindrance during protein-folding, or impaired quinone-binding or electron transfer 
(Fisher et al. 2004). Di Rago et al. (1989) reported QoI resistant laboratory mutants of S. 
cerevisiae with impaired growth and reduced oxygen consumption. Avila-Adame and KSller 
(2003a) obtained two QoI-resistant strains of Magnaporthe oryzae by in vitro forced 
selection, one with the G143A substitution and another with G143S. The G143A isolate had 
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no apparent fitness costs or reduction in pathogenicity, whereas the G143S isolate had 
reduced sporulation in vitro and in planta. G143S has been reported in laboratory mutants of 
C. beticola, but this has not been found in the field (Malandrakis et al. 2011). Fisher et al. 
(2004) compared the effects of G143A and F129L in yeast cytochrome b with the Qo-site 
altered to resemble that found in a range of species, and fitness penalties were found to be 
species-dependent. For example, G143A was found to be deleterious to protein function in 
the V. inaequalis-like protein, but not in the B. graminis-like protein. F129L did not 
drastically affect the function of either protein. In G143A-Fl29L double mutants, function of 
the V. inaequalis-like protein was markedly reduced, and as G143A alone confers resistance 
to Qols beyond field rates, it is unsurprising that no such double mutants have been reported 
in the field. 
Two studies have shown that the G143A mutation has arisen multiple times within species, 
with at least two independent origins in P. viticola (Chen et al. 2007), and at least four in M 
graminicola (Torriani et al. 2009b). Among M oryzae isolates from ryegrass turf in the 
Eastern USA, G143A was found in five different genetic backgrounds (Kim et al. 2003), and 
in European P. teres isolates carrying F 129L, three different codons for L129 were found in 
field isolates (Sierotzki et al. 2007). 
The mitochondrially-encoded nature of the Qol target site raises the question of how a 
mutation in a single mitochondrion may increase in frequency in the mitochondrial 
population within a cell. Indeed, it was initially suggested that this would be unlikely to 
happen and therefore resistance risk for QoIs was low (Koller et al. 2004). Therefore the 
rapid emergence of Qol resistance in many pathogen species demonstrates that mitochondrial 
mutations can be selected more readily than predicted. Barr et al. (2005) give some examples 
of differential replication rates within intracellular mitochondrial populations, but these relate 
to mutations directly increasing replication rates of the mitochondria themselves, not those 
that benefit the cell as a whole. In addition, there are variations in patterns of mitochondrial 
inheritance between fungal species. In anisogamous species, ascogonium-producing strains 
always act as the maternal parent, contributing organelle DNA to all progeny. However, in 
isogamous, hermaphroditic species such as B. graminis, either isolate can act as maternal 
parent (Robinson et al. 2002). Studies of the spread of mitochondrial mutations mostly focus 
on the accumulation or removal of mutations deleterious to the organism, rather than possible 
selection of beneficial mutations. Nevertheless, such studies do provide evidence that in large 
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populations and under high selective pressure at the organism level, selection at the inter- 
organism level becomes the dominant evolutionary force (Taylor et al. 2002). 
In the apple powdery mildew fungus Podosphaera leucotricha, Lesemann et al. (2006) 
reported widespread G 143A heteroplasmy in the isolates tested. Sensitive isolates contained 
nearly all G143 mitochondria, whereas less-sensitive isolates had varying proportions of 
G143A correlated with resistance. The least sensitive isolates, which were able to infect 
leaves treated with 10 times the recommended field concentration of trifloxystrobin, had 
around 50% G143A mitochondria. In V inaequalis, QoI-resistant laboratory mutants with 
predominantly GCC, the resistant genotype, at codon 143 reverted to predominantly GGC, 
the sensitive genotype, when two generations of selection on fungicide-amended medium 
were followed by growth on fungicide-free medium, showing that some wild-type 
mitochondria had persisted in the intra-cellular population. After eight generations on 
fungicide-amended medium, however, the resistant genotype appeared to have reached 
fixation (Zheng et al. 2000). Furthermore, QoI-resistant field isolates of V. inaequalis 
reported the following year appeared to be homoplasmic for G143A (Koller et al. 2004). 
Sirven et al. (2002) reported stable resistance to QoIs in P. viticola with a frequency of 
resistant cytochrome b alleles of just 2%, which has been cited as an example of 
heteroplasmy. However, sporidial populations were studied, not single-spore isolates, so it is 
not clear whether allele frequencies represent heteroplasmy within isolates or polymorphism 
between them. G143A heteroplasmy has since been reported in several pathogens (Fraaije et 
al. 2002; Ishii et al. 2007; Ishii et al. 2009), with frequency of resistant alleles often 
decreasing after several generations without fungicide, whereas in other species, such as M 
graminicola (Fraaije et al. 2005), only A143 was detected in resistant isolates. 
1.3.2 Alternative oxidase 
Another possible resistance mechanism to strobilurins is target-site circumvention by an 
alternative respiratory pathway, using the alternative oxidase (AOX) as a penultimate 
electron acceptor directly from ubiquinone, which is oxidised at the Q. site in the core 
respiratory pathway (Joseph-Home and Hollomon 2000) (Figure 1.6). 
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Figure 1.6. Schematic diagram of the mitochondrial respiratory electron transfer chain, with the Quinone 
outside pocket of Complex III inhibited by a Qol fungicide, and alternative oxidase acting as penultimate 
electron acceptor. 
Ziogas et al. (1997) describe a laboratory mutant of M graminicola with around a ten-fold 
decrease in azoxystrobin sensitivity that was negated by the addition of salicylhydroxamic 
acid (SHAM), an AOX inibitor. However, respiratory rate was lower for the alternative 
pathway and there was no loss of control in planta. In V. inaequalis, AOX activity gave a 60- 
fold reduction in kresoxim-methyl sensitivity, but again, this was not seen in planta (Olaya et 
al. 1998). The lack of in planta effect may be because AOXis induced by the generation of 
reactive oxygen species (Yukioka et al. 1998), which are inactivated by antioxidant 
compounds such as flavonoids in plant tissue (Mizutani et al. 1996; Tamura et al. 1999). 
Zheng et al. (2000) used flavones to inhibit AOX expression in V. inaequalis, achieving a 
similar synergistic effect to AOX inhibitors such as SHAM. However, laboratory mutants 
with reduced QoI sensitivity but no cytochrome b mutations, consistent with increased AOX 
activity, were also less sensitive to the effects of flavones on QoI sensitivity, demonstrating 
the potential for isolates to evolve which could express A OX in planta. 
Alternatively, the observed ineffectiveness of AOX in planta may be because its effects are 
dependent upon fungal growth stage. AOX-terminated oxidative phosphorylation bypasses 
60% of the proton-pumping activity of the core pathway, so ATP production from 
carbohydrates and oxygen is less efficient, and may be insufficient for more energy-intensive 
or food-limited stages (Wood and Hollomon 2003). Avila-Adame and Köller (2003a) found 
that older (melanised) mycelium of a wild-type M. oryzae isolate was able to grow slowly on 
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azoxystrobin-amended medium even with SHAM added, but younger mycelium and an AOX- 
minus mutant were not. The prevention of growth by AOX gene disruption shows that the 
continued growth of the older wild-type mycelium was due to AOX activity not fully 
inhibited by SHAM. In M oryzae, AOX activity did enable spore germination to occur in the 
presence of a Qol. In fact, spore germination was only reduced by 17% in the presence of 
10µg ml-1 azoxystrobin, whereas hyphal growth was reduced by 66%, compared to over 99% 
of spore germination and hyphal growth with azoxystrobin plus SHAM. However, when 
azoxystrobin-treated barley leaves were droplet-inoculated with M oryzae spores, no 
symptoms developed. Preventative QoI treatment of barley leaves before inoculation was 
effective against both an AOX deletant and a wild-type strain of M oryzae. However, curative 
treatment of leaves colonised with established mycelium was only effective against the AOX 
deletant, and the wild-type isolate continued to grow (Avila-Adame and Köller 2003b). This 
suggests that in wild-type M oryzae, either AOX activity is insufficient for the energetic 
demands of early mycelial growth post-germination, or AOX expression is prevented during 
the early stages of host colonisation. In M graminicola, a laboratory mutant with increased 
AOX activity had reduced in vitro sensitivity but no loss of in planta control (Ziogas et al. 
1997). 
Lower intrinsic QoI sensitivity in F. graminearum than M. nivale is correlated with increased 
oxygen uptake and transcriptional upregulation of the A OX gene in response to azoxystrobin 
in F. graminearum and not in M nivale. The increased oxygen uptake in F. graminearum 
was prevented by the addition of n-propyl gallate, an AOX inhibitor (Kaneko and Ishii 2009). 
Yukioka et al. (1998) reported that AOXtranscript levels increased following the addition of 
a QoI fungicide, but transcript formation appeared constant, suggesting that reduced 
transcript degradation was responsible. However, Mizutani et al. (1996) detected a 40kDa 
protein when alternative respiration was induced by a QoI fungicide, but when AOX 
induction was suppressed by a reactive oxygen scavenger, a 41.3 kDa polypeptide was 
detected, which was converted to the 40kDa protein when the oxygen scavenger was 
removed, suggesting that the induction of AOX activity in that species was due to post- 
translation modification from a precursor to the active form. Analysis of AOX expression in 
Neurospora crassa identified at least four loci required, suggesting a complex regulatory 
pathway is involved (Descheneau et al. 2005). 
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Avila-Adame and Köller (2003a) obtained Qol-resistant isolates of M. oryzae only from older 
mycelium of wild-type isolates, in which AOX enabled growth to continue in the presence of 
azoxystrobin before mutations arose. In younger mycelium and an A OX-minus mutant, 
growth was fully inhibited on the first azoxystrobin-amended plate, and so serial transfers 
were not possible. In contrast, Zheng et al. (2000) only obtained cytochrome b mutants when 
UV mutagenesis was carried out on media with SHAM and kresoxim-methyl combined. 
When carried out with the fungicide alone, only mutants with increased AOX activity were 
obtained, suggesting that the ability to use AOX removed the selective advantage of target 
site mutations which may carry a fitness penalty. However, just 0.1. ig m1 1 kresoxim-methyl 
was used in the SHAM-amended media, but 1. tg ml-1 was used alone, so it is not possible to 
say whether AOX activity would have been sufficient to remove the selection pressure for 
target-site resistance at the higher fungicide dose. It has also been suggested that AOX may 
facilitate the evolution of QoI resistance in the field, as pathogens may continue to grow in 
the presence of a Qol, effectively giving a higher pathogen population under prolonged 
selection by the fungicide (Avila-Adame and Köller 2003a; Miguez et al. 2004). 
Furthermore, it has been suggested that since inhibition of cytochrome bcj results in 
increased levels of reactive oxygen species (Mizutani et al. 1996), growth under these 
conditions may result in an elevated mutation rate of mitochondrial DNA (Avila-Adame and 
Köller 2003a). 
There have also been reports of reduced Qol sensitivity linked to active efflux of the 
fungicide out of fungal cells by membrane transported proteins. Azoxystrobin-adapted 
isolates of P. tritici-repentis generated by serial transfer on fungicide amended medium 
showed increased efflux of a fluorescent substrate, and returned to Qol-sensitivity on the 
addition of a transporter inhibitor (Reimann and Deising 2005). Aspergillus nidulans strains 
transformed with an overexpression construct of ABC transporter atrB had decreased 
sensitivity to a range of fungicides including kresoxim-methyl (Andrade et al. 2000). 
Roohparvar et al. (2008) report field strains of M. graminicola with increased expression of 
major facilitator MgMFS1 and a further decrease in QoI sensitivity in addition to that 
conferred by G143A target-site resistance. There are also some cases of Qol resistance where 
the mechanism is not yet known, such as isolates of Podosphaera fusca resistant to Qols even 
in the presence of SHAM, but with no mutations in the Qo site encoding region of the 
cytochrome b gene correlated with QoI resistance (Femandez-Ortuno et al. 2008). 
27 
Up until 2008, extensive monitoring of R. secalis did not find any target-site resistance 
(Torriani et al. 2009a). Rhynchosporium secalis field isolates resistant to Qols and carrying 
the G143A mutation were found at one site in France in 2008 (FRAC Qol Working Group 
2008). However, G143A has not yet been reported in R. secalis from any other location, and 
was not found again in France in 2009 or 2010 (FRAC Qol Working Group 2009; FRAC Qol 
Working Group 2010). McCartney (2006) identified R. secalis isolates in which in vitro 
azoxystrobin EC50 was increased around ten-fold. There were no target-site mutations, and 
the decrease in sensitivity was negated by the addition of AOX inhibitors SHAM and propyl- 
gallate, suggesting that AOX was involved, but this was not investigated at the molecular 
level. 
1.4 Triazoles 
The triazoles (Figure 1.7) are demethylation inhibitor (DMI) fungicides, along with the 
imidazoles and heterocyclic DMIs (pyrimidines, pyridines and piperazines) (FRAC 2010a). 
They inhibit the14a-demethylation step in sterol biosynthesis (Sherald and Sisler 1975; 
Buchenauer 1977). As such, DMIs fall into the wider fungicide class of sterol biosynthesis 
inhibitors (SBIs), along with the morpholines and hydroxyanilides, which inhibit different 
stages in sterol biosynthesis and are therefore in different cross-resistance groups (FRAC 
2010a). 
The first DMI fungicide, the piperazine triforine, was introduced in 1969 (Schicke and Veen 
1969). The first imidazole, imazilil, was introduced in 1972, and the first triazole, 
triadimefon, was introduced in 1973 (Schultz and Scheinpflug 1988). In 2008, triazoles 
represented 47% of UK cereal crop fungicide treatments by active substance treated area 
(Chemicals Regulation Directorate 2010) (Figure 1.3), and 41.6% of active substance treated 
area on UK barley (Garthwaite et al. 2008) (Figure 1.2). Furthermore, on UK barley in 2008, 
60.9% of QoI applications, 62.1% of morpholine applications, 57.6% of MBC applications 
and 100% of SDHI applications by active substance treatment area were in a mixture 
containing a triazole (Garthwaite et al. 2008) (Figure 1.2). 
Azoles (triazoles and imidazoles) are also used as clinical anti-fungal drugs. Initially, azoles 
were developed for topical treatments of superficial infections, and no resistance was 
reported in over fifteen years (Plempel and Berg 1988). However, since the introduction of 
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azoles for long-term systemic treatment of opportunistic pathogens such as Candida spp. and 
Aspergillus spp. in immunocompromised patients, there have been many reports of resistance 
by various mechanisms (Edlind 2008), some of which are common to pathogens of humans 
and plants. 
Some triazoles, including tebuconazole and propiconazole, are also used as plant growth 
regulators, due to their inhibition of ABA 8'-hydroxylase, a cytochrome P450 involved in 
abscisic acid catabolism in plants (Kitahata et al. 2005). 
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Figure 1.7. Structures of four triazole fungicides: (a) propiconazole, (b) tebuconazole, (c) epoxiconazole, 
(d) prothioconazole. 
1.4.1 Mode of action 
Triazoles and other DMIs inhibit the 14a-demethylation of lanosterol or eburicol (2- 
methylene-dihydrolanosterol) in sterol biosynthesis (Sherald and Sisler 1975; Buchenauer 
1977) (Figure 1.7). Sterol 14a-demethylase is encoded by the gene CYP51 (also known as 
Erg] 1 due to its role in ergosterol biosynthesis), and is a member of the cytochrome P450 
family of proteins (Lepesheva and Waterman 2007). 
The main sterol in most fungi is ergosterol, a key component of cell membranes, which is 
synthesised de novo in fungi from acetyl CoA (Paltauf et al. 1992). Treatment with DMIs 
results in a decrease in ergosterol levels, and an accumulation of sterol intermediates 
including 2-methylene-dihydrolanosterol and obtusifoliol, and the aberrant sterol 14a-methyl- 
A8,24(28)-ergostadienol (14-methyl-3,6-diol), formed by the metabolism of 14-methylfecosterol 
by sterol 5,6 desaturase (Ragsdale and Sisler 1973; Kato et al. 1980) (Figure 1.8). The sterol 
14-methyl-3,6-diol is toxic and cannot properly fulfil the function of ergosterol in cell 
membranes (Kelly et al. 1995). 
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The effects of CYP51 inhibition on sterol composition varies between species. In R. secalis, 
the proportion of ergosterol was not reduced by the addition of azole fungicides, but sterol 
intermediates downstream of 14a-demetylase were reduced, suggesting that later steps may 
have been upregulated, although total growth was reduced so the absolute level of ergosterol 
was lower (Kwok and Loeffler 1993). In R. secalis, addition of triadimenol, propiconazole or 
prochloraz resulted in an increase in [U-14C] acetate incorporation into total sterols and in 
particular lanosterol, the substrate of CYP5 1, confirming 14a-demethylase as the site of 
action (Kendall and Hollomon 1990). 
Although all DMIs share the same mode of action, cross-resistance is incomplete and 
complex (Kendall 1986), so as efficacy of older products has been eroded, new products have 
provided effective control (Klix et al. 2007). In some cases, as sensitivity to older products 
has declined, no significant cross-resistance has been found with newer products (Robbertse 
et al. 2001). In other cases, resistance has been correlated, but is quantitatively far lower for 
new products (Girling et al. 1988; Kendall et al. 1993). Furthermore, cross-resistance may 
depend on products used. Robbertse et al. (2001) found that the use of triadimenol as a seed- 
treatment selected for decreased sensitivity to triadimenol in particular, but when triadimenol 
and tebuconazole were used together as foliar treatments, isolates less sensitive to both 
triadimenol and tebuconazole were found, suggesting that different mutations or different 
mechanisms were responsible. 
In some cases, triazoles have been found to show no or negative cross-resistance with some 
imidazoles (Kendall et al. 1993; Mavroeidi and Shaw 2005). For example, the I381 V CYP51 
substitution in M graminicola results in reduced sensitivity to tebuconazole but increased 
sensitivity to prochloraz (Fraaije et al. 2007). However, the S524T substitution confers 
reduced sensitivity to all tested triazoles and to prochloraz (Cools et al. 2011). Conflicting 
results have been obtained for other pathogens. For example, following studies of C. beticola, 
Karaoglanidis and Thanassoulopoulos (2003) place DMIs into different cross- 
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Figure 1.8. Ergosterol biosynthetic pathway from lanosterol onwards, showing the effect of azole 
fungicides (Paltauf et aL 1992; Kelly et al. 1995). 
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resistance subgroups, some containing a mixture of chemical classes (triazoles, imidazoles 
and pyrimidines). This is because the chemical groups are delineated by the nature of the 
heterocyclic ring (Uesugi 1998), whereas side chain substituents, which vary within each 
group, also affect target-site binding because the chemical groups are delineated by the nature 
of the heterocyclic ring (Uesugi 1998), whereas side chain substituents, which vary within 
each group, also affect target-site binding (Ito et al. 2005). Patterns of cross-resistance also 
depend on the resistance mechanisms involved. Reported resistance mechanisms against 
triazoles are target site mutations, target site over-expression, active efflux and altered sterol 
metabolism. 
1.4.2 Target-site mutations 
In contrast to the single-site, qualitative resistance to benzimidazoles and QoIs, target-site 
resistance to triazoles involves multiple mutations with varying and interacting effects. 
For example, amino acid substitutions S405F, G464S, and R467K, found in clinical isolates 
of Candida albicans, each reduced fluconazole and ketoconazole sensitivity by a factor of 
four but itraconazole only by a factor of two, whilst substitution Y132H decreased 
itraconazole, fluconazole and ketoconazole sensitivity by factors of two, four and 16, 
respectively (Edlind 2008). Over 140 predicted CYP51 amino acid substitutions have been 
reported in clinical isolates of C. albicans, although not all have been directly linked to 
quantified resistance factors and there is extensive polymorphism even within sensitive 
isolates (Morio et al. 2010). 
In the plant pathogen M graminicola, 19 target-site mutations have so far been identified 
(Cools et al. 2010), most of which have small but additive effects on triazole sensitivity 
(Leroux et al. 2007; Cools and Fraaije 2008). However, the I381 V substitution in M 
graminicola (Fraaije et al. 2007), as well as Y136F in Uncinula necator (Delye et al. 1997), 
and K147Q in B. graminis f. sp. hordei (Wyand and Brown 2005), are associated with higher 
levels of resistance to particular compounds (tebuconazole; triadimenol; and triadimenol and 
propiconazole, respectively). Other mutations in M graminicola include Y137F, found as the 
sole change in isolates with specific resistance to triadimenol; substitutions at at codons 459- 
461, or the deletion of codons 459-460; V 136A, found in combination with changes at 
codons 459-461 but not with 1381V; and A379G, found in combination with 1381V in the 
least sensitive isolates (Leroux et al. 2007; Cools and Fraaije 2008). The specific 
combinations of changes may reflect the evolutionary origins of the different mutations 
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(Brunner et al. 2008) or structural constraints to maintain enzyme activity (Bean et al. 2009; 
Cools et al. 2010). Substitutions equivalent to Y136F, codon 459 or 461 substitutions and 
A311 G have been found in the related plant pathogen Mycosphaerella fijiensis, in isolates 
with a 4- to 20-fold reduction in propiconazole sensitivity. However, the involvement of non- 
target-site mechanisms in addition to these substitutions prevented the calculation of the 
contribution of each mutation to reduced sensitivity (Canas-Gutierrez et al. 2009). 
In the cereal eyespot fungi Oculimacula acuformis and O. yallundae, phytopathogenic fungi 
closely related to R. secalis (Goodwin 2002; Crous et al. 2003), O. acuformis is naturally less 
sensitive to triazoles than O. yallundae, but sensitivity has decreased in both species, and 
CYP5J is highly polymorphic (Albertini et al. 2003). With 14 species-specific amino acid 
substitutions, and 15 other amino acid substitutions in 27 isolates between the two species, 
individual substitutions were not definitively linked to differences in sensitivity, but 
comparisons with any mutations found in R. secalis could prove informative. 
Some filamentous ascomycetes carry two paralogous CYP51 genes. This was first observed 
in Aspergillusfumigatus, in which the two genes were designated CYP51A and CYP51B 
(Mellado et al. 2001). Subsequently, clinical isolates with reduced azole sensitivity were 
found to possess mutations (Diaz-Guerra et al. 2003; Mellado et al. 2004), or a different 
mutation accompanied by tandem repeats in the promoter region leading to over-expression 
(Mellado et al. 2007), in the CYP5JA paralogue. Furthermore, knocking out CYP51A by gene 
disruption resulted in decreased azole sensitivity in sensitive as well as less-sensitive isolates, 
suggesting that the presence of the second copy may confer reduced intrinsic sensitivity 
(Mellado et al. 2005). 
1.4.3 Target-site over-expression 
Target site over-expression may result in reduced sensitivity to azoles, by reducing the ratio 
of fungicide to target site molecules (Hamamoto et al. 2000). Field isolates of V. inaequalis 
with reduced triazole sensitivity but no associated target-site changes had a 533-bp insertion 
upstream of the CYP51 gene corresponding to increased CYP51 expression (Schnabel and 
Jones 2001). Hamamoto et al. (2000) reported field isolates of Penicillium digitatum with 
reduced triazole sensitivity, but no mutations to the CYP51 coding region, containing a 126- 
bp section of the promoter region that was tandemly repeated five times, resulting in 
constitutive CYP51 expression around 100 times higher than sensitive isolates. Ghosoph et al. 
34 
(2007) reported another CYP51 promoter aleration in P. digitatum, comprising a 199-bp 
insert within the single copy of the 126-bp promoter region, with around a tenfold increase in 
constitutive CYP51 expression measured for either modification. In recent clinical isolates of 
A. fumigatus, over-expression was linked to a single tandem repeat in the CYP51 promoter 
region, but this only conferred a marked decline in sensitivity in combination with an L98H 
substitution (Mellado et al. 2007). Field isolates of Blumeriellajapii with reduced sensitivity 
to fenbuconazole overexpressed CYP51 five- to 12-fold compared to sensitive isolates, and 
the promoter regions of these isolates contained inserts of varying lengths but all with a 
common 2120-bp section (Ma et al. 2006). Constitutive CYP51 overexpression correlated 
with reduced azole sensitivity has also been reported in C. beticola (Nikou et al. 2009) and 
Puccinia triticina (Stammler et al. 2009), but the promoter regions have not been studied. In 
field isolates of M fructicola, a repetitive insertion 117 base pairs upstream of the start of the 
CYP51 coding region has been linked to a ten-fold increase in CYP51 expression (Luo and 
Schnabe12008). 
In some clinical isolates of C. albicans in which reduced azole sensitivity was correlated with 
increased CYP51 expression, mutations were found in the transcription factor encoding gene 
Upc2p. This transcription factor is involved in the upregulation of CYP51 and other genes in 
the sterol biosynthesis pathway in response to ergosterol depletion, whereas gain of function 
mutations, resulting in substitutions G648D (Dunkel et al. 2008) and A643T (Heilmann et al. 
2010), lead to constitutive upregulation of these genes. 
There have also been reports in Candida spp. of chromosome or chromosome arm 
duplications resulting in increased expression of CYP51. Whole-chromosome duplication has 
been reported in C. glabrata, where it was associated with increased CYP51 transcript levels 
and reduced intracellular levels of fluconazole (Marichal et al. 1997). In C. albicans, 
(Selmecki et al. 2006) report clinical isolates in which reduced fluconazole sensitivity is 
associated with a partial duplication of chromosome 5 to form an isochrome comprising two 
copies of the left arm, chr5L, rather than a left arm and a right arm. Genes on chr5L include 
CYP51, as well as two efflux pump encoding genes and one ABC transporter transcription 
factor, TAC1, and expression of these genes was higher in strains with isochromosome 5L. 
Successive deletions of individual copies of each of the four genes were carried out. Copy 
number of the two efflux transporter encoding genes did not affect fluconazole sensitivity, 
whereas CYP51 and TAC1 had independent, additive effects, with each extra copy of either 
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gene leading to a doubling of fluconazole MIC (minimum inhibitory concentration) 
(Selmecki et al. 2008). 
In Cryptococcus neoformans, reduced azole sensitivity has been associated with disomy, a 
full extra copy in the haploid genome, of chromosome 1, containing CYP51 and ABC 
transporter encoding gene AFR1. A proportion of isolates with disomic chromosome 1 were 
found in the progeny of sensitive isolates and selected in the presence of azoles, but the 
disomic chromosomes were subsequently lost from the population during serial transfers on 
fungicide-free medium. The effect of chromosome 1 disomy was partly mimicked by the 
insertion of a second copy of CYP51 on a different chromosome, but also reduced by the 
deletion of AFRI, showing that both genes contributed to reduced azole sensitivity (Sionov et 
al. 2010). 
1.4.4 Enhanced efflux 
In other cases, reduced fungicide sensitivity has been linked to ATP-dependent reduction in 
the intracellular fungicide concentration (de Waard and van Nistelrooy 1980). This has been 
attributed to active efflux by ATP-binding cassette (ABC) transporter proteins (Balzi et al. 
1994). Resistance due to ABC transporters is also be referred to as multidrug resistance 
(MDR) or pleiotropic drug resistance (PDR), sometimes according to the topology of the 
ABC transporter involved, with the transmembrane domain or the ATP-binding domain at the 
N-terminal of MDR and PDR proteins, respectively (de Waard et al. 2006). Another group of 
proteins involved in active efflux of fungicides is the major facilitator superfamily (MFS) 
(Tenreiro et al. 2000), which do not bind ATP but depend on protein-motive force (Del Sorbo 
et al. 2000). 
In clinical C. albicans isolates, ABC transporters confer cross-resistance to multiple triazoles, 
whilst the MF transporter MDRI confers specific resistance to fluconazole (Sanglard and 
Odds 2002). In A. fumigatus, 278 MF and 49 ABC transporters have been identified. So far, 
genes atrF, AfumDMR3 and AfumDMR4 have been linked to reduced triazole activity, with 
increased constitutive expression, or induced expression on exposure to itraconazole, in 
isolates with a high level of itraconazole resistance (Da Silva Ferreira et al. 2005). 
The role of efflux transporter gene expression in drug resistance has prompted work on the 
regulatory pathways involved (Hiller et al. 2006). In the model organism S. cerevisiae, 
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mutations in the transcriptional regulator locus PDR1 result in over-expression of three ABC- 
transporter proteins, leading to multi-drug resistance (Carvajal et al. 1997). In C. albicans, 
the transcription factor TACT regulates the ABC transporters CDR1 and CDR2, and some less 
sensitive isolates have a gain-of-function mutation (Coste et al. 2006) or duplication of the 
chromosome arm carrying this gene (Selmecki et al. 2006), whereas gain of function 
mutations in transcription factor MRR1 resulted in constitutive overexpression of major 
facilitator gene MDR] (Morschhauser et al. 2007), although TACT and MRRI also regulate 
other genes that may be involved in cellular stress responses (Cowen and Steinbach 2008). 
In some clinical C. albicans, constitutive overexpression of the ABC transporter CDR1 in 
isolates with reduced azole sensitivity was partly due to increased transcription, but also to 
increased transcript stability (Manoharlal et al. 2008). This was subsequently found to be due 
to hyperadenylation of CDR] transcripts. CDR1 hyperadenylation correlated with poly(A)- 
polymerase 1 (PAPI) genotypes, comprising PAPI a-PAPI a in sensitive isolates and PAPI a- 
PAPI a in resistant isolates. Deletion of PAPI a from sensitive isolates results in reduced 
azole sensitivity, suggesting that PAP] a has a negative regulatory effect on poly(A)- 
polymerase 1, and the loss of this allele in less sensitive isolates results in hyperadenylation 
of CDR] transcripts (Manoharlal et al. 2010). 
In plant pathogens, over-expression of an ABC transporter has been identified in field isolates 
of P. digitatum with reduced triazole sensitivity (Nakaune et al. 1998). In laboratory mutants 
of B. cinerea showing cross-resistance to oxpoconazole, tebuconazole and prochloraz, 
constitutive and induced expression of the ABC transporter encoding gene BcatrD was 
negatively correlated with azole sensitivity (Hayashi et al. 2001). BcatrD deletion increased 
azole sensitivity, and overexpression resulted in further reductions in sensitivity (Hayashi et 
al. 2002). In other cases, identifying specific ABC transporters with a clear link to changes 
in sensitivity has proven more elusive. Zwiers et al. (2002) reported one laboratory isolate of 
M graminicola with reduced azole sensitivity in which ABC transporter MgAtrl was 
constitutively overexpressed, and deletion of this gene restored wild-type sensitivity. 
However, in other isolates, reduced azole accumulation was not linked to expression changes 
in ABC transporter encoding genes MgAtr1-MgAtr5. In M graminicola field isolates with a 
range of azole sensitivities, constitutive MgAtr expression also varied, and MgAtr4 
expression was induced by cyproconazole, but expression of these genes was not correlated 
with azole sensitivity (Stergiopoulos et al. 2003). Isolates of P. tritici-repentis described as 
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showing reduced sensitivity to QoI fungicides due to efflux transporters were also cross- 
resistant to azoles, with sensitivity increased by the addition of efflux inhibitors (Reimann 
and Deising 2005), but the transporters responsible were not identified. 
In addition to increased efflux, Mansfield et al. (2010) recently reported clinical isolates of C. 
albicans with reduced azole uptake. They present evidence of azole uptake taking place by 
facilitated diffusion, rather than active transport or passive diffusion, since uptake is 
unaffected in de-energised cells or efflux pump knockout strains, but does not take place in 
heat-killed cells, and uptake can reach saturation. Similar results were obtained for Candida 
krusei, S. cerevisiae and C. neoformans, but no filamentous ascomycetes and no plant 
pathogens were investigated. All triazole and imidazole fungicides tested appeared to use the 
same uptake mechanism, whereas other unrelated fungicides did not. They suggest that 
mutations leading to loss or loss-of-function of the protein responsible for facilitated 
diffusion of azoles may be found in C. albicans isolates with reduced uptake, but the protein 
involved has not yet been identified. 
1.4.5 Altered sterol biosynthesis 
Another possible means of reduced triazole sensitivity involves alterations in enzyme activity 
downstream of sterol 14 a-demethylase in the sterol biosynthetic pathway, producing 
alternative sterols that are non-toxic and partially functional in cell membranes. In particular, 
the presence of the 14-methyl group impairs the function of sterol 5,6-desaturase, resulting in 
the addition of a 4-methyl group (Kelly et al. 1995). It has been shown that a 14a-methyl 
group does not directly destroy membrane function, but a 4-methyl group does (Debieu et al. 
1998). 
Two fluconazole-resistant laboratory mutants of S. cerevisiae were found to have reduced 
sterol C5-6 desaturase (Erg3) activity, preventing accumulation of toxic 14-methyl-3,6-diol, 
and accumulation instead of 14a-methyl fecosterol (Watson et al. 1989) (Figure 1.8). A 
similar mutation restored aerobic growth in CYP51 deletants (under anaerobic conditions, 
yeast is able to take up exogenous ergosterol), again resulting in accumulation of 14a-methyl 
fecosterol instead of 14-methyl-3,6-diol (Kelly et al. 1995). This mechanism was 
subsequently reported in clinical C. albicans isolates (Chau et al. 2005). These isolates had 
azole MICs over 100-fold greater than sensitive isolates, correlated with internal stop codons 
in Erg3, and accumulated 14a-methylfecosterol instead of 14-methyl-3,6-diol. The changes 
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were reversed by complementation with a wild-type Erg3. There was some evidence of 
reduced virulence, as mice infected with erg3 mutant isolates survived longer than those 
infected with wild-type isolates, although tissue colonisation levels after 24 hours were 
similar and the isolates had been obtained from a patient following failure of azole treatment. 
In C. glabrata, Geber et al. (1995) found that Erg]] deletants were aerobically inviable 
whereas Erg3-Erg] 1 double deletants were viable. However, they also obtained spontaneous 
mutants of Erg] l deletants which were aerobically viable, but Erg3 was expressed and 
contained no mutations. These mutants primarily accumulated lanosterol and obtusifoliol, 
suggesting loss of function or downregulation of genes involved in a different step in the 
conversion of lanosterol to ergosterol. 
Azole tolerance in Erg3 loss-of-function mutants depends on calcineurin-Hsp90 signalling, a 
pathway involved in responses to cell wall and membrane stress, and full sensitivity is 
restored in double mutants lacking both Erg3 and components of this pathway (Cowen et al. 
2006). Subsequent studies have identified further components of the signalling pathway, 
including protein kinases Pkcl and MAPK (LaFayette et al. 2010). So far, these mechanisms 
have only been reported in laboratory and clinical isolates of Candida spp. and laboratory 
mutants of S. cerevisiae. 
1.4.6 Resistance in R. secalis 
Triadimenol, the first triazole to be recommended for winter barley in the UK, was 
introduced in the mid-1970s (Morris et al. 1977). Field strains of R. secalis with a 16-fold 
range in sensitivity to triadimenol were isolated in 1975-1981, but no loss of control was 
reported, and no differences in sensitivity were observed between isolates from azole-treated 
and untreated crops (Hollomon 1984). The potential for resistance development in R. secalis 
populations against the triazoles triadimenol and propiconazole, and the imidazole 
prochloraz, was demonstrated in glasshouse tests reported in 1986 (Hunter et al. 1986). 
Spores were transferred four times onto successive plants treated with the same fungicide, 
after which isolates showed over a thirty-fold shift in sensitivity to that fungicide (cross- 
resistance between fungicides was not tested). At that point, however, there were still no 
reports of loss of control in the field. This is in contrast to the barley pathogen B. graminis 
f. sp. hordei, in which reduced triazole sensitivity was reported in 1981, with a survey of 
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England, Wales and Scotland finding 53% of isolates were insensitive (Fletcher and Wolfe 
1981). 
A survey in England and Wales in 1987 found that triadimenol sensitivity in R. secalis 
populations, as determined by the in vitro sensitivity of 464 isolates, had declined from levels 
recorded in 1981(Jones 1990). A subsequent survey in south-west England in 1989 found that 
triadimenol sensitivity had declined further, with an increase in both the highest MIC 
recorded and the proportion of isolates with higher MIC values, and propiconazole sensitivity 
had also declined. Triadimenol sensitivity followed a bimodal distribution, with cross- 
resistance against propiconazole, but propiconazole was still effective at lower concentrations 
than triadimenol, and propiconazole or prochloraz gave good field control (Jones 1990). 
More detailed studies of eight isolates confirmed positive cross-resistance between 
triadimenol and propiconazole, but no clear cross-resistance to prochloraz (Kendall and 
Hollomon 1990). Studies with [U-14C] found lanosterol accumulation after azole treatment in 
all isolates, although a higher fungicide dose was required in less sensitive isolates. There 
was no evidence of metabolism or decreased uptake of the fungicides in less sensitive 
isolates, with ['4C] triadimenol uptake similar in all isolates and all subsequently recovered as 
unmetabolised triadimenol, so it was suggested that target-site mutations may be responsible. 
A four-year UK-wide survey of field isolates from 1987-1990 reported similar results: 
triadimenol sensitivity followed a bimodal distribution, with mean MIC 40-fold higher in 
1990 than in 1975-1981, and propiconazole sensitivity followed a unimodal distribution, with 
an eightfold shift from 1987-1990 (Kendall et al. 1993). In 1990, tebuconazole sensitivity 
was also measured, and found to be positively correlated with triadimenol and propiconazole 
sensitivity. There was no significant correlation with sensitivity to the imidazole prochloraz. 
By 1990, triadimenol no longer provided field control , and control by propiconazole alone 
was reduced, but a propiconazole-carbendazim mixture or tebuconazole were effective 
(Kendall et al. 1993). In 1993-1994, MBC resistance in R. secalis was threatening the 
performance of DMI-carbendazim mixtures, but propiconazole, alone or with carbendazim, 
gave good disease control in field trials in Northern Ireland, even where control failed with 
carbendazim alone (Taggart et al. 1998). 
In 1996-1998, new fungicides showed some promise against R. secalis, with the new triazole 
epoxiconazole and new mixing partners in the form of QoIs and cyprodinil introduced to the 
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market (Jones et al. 2000). However, in field trials in Northern Ireland and south west 
England in 1998-2000, epoxiconazole use resulted in sensitivity shifts, both between pre- and 
post-treatment isolates and between years, although epoxiconazole continued to provide yield 
benefits and some visible disease control in the field, especially in combination with 
azoxystrobin or cyprodinil (Cooke et al. 2004). By 2002, sensitivity shifts to epoxiconazole 
were reported in field isolates of R. secalis. Sensitivity of the population appeared to be 
moving towards a bimodal distribution in 2000-2002, with an increase in isolates with higher 
MICs (Oxley et al. 2003). By 2005-2007, epoxiconazole sensitivity had declined, especially 
in northern Scotland, but it was generally still moderately effective (Oxley et al. 2008). 
Prothioconazole had been introduced and was proving highly effective against R. secalis. 
Sensitivity shifts were observed when prothioconazole was used alone, with some evidence 
of cross-resistance with epoxiconazole (Oxley et al. 2008), but in general prothioconazole 
sensitivity appeared stable from 2005-2008 (Oxley and Hunter 2009). 
Studies in other countries have also found successive declines in sensitivity to various 
triazole fungicides. In New Zealand, Sheridan and Nendick (1989) obtained R. secalis 
isolates with reduced triadimenol sensitivity from a field trial in 1988-1989, and disease 
control by triadimenol seed treatment or foliar spray was reduced, but cyproconazole seed 
treatment and propiconazole sprays were effective. In South Africa, Robbertse et al. (2001) 
reported isolates collected in 1993-1995 with significantly reduced sensitivity to triadimenol, 
propiconazole, flusilazole and tebuconazole compared to `wild-type' isolates collected from 
an untreated field in a predominantly wheat-growing region. Triadimenol sensitivity was 
further reduced in 1995 compared to 1993-1994, a shift which the authors attributed to the 
heavy use of triadimenol as a seed treatment. Also, tebuconazole sensitivity was lower in 
isolates collected from two sites where barley had been grown and treated with tebuconazole 
every year for five and six years, but otherwise triazole sensitivity fluctuated between years. 
Current HGCA monitoring in the UK has reported reduced azole sensitivity in R. secalis, 
with higher doses required for control of less sensitive strains, although sensitivity is higher 
in Northern Ireland (Blake et al. 2011). Prothioconazole and higher doses of epoxiconazole 
still provide disease control (Blake et al. 2011), although curative activity of epoxiconazole is 
reduced so this azole may now be more useful as a protectant (Oxley and Burnett 2010), and 
shifts in sensitivity to prothioconazole when used alone (Oxley et al. 2008) mean chemical 
diversity is important and there is a need for reistance monitoring and management. 
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In summary, QoI and triazole fungicides are important in the control of R. secalis. For the 
Qols, a single case of target site resistance has been reported, so continued monitoring is 
needed. Furthermore, the role of AOX in reduced QoI sensitivity merits further investigation. 
In the case of the triazoles, previous studies have reported sensitivity shifts to different 
compounds, but the resistance mechanism is not yet known. Further sensitivity testing is 
needed to clarify the sensitivity shifts that may have occurred over time against different 
triazoles, using a consistent sensitivity assay method in order to obtain comparable results. 
Identifying the molecular mechanism or mechanisms underlying triazole sensitivity shifts in 
R. secalis would enable molecular diagnostics to be developed. 
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1.5 Aims of current work 
This project aims to optimise culture conditions and develop a high-throughput fungicide 
sensitivity assay for R. secalis, in order to assess the Qol and triazole sensitivity of a range of 
older and recent isolates. 
In the case of the Qols, isolates will be screened for sensitivity shifts due to target-site 
mutations or AOX. The cytochrome b gene will be sequenced from a range of isolates to look 
for target-site mutations. The effect of AOX will be assessed through the use of AOX 
inhibitors, and analysis of AOX gene sequences and expression levels. 
Isolates will also be screened for sensitivity shifts to a range of azole fungicides. The CYPSJ 
genes will be sequenced from a range of isolates to determine whether sensitivity shifts 
correlate with target-site mutations. A possible role of efflux transporters in azole sensitivity 
will also be tested through the use of efflux inhibitors. 
The occurrence of multiple CYP51 paralogues in fungal genomes will be surveyed through 
bioinformatic and phylogenetic methods. The role of multiple CYP51 paralogues in azole 
sensitivity in R. secalis will be investigated. Assays will be developed to detect CYP51 
paralogues in R. secalis isolates, expression analysis of the CYP51 genes will be carried out, 
and a pyrosequencing assay will be used to investigate the occurrence of CYP51 paralogues 
in R. secalis populations from the Hoosfield spring barley experiment. 
Elucidation of the methods responsible for altered fungicide sensitivity in R. secalis and 
investigation of their occurrence will help to inform future fungicide use and resistance 
management, as well as providing fundamental insights into the evolution of fungicide 
resistance and the adaptive potential of R. secalis populations. 
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Chapter 2 
Method development: R. secalis culture conditions and fungicide 
sensitivity assay 
2.1 Introduction 
Assessing the occurrence of fungal strains with reduced sensitivity and investigating the 
molecular mechanisms responsible requires accurate measurements of the fungicide 
sensitivity of individual isolates. An in vitro fungicide sensitivity bioassay can be used to 
determine the fungicide concentrations required to inhibit growth of fungal isolates. 
Most previous studies of fungicide sensitivity in R. secalis have used agar media amended 
with a range of fungicide concentrations. Some methods have used agar slants in test tubes, 
which are inoculated with spores and the Minimum Inhibitory Concentration (MIC) assessed 
as the lowest fungicide concentration at which no growth occurs (Hollomon 1984). Other 
methods use agar in petri dishes or 24-well plates, on which a mycelial disc is placed. MIC 
may be assessed as the lowest concentration at which no growth occurs, as for agar slants, 
Kendall et al. (1993), or the Effective Concentration at which growth is reduced by 50% (the 
EC50) may be assessed based on measurements of colony diameter (Sierotzki and Morchoisne 
2006). 
In other species, fungal growth has been assessed by optical density, measuring turbidity by 
passing light through a liquid culture. Georgopoulos and Sisler (1970) compared U. maydis 
growth in liquid culture in microtubes with and without fungicide. They subsequently 
measured growth at a range of fungicide concentrations and generated a dose response curve, 
but each fungicide concentration had to be set up and read in a separate tube, limiting the 
number of isolates that could be tested (Georgopoulos et al. 1972). In 1978, the first 96-well 
microplate reader was introduced, initially for ELISA (Enzyme-linked immunosorbant assay) 
plates (Thermo Scientific 2008). In 1982, Genta et al. (1982) reported using a microplate 
reader for a microtitre sensitivity assay for bacteria, and in 1986, Drouhet et al. (1986) 
described the use of this assay for a range of clinical pathogenic fungal species, including C. 
albicans, C. neoformans and A. fumigatus. The assay used is based on serial dilutions of 
fungicide in liquid growth media. Fungal isolates are then grown in 96-well microtitre plates 
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with a concentration series of fungicide-amended medium. Fungal growth is assessed by 
optical density readings, or with fluorescent metabolic indicators, using an automated plate 
reader. Dose-response curves are fitted, and MICs calculated. This method has also been 
developed for M graminicola, for which EC50 values were calculated from the dose-response 
curves (Pijls et al. 1994; Fraaije and Cools 2006). This assay is preferable to those previously 
used for R. secalis. The 96-well format is suitable for high-throughput screening of large 
numbers of isolates, EC50 values reflect the point at which the majority of fungal growth is 
inhibited whereas MICs may be elevated when low levels of residual growth occur, and the 
automated reading of plates removes the need for subjective judgements in assessing fungal 
growth by eye. 
The liquid-media based sensitivity bioassay requires spores as inoculum. Therefore it was 
necessary to optimise growth conditions of R. secalis in culture for conidia production. 
Previous authors have noted that R. secalis grows slowly in culture (Brooks 1928; Caldwell 
1937; Schein and Kerelo 1956). A range of different growth media have been used. Caldwell 
(1937) tried agar media containing barley leaf decoction, potato or corn meal with and 
without dextrose, lima bean, oatmeal and malt extract, of which the fastest growth was 
observed on potato dextrose agar. Lebedeva (2005) reported the fastest growth in colony 
diameter on yeast potato sucrose agar, followed by potato sucrose agar, oatmeal agar, carrot 
dextrose, Czapek dox and finally water agar. Cooke et al. (2004) used malt yeast agar to 
isolate R. secalis, Czapek dox agar with mycological peptone for subculturing and yeast 
glucose medium for fungicide sensitivity testing. 
Skoropad (1966) noted that when R. secalis grows saprophytically on barely debris, 
conditions conducive to sporulation did not result in greater hyphal growth. Similar 
observations had been made in culture by Schein and Kerelo (1956), who noted that only 
slow hyphal growth and small colonies were obtained on the media producing the highest 
spore yields, whereas potato dextrose agar, which previous studies reported as giving good 
growth, produced very low spore yields. Therefore conditions must be optimised for spore 
production without excessive hyphal growth, to produce suitable inoculum for an optical 
density-based sensitivity assay. 
Rhynchosporium secalis growth is also temperature-dependent. Bartels (1928) found the 
optimal growth temperature to be 19-21°C, with a minimum temperature of 2-3°C and a 
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maximum of 30-31 °C. Caldwell (1937) recorded maximum growth at temperatures of 18- 
21 °C. The minimum temperature for germination and growth was 2-4°C. The maximum 
temperature was 28-30°C, with spores in water rupturing above 30°C, but growth rates 
dropped rapidly as temperature increased above 21 °C. Subsequent studies have reported 
similar results for growth in culture (Schein and Kerelo 1956; Owen 1958; Lebedeva 2005) 
and infection and sporulation in planta (Skoropad 1959). 
It was then necessary to optimise growth conditions for the bioassay itself. For sensitivity 
testing, sporulation is not required and maximising total growth rate would allow 
measurements to be taken after a shorter incubation time. Therefore different growth media 
and temperatures were tested again, and the inoculum density was also optimised for the 
sensitivity assay. However, a major problem with the use of optical density readings for R. 
secalis is the heterogeneous growth, or "clumping", of R. secalis in liquid culture. This 
covers two different growth states. Initially, R. secalis grows in discrete colonies: different 
growth levels result in smaller colonies with larger gaps, or larger colonies with smaller gaps, 
rather than homogeneous growth at lower or higher density as is seen with the yeast-like 
growth of M graminicola. Later, fungal material forms thick clumps in the middle of each 
well. Neither state is conducive to the accurate assessment of growth by turbidity 
measurements. Different approaches have been used to deal with this, including gelatin- 
amended growth medium (Havis 2006), or the use of fluorescent metabolic indicators such as 
resazurin so fluorescence rather than optical density is measured (McCartney 2006). Earlier 
plate readers scanned plates with a light beam covering approximately a 3mm diameter in the 
centre of each well (Pijls et al. 1994). The plate reader used in the current study (Optima 
Fluostar, BMG Labtech, Germany) measures a single point at the centre of each well. 
Finally, for DNA and RNA extraction, rapid growth in liquid culture was required, since agar 
contamination or secondary metabolites from older cultures may inhibit subsequent reactions 
such as PCR. Furthermore, for analysis of induced gene expression in response to fungicides, 
fungicide addition and RNA extraction should take place during the linear phase of growth, 
after spore germination but while the fungus is still actively growing. Therefore growth 
curves were produced for R. secalis in suitable growth conditions. 
This chapter describes experiments carried out to optimise growth conditions for R. secalis in 
culture and to develop a protocol for a high-throughput in vitro fungicide sensitivity bioassay. 
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2.2 Materials and Methods 
2.2.1 Culture conditions 
2.2.1.1 Medium 
Isolates used in initial tests were OSB 28-2-2, LARS 12-4-2 and LARS 12-4-3 and SAC 0003 
1-4-2 30 (Table 2.1), collected by J. Fountaine from field trials in 2001-2002 and stored as 
conidia in silica gel at -80°C. All were grown on Czapek Dox agar with mycological peptone 
at 15°C for 12 days, and spores harvested into sterile distilled water. 
Media tested for spore production were malt yeast glucose agar 1, as described in Cooke et 
al. (2004) (yeast extract 10 g 1-1, malt extract 10 g 1"1, agar 20 g 1"1); CDM agar (Czapek Dox 
broth mix 33.25 g 1"1, mycological peptone 5g 1"', agar 20 g 1-1); V8 agar (V8 juice 165 ml 1" 
I, calcium chloride 2g 1"1, agar 16 g 1"1; pH-adjusted to pH7 with sodium hydroxide); 
Sabouraud agar (Sabouraud broth mix 30 g 1-1, agar 20 g 1-1); malt yeast glucose agar 2, with 
added glucose (yeast extract 10 g 1"', malt extract 10 g 1'1, glucose 20gl", agar 20 g 1"1); PDA 
(potato dextrose agar) and YPD (yeast peptone dextrose) agar (according to pack 
instructions). Media were poured into 90mm diameter Petri dishes, inoculated with 50µl 
spore suspension, sealed with parafilm and incubated in darkness at 15°C for seven days. 
Subsequently, when a link between inoculum density and spore yield was established 
(Section 2.3.1.3), the experiment was repeated with a fixed inoculum density of 2.5 x 106 
spores ml-1, with 50µl spore suspension spread evenly over the plate surface. Isolates OSB 
28-2-2 and LARS 12-4-2 were used, with two replicates of each. 
Spores were harvested by adding 2ml sterile distilled water to the plate, scraping the surface 
with a sterile disposable spreader for two minutes, and pouring off the spore suspension. 
Spores were counted in an Improved Neubauer haemocytometer (Weber Scientific 
International, Middlesex, UK), with 5/25 squares chosen by random number. 
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Table 2.1. List of R. secalis isolates used in this project 
Isolate Year of Location 
collection 
K1124 Pre-1994 Long Ashton Research Station, UK 
SK7 1984 Long Ashton Research Station, UK 
NKT 12 1996 Norway 
FI12-63 1996 Finland 
R157 (1) 1997 USA 
R157 (2) 1997 USA 
788 1997 France 
SAC 0003 1-4-2 30 2000 Scottish Agricultural College, UK 
SAC 1-4-8 (0003) 2000 Scottish Agricultural College, UK 
SAC 8-3-8 (0003) 2000 Scottish Agricultural College, UK 
SAC 0004 1.15 0030 2000 Scottish Agricultural College, UK 
SAC 8.83 00 (0.04) 2000 Scottish Agricultural College, UK 
SAC 0003 1.2.4 00 (3.33) 2000 Scottish Agricultural College, UK 
SAC 0003 1.2.5 00 1.11 2000 Scottish Agricultural College, UK 
SAC 0003 1.4.8 00 (10) 2000 Scottish Agricultural College, UK 
SAC 0003 8.1.8 00 (0.123) 2000 Scottish Agricultural College, UK 
SAC 0004 8.1.2 2000 10.07 2000 Scottish Agricultural College, UK 
SAC 0004 1.2.4 00 2000 Scottish Agricultural College, UK 
SAC 0003 16/20 2000 Scottish Agricultural College, UK 
QUB 9-10 2001 Northern Ireland 
QUB 30-10 2001 Northern Ireland 
QUB 18-2 2001 Northern Ireland 
QUB 30-13 2001 Northern Ireland 
QUB 12-3 2001 Northern Ireland 
QUB 18-9 2001 Northern Ireland 
R 9517.1 2001 ARINI, Northern Ireland 
R 9524.2 2001 ARINI, Northern Ireland 
R 9528.4 2001 ARINI, Northern Ireland 
R 9516.1 2001 ARINI, Northern Ireland 
R 9511.4 2001 ARINI, Northern Ireland 
R 9522.3 2001 ARINI, Northern Ireland 
R 9519.2 2001 ARINI, Northern Ireland 
RSO 1 ch2.126 2001 Switzerland 
RSO l ch2.126.5.5 2001 Switzerland 
RSO l ch2.306.5.5 2001 Switzerland 
RSO l ch01 Al 2a5.5 2001 Switzerland 
3.1 2/7 2001 Rothamsted Research, UK 
3.1 4/7 2001 Rothamsted Research, UK 
3.1 5/7 2001 Rothamsted Research, UK 
5.2 2/7 2001 Rothamsted Research, UK 
T. I. 3.1 11/7 2001 Trenthome Farm, Nottingham, UK 
M. S. 1.1 13/7 2001 Trenthome Farm, Nottingham, UK 
M. S. 5.1 13/7 2001 Trenthome Farm, Nottingham, UK 
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Table 2.1 continued 
Isolate Year of Location 
collection 
GKII 18-2-1 2002 Rothamsted Research, UK 
GKII 18-2-3 2002 Rothamsted Research, UK 
GKII 18-3-1 2002 Rothamsted Research, UK 
GKII 18-3-2 2002 Rothamsted Research, UK 
GKII 18-3-3 2002 Rothamsted Research, UK 
GKII 20-3-1 2002 Rothamsted Research, UK 
OSA 28-2-2 2002 Rothamsted Research, UK 
OSA 10-4-1 2002 Rothamsted Research, UK 
OSA 10-4-28 2002 Rothamsted Research, UK 
OSB 28-2-2 2002 Rothamsted Research, UK 
OSB 24-4-1 2002 Rothamsted Research, UK 
OSB 24-4-21 2002 Rothamsted Research, UK 
OSB 24-4-47 2002 Rothamsted Research, UK 
LARS 12-4-2 2002 Long Ashton Research Station, UK 
LARS 12-4-3 2002 Long Ashton Research Station, UK 
LARS 8-4-2.5 2002 Long Ashton Research Station, UK 
Sheringham 1 2002 Sheringham, Norfolk, UK 
Sheringham 2 2002 Sheringham, Norfolk, UK 
XNC 2000 3-2 TI A 2002 Northern Ireland 
XNC 2000 3-2 Ti B 2002 Northern Ireland 
XNC 2000 4-2-4 T1 2002 Northern Ireland 
SAC 09/943/186 2007 Scottish Agricultural College, UK 
SAC 09/943/62 2007 Scottish Agricultural College, UK 
SAC 09/943/73 2007 Scottish Agricultural College, UK 
SAC 09/943/13 2007 Scottish Agricultural College, UK 
SAC 09/943/115 2007 Scottish Agricultural College, UK 
SAC 09/943/131 2007 Scottish Agricultural College, UK 
SAC 09/943/14 2007 Scottish Agricultural College, UK 
SAC 09/943/132 2007 Scottish Agricultural College, UK 
SAC 09/943/178 2007 Scottish Agricultural College, UK 
RS 219 2004 UK (Syngenta sensitive reference isolate) 
RS 683 2004 UK (Syngenta intermediate reference) 
RS 783 2004 UK (Syngenta less sensitive reference) 
R. s. 2310 4.2 2008 France (BASF Qol monitoring) 
R. s. 2313 4.2 2008 France (BASF QoI monitoring) 
R. s. 2314 4.2 2008 France (BASF QoI monitoring) 
R. s. 2318 4.2 2008 France (BASF QoI monitoring) 
SCRI 13-13 Scottish Crop Research Institute, UK 
(genome sequencing) 
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2.2.1.2 Temperature 
Silica gel stocks of the four isolates used in media tests were used to inoculate CDM Agar. 
These were incubated at 15°C and 21°C. Spores were harvested and counted after ten days. 
2.2.1.3 Inoculum density 
The four isolates used in the media tests were sub-cultured onto CDM Agar. Spore 
suspensions were diluted to concentrations of 2.5 x 104,2.5 x 105,2.5 x 106 and 2.5 x 107 
spores ml'', with 50pl spore suspension used per 90mm diameter Petri dish. There were two 
replicates at each concentration, except LARS 12-4-2, LARS 12-4-3 and SAC 0003 1-4-2 30 
at 2.5 x 107, for which insufficient inoculum was available. Plates were incubated in darkness 
at 15°C. Spores were harvested and counted after ten days. 
2.2.2 Assay method 
2.2.2.1 Medium 
The preliminary assay used the same four isolates as culture condition tests. Spore 
suspensions were harvested from 10-day-old cultures on CDM agar. Spore counts were 
carried out, and spore concentration was adjusted to 2.5 x 105 spores ml-1 by dilution in sterile 
distilled water. Double-strength media were amended with epoxiconazole. A 10 mg ml- 
solution of epoxiconazole in acetone was made, and added to the media to a final 
concentration of 100 gg ml- 1. Ten serial dilutions were carried out with a dilution factor of 
2/5. Media used were Czapek Dox (McCartney, 2006), Sabouraud (Pijls et al. 1994), alkyl 
ester (Sierotzki and Morchoisne 2006) and yeast glucose (Cooke et al. 2004). 
The assay was carried out in 96-well microtitre plates (TPP, Switzerland). l00pl of 
fungicide-amended medium and 100gl of concentration-adjusted spore suspension were 
added to each well. Columns 1-12 contained increasing concentrations of epoxiconazole, 
with a final concentration of 50 gg ml-1 in column 12, ten serial dilutions (dilution factor 2/5) 
in columns 11-2 and 0 µg ml-1 in column 1. Rows A-H comprised two replicate rows for each 
of the four isolates. Plates were sealed with parafilm and incubated in darkness at 15°C. 
After 7,9,11 and 13 days, fungal growth was measured by optical absorbance at 620nm 
using an Optima Fluostar plate reader (BMG Labtech, Germany), with the accompanying 
software used to fit a dose-response curve (4-parameter fit) and calculate EC50 values. 
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2.2.2.2 Incubation Temperature and Time 
Epoxiconazole sensitivity assays were carried out as described above, but with Sabouraud 
medium used throughout and one plate incubated at 15°C, one at 18°C and one at 21°C. 
Growth was measured after 7,9 and 12 days. 
2.2.2.3 Inoculum density 
Epoxiconazole sensitivity assays were set up as described above, using Sabouraud medium 
throughout, and isolates OSB 28-2-2 and LARS 12-4-2. Inoculum concentrations of 2.5 x 
104,1 x 105,2.5 x 105,1 x 106 and 2.5 x 106 spores ml"' were used. 
Plates were incubated at 18°C for seven days. 
2.2.2.4 Growth Heterogeneity: Gelatin 
Double-strength Sabouraud medium was amended with 180-bloom gelatin to final 
concentrations of 0,0.4,1,2 and 4% w/v. Epoxiconazole sensitivity assays were set up as 
described above, for those four isolates, with plates incubated at 18°C and read after seven 
days. This was then repeated for final gelatin concentrations of 0 and 1 %. 
2.2.2.5 Growth Hetero eg neity: Shakin 
Epoxiconazole sensitivity assays were set up as described above, using Sabouraud medium, 
spore suspension at 2.5 x 105 spores ml-1, incubating at 15°C for 12 days. In addition to 
isolates OSB 28-2-2 and LARS 12-4-2, isolates QUB 9.10 and QUB 30.10, previously found 
to have differing levels of sensitivity to epoxiconazole (L Black, unpublished data), were 
used. Plates were read without shaking, then after 30 seconds shaking at medium speed (c. 
1125 rpm), 2 minutes at medium speed, 2 minutes at top speed (1300 rpm) then 5 minutes at 
top speed, on an Orbis Plate Shaker (Mikura, West Sussex). Further assays were carried out 
taking readings before and after shaking for 30 seconds at medium speed, with a wider range 
of isolates and the four triazole fungicides described in Chapter Four. 
2.2.2.6 Growth Heterogeneity: Fluorescence-Based Assays 
Epoxiconazole sensitivity assays were set up as described. After seven days, optical density 
readings were taken and 20 pl of 80 µg ml" resazurin solution was added to each well. Plates 
were incubated overnight (16 hours) in darkness at 18°C, then fluorescence at 530 nm was 
measured using the Optima Fluostar plate reader (BMG Labtech, Germany). 
51 
2.2.2.7 Growth Heterogeneity: Reader Settings 
An Epoxiconazole sensitivity assay was set up using Sabouraud medium, spore suspension at 
2.5 x 105 spores ml-1, and incubating at 18°C for seven days. Isolates SAC 09/943/186, SAC 
09/943/73, SAC 09/943/115 and RS 219 were used. The assay plate was read with the 
following settings (well inside diameter = 6.7 mm): endpoint mode, single reading per well; 
endpoint mode, orbital averaging, 20 flashes around a 4mm-diameter orbit; well-scanning 
mode, 3x3 matrix, 6mm diameter; well-scanning mode, 6x6 matrix, 6mm diameter; well- 
scanning mode, 6x6 matrix, 4mm diameter; well-scanning mode, 4x4 matrix, 3mm diameter. 
The well-scanning points are arranged in a square grid with sides equal to the specified 
diameter; points in the matrix that fall wholly outside a circle of the specified diameter are 
excluded. Hence for a 3x3,4x4 and 6x6 matrix, readings are taken at 9,12 and 32 points, 
respectively. Further assays were carried out taking readings in end-point mode and in well- 
scanning mode with a 4x4 matrix of 3mm diameter before and after shaking for 30 seconds at 
medium speed, with a wider range of isolates and the four triazole fungicides described in 
Chapter 4. 
2.2.3 Growth curve 
Isolates 788 and K1124 were each grown in 50 ml tubes containing 10 ml Sabouraud medium 
inoculated with 2.5 x 104 spores ml"1, in an orbital shaker at 150 rpm at 20 °C. At day 0 and 
subsequent 2-day intervals, 2 tubes of each isolate were selected at random, removed, and 
frozen at 20 °C. Subsequently all isolates were harvested by vacuum filtration onto a nylon 
filter disc, placed into individual plastic bags, re-frozen and freeze-dried. The dry mass of 
fungus on the filter discs was measured on a fine balance. 
2.3 Results 
2.3.1 Culture conditions 
2.3.1.1 Medium 
CDM agar yielded the highest spore numbers, V8 agar produced good hyphal growth but 
lower spore counts, and the malt yeast glucose agar and PDA gave no growth after seven 
days for all four isolates tested (Table 2.2). 
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Table 2.2. Spore yields obtained by subculturing R. secalis isolates on different agar media 
Spore counts (105 spores ml"' ) 
Agar Medium 
Isolate Czapek Dox with V8 Malt Yeast Potato Dextrose 
mycological Glucose I 
peptone 
OSB 28-2-2 95 46.5 Na N 
LARS 12-4-2 26.5 5 N N 
LARS 12-4-3 22.5 5.5 N N 
SAC 0003 1- 51 6.5 N N 
4-2 30 
aN indicates no growth. 
In the second experiment, spore counts for both isolates were highest on CDM agar. V8 agar 
still produced good hyphal growth but lower spore counts, as did the Sabouraud agar. The 
addition of extra glucose to the malt yeast glucose agar and yeast extract to the potato 
dextrose agar resulted in some growth and sporulation, but less than was obtained with the 
CDM agar (Table 2.3). 
Table 2.3. Spore yields obtained by subculturing R. secalis isolates on five different agar media. 
Spore counts (10 spores ml-) 
Agar Medium 
Isolate Czapek Dox + V8 Malt Yeast Yeast Sabouraud 
Mycological Glucose 2 Potato 
Peptone Dextrose 
OSB 28-2- 339 11 21.8 40.5 19.8 
2 
LARS 12- 159.5 17.5 24.8 45 85.5 
4-2 
2.3.1.2 Temperature and Time 
All four isolates grew well at 15°C, sporulating within ten days. There was little or no 
germination and growth at 21 °C. 
2.3.1.3 Inoculum density 
Spore yields for all isolates increased with inoculum density for inoculum concentrations up 
to 2.5 x 106 spores ml"' (Figure 2.1). However, increasing inoculum concentration to 2.5 x 
107 spores ml-1 resulted in a far lower increase in spore yield for isolate LARS 12-4-3, and 
decreased spore yields for the other isolates. An inoculum density of 2.5 x 106 spores ml-1 
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was selected for all future work, as it produced consistently high spore yields for both 
replicates of all four isolates. 
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Figure 2.1. Spore yield against inoculum level for four R. secalis isolates. Spore counts of zero are shown 
as 5x 103 spores ml'', the lowest detectable level, due to the log scale. Circle, isolate OSB 28-2-2; square, 
LARS 12-4-2; diamond, LARS 12-4-3; triangle, SAC 0003 1-4-2. 
2.3.2 Assay method 
2.3.2.1 Medium 
The control growth, i. e. 0 pg ml-1 epoxiconazole, was greatest in Sabouraud medium, 
followed by yeast glucose, alkyl ester then Czapek Dox, for all four isolates at all four 
measurement times. Data shown are measurements at 13 days (Figure 2.2). 
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Figure 2.2. Growth of four R. secalis isolates after 13 days, from an initial inoculum concentration of 2.5 x 
10-5 spores ml-1, in four different liquid media, measured by optical absorbance. 
The growth rate affected the quality of dose-response curves obtained (Figure 2.3). In Czapek 
Dox and alkyl ester media, some isolates did not grow sufficiently to obtain an EC50 value 
even after 13 days, but better data are obtained with yeast glucose medium, and better still 
with Sabouraud. This is reflected in the consistency of EC50 values between replicates, with 
Sabouraud producing the most consistent results (Figure 2.4). Therefore, Sabouraud medium 
was selected as the first choice of assay medium for future assays, with the caveat that a very 
rich medium may not be suitable for all fungicides. 
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Figure 2.3. Dose-response curves of fungal growth against epoxiconazole concentration for four R. secalis 
isolates in four different liquid media: (a) Czapek Dox, (b) alkyl ester, (c) yeast glucose, (d) Sabouraud. 
Black/grey: isolate OSB 28-2-2; red/orange: LARS 12-4-2; blue/light blue, LARS 12-4-3; green/light 
green, SAC 0003 1-4-2 30. 
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Figure 2.4. Epoxiconazole EC50 values obtained for four R. secalis isolates in four different growth media, 
with two replicates per isolate: Black, isolate OSB 28-2-2; light grey, LARS 12-4-2; dark grey, LARS 12- 
4-3; white, SAC 0003 1-4-2. Circle, replicate 1; square, replicate 2. 
2.3.2.2 Temperature and Time 
Growth after seven days was greatest at 18°C for three of the four isolates, slightly lower at 
15°C and markedly lower at 21°C (Figure 2.5). Readings at seven days produced the most 
consistent epoxiconazole EC50 values between replicates at15°C and 18°C incubation 
temperatures, with greater differences at 9 and 12 days (Figure 2.6). The opposite pattern was 
seen at 21 °C, as the slower growth rate meant the optimal measuring time had not been 
reached at the earlier readings. 
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Figure 2.5. Growth of four R. secalis isolates at three different temperatures after 7 days, measured by 
optical absorbance. Black, isolate OSB 28-2-2; mid-grey, LARS 12-4-2; dark grey, LARS 12-4-3; light 
grey, SAC 0003 1-4-2; white, all isolates. 
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Figure 2.6. Epoxiconazole ECso values obtained for four R. secalis isolates at three different temperatures 
with readings taken at three times, with two replicates per isolate: Black, isolate OSB 28-2-2; light grey, 
LARS 12-4-2; dark grey, LARS 12-4-3; white, SAC 0003 1-4-2. 
2.3.2.3 Inoculum density 
Spore concentrations of 1 O5 to 106 spores ml-1 produced better dose-response curves with 
more consistent EC50 values (Figure 2.7). At lower concentrations, growth was too sparse, 
whereas higher concentrations resulted in excess turbidity from inoculum material, giving 
elevated optical absorbance readings in the absence of any further growth. 
2.3.2.4 Growth Heterogeneity: Gelatin 
Initially, it appeared that a final gelatin concentration of I% produced the most consistent 
EC50 values (Figure 2.8). However, this is solely due to the absence of outlying EC5o data 
points for that data set, with no general pattern of improved data quality around an optimum 
gelatin concentration. When the experiment was repeated with 0 and 1% gelatin, the assay 
with 0% gelatin produced more consistent results. 
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Figure 2.7. Epoxiconazole ECso values obtained for two R. secalis isolates with five different inoculum 
concentrations, with two replicates per isolate: Black, isolate OSB 28-2-2; grey, LARS 12-4-2. 
60 
le+1 
1 e+0 
le-1 
1e-2 
1 
E 1e-3 
cm 
5°, 1 e-4 
U 
W 
le-5 
1e-6 
1e-7 
1e-8 
1-- 0 
' a " t 
S 
0 0.4 124 Oa 1a 
Gelatin concentration (% w/v) 
Figure 2.8. Epoxiconazole ECso values obtained for four R. secalis isolates in Sabouraud medium 
amended with different concentrations of gelatin, with two replicates per isolate: Black, isolate OSB 28-2- 
2; light grey, LARS 12-4-2; dark grey, LARS 12-4-3; white, SAC 0003 1-4-2. a' Assays with 0% and I% 
gelatin were carried out twice. 
2.3.2.5 Growth Heterogeneity: Shaking 
Shaking for 30 seconds appeared to give a slight improvement in dose-response curves and 
EC50 value consistency by breaking up some clumps of fungal growth. However, further 
shaking did not yield any further improvements (Figure 2.9). In subsequent assays, shaking 
was generally beneficial to data quality (Figure 2.10). However, in some cases, especially in 
prothioconazole sensitivity assays, the opposite effect was seen (Figure 2.11). 
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Figure 2.9. Epoxiconazole EC50 values obtained for four R. secalis isolates with five different levels of 
shaking to disperse clumps of fungal material, with two replicates per isolate. Black, isolate OSB 28-2-2; 
red, LARS 12-4-2; purple, QUB 9.10; orange, QUB 30.10. Shaking used: 1, no shaking; 2,30 seconds 
medium speed; 3,2 minutes medium speed; 4,2 minutes top speed; 5, five minutes top speed. 
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Figure 2.10. Dose-response curves of fungal growth against epoxiconazole concentration, and 
epoxiconazole EC50 values, for four R. secalis isolates, with and without shaking the assay plates: (a) 
Dose-response curves obtained before shaking; (b) Dose-response curves obtained after shaking the plates 
for 30 seconds; (c) Comparison of EC50 values obtained before shaking (0) and after shaking for 30 
seconds (1). Black/grey: isolate OSB 28-2-2; red/orange: LARS 12-4-2; blue/light blue, LARS 12-4-3; 
purple/light purple, QUB 9-10. 
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Figure 2.11. Dose-response curves of fungal growth against prothioconazole concentration, and 
prothioconazole EC50 values, for four R. secalis isolates, with and without shaking the assay plates: (a) 
Dose-response curves obtained before shaking; (b) Dose-response curves obtained after shaking; (c) 
Comparison of EC50 values obtained before (0) and after shaking (1). Black/grey: isolate OSA 10-4-1; 
red/orange: OSA 10-4-28; blue/light blue, LARS 8-4-2.5; green/light green, OSB 24-4-47. 
2.3.2.6 Fluorescence-Based Assays 
Most assay plates failed to give the expected dose-response curves from fluorescence 
measurements. In many cases, the highest fluorescence readings were obtained for mid-range 
or high fungicide concentrations (Figure 2.12), whereas for slower-growing isolates, growth 
was insufficient for EC50 to be determined accurately by this method (Figure 2.13). 
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Figure 2.12. Dose-response curves of fungal growth, measured as fluorescence produced by the ingrowth 
indicator resazurin, against epoxiconazole concentration, for three R. secalis isolates. Black/grey: Isolate 
LARS 12-4-2; red/orange: LARS 12-4-3; blue/light blue: QUB 9-10. Fluorescence is highest for 
intermediate growth due to the reduction of resazurin to resorufin, and lower where growth is greatest 
due to the reduction of resorufin to non-fluorescent hydroresorufin. 
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Figure 2.13. Dose-response curves of fungal growth, measured as fluorescence produced by the indicator 
substance resazurin, against epoxiconazole concentration, for two R. secalis isolates. Black/grey: Isolate 
R157; Red/orange: isolate RSOlch2.126. Isolate RSOlch2.126 shows insufficient growth to give a reliable 
ECso value. 
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2.3.2.7 Growth Heterogeneity: Reader Settings 
The data produced in end-point mode when testing reader settings were better than for some 
other plates, but not all points fit on a smooth dose-response curve, especially for isolates 
SAC 09/943/186 and SAC 09/943/73 (Figure 2.14a). The reading with orbital averaging 
(setting 2) produced very poor data (Figure 2.14b), as did the first reading in well-scanning 
mode (setting 3) (Figure 2.14c), with several optical density readings increasing at the highest 
fungicide concentrations, contradicting what was shown by the endpoint readings and visual 
inspection of the plate. Data from individual reading points within the wells showed that this 
was due to inaccurate readings closer to the edges of the wells (Figure 2.15). 
When more readings per well were taken (setting 4), the outermost readings could be 
excluded, improving the in data quality (Figure 2.16, Figure 2.17). Taking all readings within 
a smaller diameter (setting 5) produced better data still (Figure 2.18b-c, Figure 2.19). 
Reducing the matrix from 6x6 to 4x4 data points cut the time taken to read each plate from an 
hour to twenty minutes, with relatively little reduction in data quality (Figure 2.18d, Figure 
2.19). 
Further assays with a larger set of isolates gave consistently better readings in well-scanning 
mode with a 4x4 matrix and 3mm diameter than in end-point mode, even when end-point 
readings gave very poor data (for example, Figure 2.20). 
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Figure 2.14. Dose-response curves of fungal growth against epoxiconazole concentration for four R. 
secalis isolates. (a) Readings obtained from a single optical density measurement per well; (b) readings 
obtained from 20 optical density measurments, taken in a 6mm diameter circle, per well; (c) obtained 
from a 3x3 matrix of optical density measurments, within a 6mm diameter, per well. Black/grey: isolate 
SAC 09/943/186; red/orange: SAC 09/943/73; blue/light blue, SAC 09/943/115; green/light green, RS 219. 
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Figure 2.15. Individual data points from an epoxinconazole sensitivity bioassay in a 96-well microtitre 
plate, with 9 data points per well, read in well-scanning mode with a 3x3 matrix of 6mm diameter (well 
diameter = 6.7 mm). Columns 1-12 contain increasing epoxiconazole concentrations. Rows A-B contain R. 
secalis isolate SAC 09/943/186; C-D, isolate SAC 09/943/73; E-F, isolate SAC 09/943/115 and G-H, isolate 
RS 219. 
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Figure 2.16. Dose-response curves of fungal growth against epoxiconazole concentration for four R. 
secalis isolates, obtained from a 6x6 matrix of optical density measurments, within a 6mm diameter, per 
well. (a) All readings included; (b) only readings within a 5mm diameter included; (c) only readings 
within a 4mm diameter included; (d) only readings within a 3mm diameter included. Black/grey: isolate 
SAC 09/943/186; red/orange: SAC 09/943/73; blue/light blue, SAC 09/943/115; green/light green, RS 219. 
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Figure 2.17. Epoxiconazole ECsa values for four R. secalis isolates with two replicates per isolate, obtained 
from a 6x6 matrix of optical density measurements, within a 6mm diameter, per well. (a) All readings 
included; (b) only readings within a 5mm diameter included; (c) only readings within a 4mm diameter 
included; (d) only readings within a 3mm diameter included. Black: isolate SAC 09/943/186; light grey: 
SAC 09/943/73; dark grey, SAC 09/943/115; white, RS 219. 
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Figure 2.18. Dose-response curves of fungal growth against epoxiconazole concentration for four R. 
secalis isolates. (a) Obtained from one reading per well; (b) Obtained from a 6x6 matrix of measurements, 
taken within a 6mm square, per well, with only the 4 readings falling within a 3mm diameter included; (c) 
Obtained from a 6x6 matrix of measurements, taken within a 4mm square, per well, with only the 16 
readings falling within a 3mm diameter included; (d) Obtained from a 4x4 matrix of measurements, 
taken within a 3mm square, per well, with only the 12 readings falling within a 3mm diameter included. 
Black/grey: isolate SAC 09/943/186; red/orange: SAC 09/943/73; blue/light blue, SAC 09/943/115; 
green/light green, RS 219. 
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Figure 2.19. Epoxiconazole EC% values obtained for four R. secalis isolates with two replicates per isolate. 
(a) Obtained from one reading per well; (b) Obtained from a 6x6 matrix of measurements, taken within a 
6mm, diameter per well, with only the 4 readings falling within a 3mm diameter included; (c) Obtained 
from a 6x6 matrix of measurements, taken within a 4mm diameter, per well, with only the 16 readings 
falling within a 3mm diameter included; (d) Obtained from a 4x4 matrix of measurements, taken within a 
3mm diameter, per well, with only the 12 readings falling within a 3mm diameter included. Black/grey: 
isolate SAC 09/943/186; red/orange: SAC 09/943/73; blue/light blue, SAC 09/943/115; green/light green, 
RS 219. 
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Figure 2.20. Dose-response curves of fungal growth against epoxiconazole concentration, and 
epoxiconazole EC50 values, for four R. secalis isolates, with optical absorbance readings taken at single 
and multiple points per well: (a) Dose-response curves obtained in end-point mode (one reading per 
well); (b) Dose-response curves obtained in well-scanning mode with 4x4 matrix and 3mm diameter (12 
readings per well); (c) Comparison of ECso values obtained with each setting. Black/grey: isolate OSB 24- 
4-1; red/orange: OSA 10-4-1; blue/light blue, OSB 24-4-21; green/light green, LARS 8-4-2.5. 
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2.3.3 Growth curve 
Fungal mass was plotted against time for the two isolates (Figure 2.21). Both isolates show a 
lag phase up to day 6, followed by linear growth. Some reduction in growth rate is apparent 
for isolate K1124 from days 12-14, whereas isolate 788 reaches stationary or declining mass 
after 16 days. 
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Figure 2.21. Dry mass obtained from fungal cultures at two-day intervals, for isolates 788 (black) and 
K1124 (white). 
2.4 Discussion 
2.4.1 Culture conditions 
Of the media tested, CDM agar gave the most consistently high spore yields, and was 
selected as the growth medium. The malt yeast glucose agars, PDA and YDP agar resulted in 
lower total growth, whereas Sabouraud medium, and for some isolates V8 agar, resulted in 
extensive hyphal growth but lower sporulation. The lack of growth on PDA is in contrast 
with previous studies that have reported good growth on PDA, such as Caldwell (1937) who 
reported the fastest growth on PDA of all media tested. This may be because in the present 
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study the PDA was inoculated with spores that had been frozen on silica gel, resulting in 
additional germination requirements following prolonged dormancy. Schein and Kerelo 
(1956) also obtained no detectable spores on PDA, but did not mention the level of vegetative 
growth on this medium. Sporulation was greater on potato sucrose agar, and also on lima 
bean agar, with intermediate levels of sporulation on various other media including V8 and 
malt extract agars. Lebedeva (2005) also reported the fastest growth in colony diameter on 
potato sucrose agar. CDM agar, the medium with the greatest spore yields in the present 
study, also contains sucrose as the carbon source. 
The high hyphal growth but lack of sporulation on the Sabouraud and V8 media is similar to 
the observations of Schein and Kerelo (1956), who noted that the best media for spore 
production gave only slow growth and small colonies. Owen (1958) also noted that 
sporulation was generally higher on media with relatively low soluble nutrient content. 
However, Lebedeva (2005) and Schein and Kerelo (1956) observed the lowest growth and 
sporulation respectively on water agar. Therefore it would appear that the best spore yields 
are obtained at intermediate levels of available nutrients, enabling some growth but not 
extensive vegetative hyphal mass. 
The isolates tested grew at 15°C but not at 21°C. When comparing assay methods, 18°C gave 
faster growth than 15°C or 21°C, and was selected for all further work. An optimal growth 
temperature of 18°C and reduced growth at 21 °C is consistent with many previous studies, 
including Bartels (1928), who reported an optimal growth temperature of 19-21°C, Caldwell 
(1937), who reported an optimum temperature for germination and germ-tube elongation of 
18-21 °C and a rapid reduction in growth as temperature increased above 21 °C, and Lebedeva 
(2005), who reported maximum in vitro growth in colony diameter of R. secalis isolates from 
barley at 15-20°C. Cooke et al. (2004) and Oxley et al. (2006) also used an incubation 
temperature of 18°C. Skoropad (1959) reported an optimum temperature of 16°C for seedling 
infection from seed, with a rapid reduction above 20°C. The lower optimum temperature in 
this case may reflect faster growth of the seedling at higher temperatures, allowing early 
disease escape. 
The four isolates used in initial tests sporulated within seven days of inoculation, but slower- 
growing isolates required 10 days. A 10-day incubation time was selected to allow a 
consistent protocol to be used for all isolates. 
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Spore yields for some isolates fluctuated greatly with subculturing, with low yields 
sometimes obtained from cultures inoculated with a high concentration of spores. Therefore, 
the effect of inoculum concentration on spore density was investigated. 
Spore yields for all isolates increased with inoculum density for concentrations up to 2.5 x 
106 spores ml-1, but plateaued or decreased at higher inoculum densities. This was consistent 
with the appearance of the cultures: at lower inoculum concentrations, growth was limited to 
separate colonies with unutilised space between them; at 2.5 x 106 spores ml-1, the surface 
was mostly covered but colonies remained separate; and at the highest inoculum 
concentration, the agar surface was covered with continuous dense hyphal growth but with 
lower sporulation levels. Furthermore, higher inoculum levels produced more hyphal 
material, which increased the turbidity of the resulting concentration-adjusted spore 
suspension for use in sensitivity bioassays, giving elevated optical absorbance readings in the 
absence of any further growth. Therefore an inoculum density equivalent to 50µ1 per 90mm 
plate at 2.5 x 106 spores ml-1 was selected for all future work, as it produced consistently high 
spore yields for both replicates of all four isolates. Consequently, isolates stored in silica gel 
at -80°C are first grown from those stocks, and then subcultured at the optimal inoculum 
density. 
Previous publications have not addressed the impact of inoculum density on spore yields, 
although Schein and Kerelo (1956) mentioned that high spore yields were obtained using `a 
zigzag smear technique', which would reduce overcrowding and ensure most growth took 
place close to the edge of the streak of fungal mass. Ayres and Owen (1969) suggested that 
spores may produce a `self-inhibitor of germination', preventing germination when spores are 
present at high density, such as within a sporulating lesion on crop debris. However, in the 
present study, germination did not appear to be reduced. In fact, dense hyphal growth was 
produced, but with lower spore yields, similar to growth on some richer media. It is not clear 
whether this is due to later allelopathic effects or resource depletion by the crowded 
mycelium, or a response to conditions resembling in planta conditions during pre-sporulation 
stages in the infection process. 
2.4.2 Assay method 
To measure fungal growth in a sensitivity assay, total growth, rather than spore production, 
should be maximised. Growth rate was greatest in Sabouraud medium, resulting in the most 
consistent EC50 values between replicates. Therefore, Sabouraud medium was selected as the 
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first choice of assay medium for future assays, with the caveat that a very rich medium may 
be unsuitable for some fungicides. For example, anilinopyrimidines may be less effective 
when the medium contains a rich source of methionine (Masner et al. 1994), and SDHI 
effectiveness in vitro may depend on the carbon source (Shima et al. 2009). 
Growth after seven days was greatest at 18°C for three of the four isolates, and readings taken 
after seven days produced the most consistent EC50 values at 18°C. Therefore, incubation at 
18°C for seven days is optimal, which is consistent with previous studies, as previously 
discussed. Inoculum concentrations within the range of 105 to 106 spores ml"' gave the most 
consistent EC50 values. Therefore an inoculum concentration of 2.5 x 105 was selected for 
future assays. 
Despite the optimisation of growth medium, temperature, time and inoculum level, data 
quality was still excessively variable, due to the heterogeneous growth of R. secalis in liquid 
culture. Gelatin-amended growth medium, as described by Havis (2006), did not result in a 
consistent improvement in data quality. Furthermore, when plates were shaken, gelatin- 
amended medium formed large air bubbles, resulting in inaccurate optical absorbance 
readings. Therefore, gelatin was not used in any further tests. Shaking for 30 seconds slightly 
improved the data quality by breaking up some clumps of fungal growth, but further shaking 
gave no further improvements. Therefore shaking for 30 seconds at medium speed was 
selected for further assays. When further assays were carried out, in many cases shaking was 
beneficial to data quality, visibly dispersing clumps of fungal material and reducing 
corresponding anomalous data points. However, in other cases, the opposite effect was seen, 
with fungal material being loosened from the well bottom. This was most common in 
prothioconazole sensitivity assays, as fungal growth tended to form a thin film across the 
bottom of the well, which loosened and crumpled when the plates were shaken. 
A fluorescence-based method was also tried, using the metabolic indicator resazurin. 
Whilst a colour gradient was observed on many plates after incubation with resazurin, most 
failed to give the expected dose-response curves from fluorescence measurements. 
In many cases, the highest fluorescence readings were obtained at mid-range or higher 
fungicide concentrations. This is because resazurin undergoes two reduction reactions. It is 
reduced first to resorufm, the fluorescent product, but then to hydroresorufin, which is non- 
fluorescent (O'Brien et al. 2000). Therefore, to use resazurin to obtain EC50 values, it would 
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be necessary to find an incubation time at which the first reaction, but not the second, will 
take place in fungicide concentrations where growth has been inhibited by less than 50% for 
all isolates. However, preliminary tests found that for the range of isolates being tested here, 
variation in growth rates is such that no one timing would be universally acceptable: either 
the slower-growing isolates will have insufficient growth for EC50 to be determined 
accurately (Figure 2.12), or the faster-growing isolates will reduce the resazurin to 
hydroresorufin at the lowest fungicide concentrations (Figure 2.13). 
In all assays discussed so far, the plate reader (Optima Fluostar, BMG Labtech, Germany) 
had been used in end-point mode, taking a single reading per well. This produces good results 
for M graminicola (for example, Bean et al. 2009), which gives homogeneous yeast-like 
growth in suitable culture conditions, but for the more heterogeneous growth of R. secalis, 
multiple readings per well can be made. 
Taking multiple readings per plate, using orbital-averaging or well-scanning settings on the 
plate reader, initially produced very poor data due to inaccurate readings close to the edge of 
each well. However, reducing the diameter within which readings were taken to 3mm clearly 
improved the data quality, with readings lying closer to a smooth yield-density curve, 
resulting in more consistent EC50 values. This may be due to optical effects from the well 
walls or differences in fungal growth at the edge of the well. The 3mm diameter is similar to 
that scanned by the more diffuse light sources of some other plates readers (Pijls et al. 1994). 
Within a 3mm diameter, taking multiple readings per well improved data quality, as a more 
representative sample of the fungal growth was measured and chance effects of whether a 
single reading point fell within or between fungal colonies was reduced. Increasing the matrix 
of measurement points per well from a single point, to a 2x2,3x3 then 4x4 matrix, gave 
successive improvements in data quality, with smoother yield-density curves and more 
consistent readings between replicates. However, increasing the matrix from 4x4 to 6x6 data 
points increased the time taken to read each plate from twenty minutes to an hour, with 
relatively little further improvement in data quality. 
Therefore, well-scanning mode was selected for use in all further assays. A 4x4 matrix gave a 
suitable balance between data quality and read time, and reading within a 3mm diameter gave 
sufficient coverage to allow for growth heterogeneity while avoiding inaccurate readings 
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from around the well edges. When well-scanning was used, shaking plates was no longer 
necessary. The assay plate used to test these settings produced relatively good data even in 
end-point mode, but further assays with a wider range of isolates and fungicides gave 
consistently better readings in well-scanning mode (with a 4x4 matrix and 3mm diameter) 
than in end-point mode, particularly when end-point readings gave very poor data due to 
patchy growth. The final assay protocol is described in Section 3.2.1. 
2.4.3 Growth curve 
When testing liquid media for the fungicide sensitivity assay, growth was highest in 
Sabouraud medium, and so it was selected for growing liquid cultures for nucleic acid 
extraction. Similarly, a temperature of 18°C was selected based on previously discussed data. 
A lag phase of growth was observed up to day 6 for both isolates. Therefore for gene 
expression analyses, any treatments should be applied and samples taken from day 7 
onwards, once the culture has entered linear growth. This is consistent with the observations 
of Caldwell (1937) that R. secalis growing in culture takes 4-5 days "to become 
macroscopically evident". An upper time limit of 10-12 days ensures that cultures are in 
linear growth, and not entering a stationary or declining phase. Lebedeva (2005) also 
observed a lower growth rate in colony diameter at 14-21 days compared to 0-14 days. 
Furthermore, an upper time limit of ten days for culture growth for nucleic acid extractions 
avoided the accumulation of putative secondary metabolites, which results in a melanised 
appearance, correlated with poor PCR performance of extracted DNA, for older cultures. The 
melanisation of older cultures was also described by Schein and Kerelo (1956) and Owen 
(1958), with the age at which cultures become melanised depending on the growth media 
used. 
79 
Chapter 3 
Qol fungicide sensitivity in R. secalis 
3.1 Introduction 
The Quinone Outside Inhibitors (Qols), including the strobilurins, inhibit cytochrome b in the 
electron transfer chain of mitochondrial respiration. Target-site resistance has been found in 
many species (FRAC 2010b), often due to the G143A substitution. Isolates of B. graminis 
f. sp. tritici with a G143A-encoding mutation and a 200-fold reduction in QoI sensitivity were 
found in 1998 (Sierotzki et al. 2000b), but no target-site resistance was reported in R. secalis 
for the following ten years (Torriani et al. 2009a). In 2008, target-site resistance to Qols in R. 
secalis was reported in field isolates from one site in France, and this was found to be due to 
the G143A substitution (FRAC QoI Working Group 2008). So far this has not been found in 
the UK, but alternative oxidase (AOX) activity has been implicated in the reduced in vitro 
Qol sensitivity of some isolates (McCartney 2006). 
AOX can act as an alternative electron acceptor from ubiquinone, circumventing cytochrome 
b (Joseph-Home and Hollomon 2000). However, its role in planta is not clear, as it may be 
inhibited by plant secondary metabolites, or the reduced ATP generation resulting from the 
alternative respiratory pathway may be insufficient for some stages of fungal growth (Wood 
and Hollomon 2003). McCartney (2006) reported a ten-fold reduction in QoI sensitivity of 
some R. secalis isolates in vitro when AOX inhibitors were added, but this was not 
investigated at the molecular level. AOX expression in M oryzae was induced following the 
addition of a QoI fungicide (Yukioka et al. 1998), and inter-specific differences in QoI 
sensitivity between F. graminearum and M nivale correlated with induced expression of 
AOX (Kaneko and Ishii 2009), but so far there are no published reports of intraspecific 
differences in A OX expression in relation to Qol fungicide sensitivity. 
Huh and Kang (2001) reported the presence of two AOXparalogues in C. albicans. One 
paralogue was expressed constitutively. Expression of the other was induced by complex III 
inhibitors, and varied with growth stage. Tanton et al. (2003) reported the presence of two 
AOX paralogues in N. crassa. One paralogue was constitutively expressed at a low level, and 
increased expression was induced by addition of a complex III inhibitor; the other was not 
expressed under the conditions used. McDonald and Vanlerberghe (2006) list multiple AOX 
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genes in several other fungal species, including the leotiomycete B. cinerea. It is not clear 
whether these represent independent duplications within a few lineages, or a basal duplication 
into two fungal A OXparalogues. 
This chapter describes Qol sensitivity testing in R. secalis, and the effect of adding the AOX 
inhibitor SHAM. The cytochrome b Qol target site encoding gene was sequenced for a 
selection of isolates with a range of Qol sensitivities. The R. secalis AOX gene was identified, 
and phylogenetic analyses were carried out to investigate the occurrence of multiple fungal 
AOX paralogues. The AOX gene was sequenced for a selection of R. secalis isolates, and 
expression levels analysed. 
3.2 Materials and Methods 
3.2.1 Sensitivity testing 
Isolates used for initial tests comprised reference isolates from a range of locations, and field 
isolates collected by J. Fountaine from field trials in 2001-2002, stored in silica gel at -80°C. 
Additional isolates were obtained from Syngenta Crop Protection, the Scottish Agricultural 
College and BASF. Isolates used are shown in Table 2.1. 
Sensitivity testing was carried out using the method developed in Chapter 2. In brief, isolates 
were grown on Czapek Dox agar with mycological peptone (Czapek Dox broth mix 
33.25 g 1"', mycological peptone 5g 1"1, agar 20 g 1-1), with an inoculum density of 1.25 x 105 
spores per 90mm Petri dish, at 18°C for 10 days. Spores were harvested and suspended in 
sterile distilled water. Fungicide sensitivity assays were carried out in 96-well microtitre 
plates (TPP, Switzerland). Fungicide-amended 2x Sabouraud medium (100µl) and 
concentration-adjusted spore suspension (100µl at 2.5 x 105 spores ml-1) was added to each 
well. Columns 1-12 contained increasing concentrations of technical-grade azoxystrobin, as 
shown in Table 3.1. Rows A-H comprised two pseudo-replicate rows for each of four 
isolates. Each assay was repeated with 10µl ml-1 of 8mg ml" SHAM (salicylhydroxamic 
acid; Sigma-Aldrich, Germany) solution in DMSO added to the medium, to give a final 
concentration of 40 µg ml" SHAM, to inhibit AOX activity. Plates were sealed with parafilm 
and incubated in darkness at 18°C for seven days. 
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Table 3.1. Final fungicide concentrations used in strobilurin sensitivity bioassays, carried out in 96-well 
microtitre plates. 
Microtitre plate 123456789 10 11 12 column 
Final azoxystrobin 
or pyraclostrobin 0 0.00169 0.00508 0.0152 0.0457 0.137 0.412 1.235 3.70 11.1 333 100 
concentration 
(µg ml-') (3 s. f. ) 
After 7 days, fungal growth was measured by optical absorbance at 620nm using an Optima 
Fluostar plate reader (BMG Labtech, Germany), in well-scanning mode with a 4x4 matrix of 
scanning points within a 3mm diameter. The accompanying software was used to fit a dose- 
response curve (4-parameter fit) and calculate EC50 values. Correlation between EC50 values 
with and without SHAM, and between Qol and triazole sensitivity (chapter 4), was tested by 
least squares linear regression analysis in GenStat 13th Edition (VSN International, 
Hertfordshire, UK). 
3.2.2 SHAM matrix assays 
The assay procedure was carried out as described above, but with a single isolate per plate. 
Spore suspensions were diluted to 5x 105 spores ml-1, and 50µl was added to each well. 
SHAM was dissolved in DMSO at 432 mg ml-1, then 10 µl ml-1 was added to sterile distilled 
water. Six serial dilutions were carried out at a dilution factor of 1/3, and 50µl was added to 
each well to give the following final concentrations: 0µg ml-1 (5041 distilled water only), then 
1.48 µg ml", 4.44 gg ml"', 13.3µg ml"1,40 gg ml"', 120 gg m1"', 360 gg ml-1 and 
1080 µg ml"'. Isolates SAC 09/943/186, SAC 09/943/73, SAC 09/943/115 and RS 219 were 
tested. Plates were incubated and read as described in section 3.2.1. 
The assay was then carried out for isolates R. s. 2310 4.2, R. s. 2313 4.2 and R. s. 2314 4.2. 
SHAM was dissolved in DMSO at 16 mg ml"', then 10 µl ml-1 was added to sterile distilled 
water, and six serial dilutions carried out at a dilution factor of 1/3, to give the following final 
concentrations: two rows at 0µg ml-1 (50µl distilled water only), then one row each at 0.123 
pg m1-1,0.494 pg ml-1,1.48 pg ml'', 4.44 µg ml-1,13.3 µg ml" and 40µg ml-1. A subsequent 
experiment tested pyraclostrobin sensitivity of isolates R. s. 2310 4.2, R. s. 2313 4.2, R. s. 2314 
4.2 and R. s. 2318 4.2 with the same concentrations of SHAM and fungicide, in order to 
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obtain EC50 values for the azoxystrobin-resistant isolates, since pyraclostrobin has greater 
intrinsic activity than azoxystrobin. 
3.2.3 DNA extraction 
Isolates QUB 30-10,788, K1124, Rs 9528.4, GKII 18-2-3, RS 219, RS 783, R. s. 2310 4.2, 
R. s. 2318 4.2, R. s. 2313 4.2 and R. s. 2314 4.2 were selected for DNA extraction and 
sequencing as they had a range of Qol sensitivities. 
Isolates were grown in Sabouraud liquid medium for ten days. Fungal material was harvested 
by filtration and freeze-dried. DNA was extracted by grinding for 45 seconds at 5 m/s in a 
FastPrep-24 homogeniser (MP Biomedicals, Ohio) with 7O0µ1 DNA extraction buffer (95m1 
2x TEN (400mM Trizma hydrochloride, 50mM EDTA, 500mM sodium chloride), 95m12% 
SDS, 0.39g phenanthroline monohydrate C18H8N-HZO (Sigma), 4. Og polyvinylpyrrolidone 
(Sigma), 9.5ml 1% ß-mercaptoethanol). Samples were incubated at 65°C for 20 minutes, 
350pl ice-cold ammonium acetate was added, samples incubated on ice for 20 minutes then 
centrifuged at 13200 rpm for 15 minutes. The supernatant was added to 900µl ice-cold 
isopropanol, incubated at room temperature for 15 minutes and centrifuged for 15 minutes. 
The supernatant was discarded, the pellet washed twice with 4O0µ170% ethanol, dried on a 
heat block at 65°C and re-suspended in 200µ1 sterile distilled water. DNA was quantified 
with a NanoDrop spectrophotometer (NanoDrop products, Detroit), then diluted to 20ng µl"1 
in sterile distilled water. 
3.2.4 Target site sequence analysis 
A PCR reaction was carried out using Red Hot Taq (ABgene, Epsom, UK) according to 
manufacturer's instructions, with 1.5mM MgC12,0.2µM dNTPs, 0.2µM primers and 2ng µl"1 
template, with cytochrome b primers Forwards 1 and Reverse 1 (Table 3.2). Primers were 
designed in Vector NTI (Invitrogen Corporation), based on the cytochrome b sequence of R. 
secalis isolate Syl-14. The PCR programme comprised 2 minutes at 94°C; followed by 40 
cycles of 30 seconds at 94°C, 1 minute at 58°C and 90 seconds at 72°C; followed by 5 
minutes at 72°C. 
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Table 3.2. Primers used for amplification and expression analysis of cytochrome b and AOX genes of R. 
secalis 
Gene Primer name Primer sequence 
cytochrome b Forward 1 5'-CGATTCACCACAACCATCTAATCTAAG-3' 
Reverse 1 5'-AAGGCGAAGAATAGTCTATTGACGTGTT-3' 
AOX Forward 1 5'-GAACACCAGGTTTGACTCCCAATCAT-3' 
Reverse 1 5'-CATCTTAGTCTTTCCGTCGTGTTCAT-3' 
Expression F 5'-TCTCCACAACACCTCGAACACAACTA-3' 
Expression R 5'-AAGGCTTGGTTTCCGTAACAGCATT-3' 
ß-tubulin 
Expression F 5'-GTGCAGTCACTGTTCCAGAGTTGACC -3' (RT-qPCR 
Expression R 5'-GCGGTTTGGACATTGGTGGG -3' 
endogenous control) 
Products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega, 
Wisconsin, USA), eluting into 50µl sterile distilled water. Purified PCR products were ligated 
into the pGEM-t Easy plasmid vector (Promega) using T4 DNA ligase (Promega) according 
to manufacturer's instructions. JM109 competent cells (Promega) were transformed 
according to manufacturer's instructions, using blue-white screening for plasmids with 
inserts. White transformant colonies were suspended in 50µl sterile distilled water. PCR 
reactions to screen colonies were set up as described above, with 10% volume transformant 
suspension as template. The PCR programme started with 2.5 minutes at 94°C to lyse the 
bacterial cells, followed by 40 cycles of 30 seconds at 94°C, 60 seconds at 58°C and 60 
seconds at 72°C, followed by 5.5 minutes at 72°C. One transformant for each PCR product 
was selected for sequencing. The bacterial suspension was added to 5ml LB broth and 
incubated overnight at 37°C with shaking. Plasmid DNA was then extracted and purified 
using the GeneElute (Sigma) or QIASpin (Qiagen) mini-prep kits, according to pack 
instructions. DNA samples were sequenced by Eurofins MWG (Germany). Sequences were 
assembled in the ContigExpress module of Vector NTI (Invitrogen Corporation), vector 
sequence was removed and amino acid sequences predicted in Vector NTI, and sequences 
aligned using the ClustalW algorithm implemented in the AlignX module of Vector NTI. 
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3.2.5 AOX sequence analysis 
A text search was carried out for A OX and "Alternative Oxidase" on GenBank 
(http: //www. ncbi. nlm. nih. gov/genbank/), within the Leotiomycetes (Goodwin 2002), 
followed by BLAST cross-searching. A tBLASTn search of the translated S. sclerotiorum, B. 
cinerea and B. graminis f. sp. tritici sequences was carried out against the R. secalis genome 
currently in preparation at the Scottish Crop Research Institute (Anna Avrova, personal 
communication). 
The R. secalis A OX gene was amplified from genomic DNA, extracted as described in section 
3.2.3, for isolates K1124, RS 783 and SCRI 13-13. Additionally, for isolates KI 124 and RS 
783, AOX was amplified from cDNA, synthesised as described in section 3.2.6. PCR 
reactions were carried out using Easy-A High-Fidelity PCR Cloning Enzyme (Stratagene, 
California, USA) according to manufacturer's instructions, with 50 ng genomic or 1% cDNA 
template. The PCR programme comprised 2 minutes at 95°C; followed by 30 cycles of 40 
seconds at 95°C, 30 seconds at 65°C and 2 minutes at 72°C; followed by 7 minutes at 72°C. 
PCR was carried out with primers AOX Forward 1 and Reverse 1 (Table 3.2). Primers were 
designed based on the AOX BLAST match from the R. secalis genome (Section 3.3.4) in 
Vector NTI (Invitrogen Corporation). PCR products were purified, cloned and sequenced as 
described in section 3.2.4. 
Sequences were assembled in the ContigExpress module of Vector NTI (Invitrogen 
Corporation), vector sequence was removed and amino acid sequences predicted in Vector 
NTI, and sequences aligned using the ClustaiW and MUSCLE algorithms implemented in 
BioEdit (Hall 1999). The R. secalis AOX predicted amino acid sequence was analysed for 
possible mitochondrial import using MitoProt II (Claros and Vincens 1996). 
Phylogenetic analyses were carried out with R. secalis AOX sequences and the AOX 
sequences from GenBank, along with AOX sequences from selected fungal genomes, as 
shown in Figure 3.8 - Figure 3.10. tBLASTn searches were carried out on fungal genomes 
using the predicted protein sequences of both C. albicans AOX paralogues as query 
sequences. Amino acid sequences were aligned using the ClustalW algorithm implemented in 
BioEdit (Hall 1999). Corresponding alignments of coding nucleotide sequences were created 
in PAL2NAL (Suyama et al. 2006). Neighbour joining and maximum parsimony trees were 
calculated from the PAL2NAL alignment of coding DNA sequences in PAUP* 4. Obeta 
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(Swofford 1991), with 100 bootstrap replicates. A maximum likelihood tree was 
reconstructed from the coding DNA sequence alignment using the CodeML programme 
implemented in TOPALi, with the GTR+I+G substitution model selected according to the 
Akaike Information Criterion, and 1000 bootstrap runs. Bayesian analysis was carried out in 
MrBayes, with the GTR+I+G model, and other parameters on default settings including a 
random starting tree. A two-chain MCMC analysis was carried out for 500,000 generations, 
sampling every 100 generations, with a bum-in of 1250 samples, and a 50% strict consensus 
tree was constructed. 
3.2.6 AOX expression analysis 
To investigate constitutive and induced expression, isolates 788, K1124, RS 783, R. s. 2310 
4.2, R. s. 2313 4.2, R. s. 2314 4.2 and R. s. 2318 4.2 were selected to cover a range of QoI 
sensitivities. Isolates were grown in 100ml Sabouraud liquid medium at 2.5 x 104 spores ml-1 
in an orbital shaker at 150 rpm at 20°C, with two flasks per isolate. Azoxystrobin sensitivity 
assays with 0 and 40 µg ml-1 SHAM were set up as described above using the same inoculum. 
After seven days, 10µl of 10mg ml-1 azoxystrobin in acetone, giving a final azoxystrobin 
concentration of 1µg ml"', was added to one flask of each isolate, and l0µ1 of acetone only 
was added to the other flask. The cultures were harvested three days later. 
Induced expression was then measured over a shorter time after fungicide addition. To 
investigate induced expression, it was not possible to add a concentration of azoxystrobin that 
would inhibit cytochrome b in isolates carrying the G143A substitution without killing all 
other isolates, so four pre-2008 isolates with a range of QoI sensitivities were used. Isolates 
788, KI 124, R 9528.4 and RS 783 were grown as described. After seven days, one flask per 
isolate was harvested before adding azoxystrobin. The remaining flasks were harvested 30 
minutes, 1 hour, 2 hours and 4 hours after adding the fungicide. 
Fungal material was harvested by vacuum filtration, immediately placed into liquid nitrogen 
then stored at -80°C before freeze-drying. RNA extraction was carried out with TRIzol 
Reagent (Invitrogen, California, USA), according to manufacturer's instructions, using a 
tissue homogeniser for 2 minutes, with two phase separation steps, and resuspending the 
pellet in 50µl TE. An equal volume of 8M lithium chloride was added, the mixture was 
incubated overnight at 4°C, then centrifuged at 4°C for 30 minutes and the supernatant 
discarded. The RNA pellet was washed with 70% ethanol, dried at room temperature, 
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resuspended in RNase-free water and stored at -80°C. The RNA was treated with the TURBO 
DNA-free Kit (Applied Biosystems, California, USA). cDNA was synthesised with the 
Superscript III first-strand synthesis system (Invitrogen, California, USA). End-point PCRs 
were carried out with Red Hot Taq as described in section 3.2.4 with AOX primers 
Expression F and Expression R (Table 3.2) to check for genomic DNA contamination. 
Quantitative PCR was carried out using SYBR Green JumpStart Taq ReadyMix (Sigma), in 
25µ1 reactions with 0.25µM primers and 0.2% cDNA template, with the 7500 Real Time 
PCR System (Applied Biosystems). AOX and ß-tubulin primers Expression F and Expression 
R were used (Table 3.2), withß-tubulin used as the endogenous control. Primers were 
designed in Vector NTI (Invitrogen Corporation), based on the AOX BLAST match from the 
R. secalis genome (Section 3.3.4) and an R. secalis ß-tubulin sequence provided by Bart 
Fraaije (unpublished data). The PCR cycle comprised 2 minutes at 95°C; followed by 40 
cycles of 15 seconds at 95°C, 30 seconds at 58°C and 36 seconds at 72°C at which point the 
reading was taken; followed by a dissociation cycle of 15 seconds at 95°C, 1 minute at 60°C 
and 15 seconds at 95°C. 
Results were analysed using the 7500 System software (Applied Biosystems). Relative gene 
expression was calculated as 2-6'°CT (Livak and Schmittgen 2001), where CT is the threshold 
cycle number and At CT is the target CT relative to the endogenous control gene and a 
calibrator sample. In this case ß-tubulin was used as the endogenous control gene, and isolate 
788 without fungicide was the calibrator sample for each experiment. Three technical 
replicates were carried out for each reaction. 
SHAM potentiation was calculated as 
PSHAM = 
ECSO(Azoxystrobin)afone 
(Wood and Hollomon 2003). ECsO(Azoxystrobin)+4o µg MI-1SHAM 
Correlation of SHAM potentiation with AOX expression was tested by least squares linear 
regression analysis in GenStat 13th Edition (VSN International, Hertfordshire, UK). 
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3.3 Results 
3.3.1 Sensitivity testing 
A full list of azoxystrobin EC50 values is given in Appendix 1. For pre-2008 isolates, EC50 
values obtained without SHAM show considerable variability, ranging from 0.0135 to 2.58 
µg ml-1. The EC50 values obtained with 40 . tg ml-' SHAM were generally lower than those 
without AOX inhibition, and 90% are within the range 0.015 to 0.15 µg ml-' (Figure 3.1). 
There was a significant (P<0.01) positive correlation between azoxystrobin EC50 values with 
and without 40 . tg ml-' SHAM. However, on closer examination of the data, the correlation 
was significant (P<0.01) among those isolates with azoxystrobin EC50 values less than 0.06 
µg ml-' without SHAM, but not significant (P>0.1) among those isolates with higher EC5o 
values (Figure 3.1). Of the 2008 isolates, R. s. 2310 4.2 and R. s. 2318 4.2 had azoxystrobin 
EC50 values within the ranges previously seen with and without 40 µg ml"' SHAM (Figure 
3.1), whereas isolates R. s. 2313 4.2 and R. s. 2314 4.2 did not show a 50% reduction in 
growth even at the maximum tested concentration of 100µg ml-' azoxystrobin, with 0 or 
40µg ml-1 SHAM, and therefore could not be included in Figure 3.1. 
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Figure 3.1. Scatter plots showing EC50 for azoxystrobin with 40 µg ml-' SHAM against EC50 values for 
azoxystrobin without SHAM for R. secalis isolates. Black: isolates with azoxystrobin EC50 without SHAM 
less than 0.06 µg ml-'; white: isolates with azoxystrobin EC50 without SHAM greater than 0.06 µg ml-'; 
grey, isolates selected for sequence analysis. 1: 788; 2: R. s. 2310 4.2; 3: RS 219; 4: R. s. 2318 4.2; 5: GKII 
18-2-3; 6: R9528.4; 7: KI 124; 8: RS 783. Bold numbers indicate isolates used in the 4-hour AOX 
expression analysis experiment. 
3.3.2 SHAM matrix assays 
As SHAM concentration increased from 0 to 120 pg ml-1, the azoxystrobin EC50 of isolate 
788 remained in the range 0.014 to 0.030 µg ml-' (Figure 3.2 a and e), whereas the 
azoxystrobin EC50 of isolates K1124 and RS 783 decreased from 0.094 to 0.017 . ig ml-' 
(Figure 3.2 b and e), and from 2.54 to 0.049 µg ml-' (Figure 3.2 c and e), respectively. Isolate 
R9528.4 was intermediate between isolates 788 and K1124 (Figure 3.2 e). Above 
120 µg ml-1, SHAM itself was toxic, with EC50s for SHAM alone ranging from 140-470 µg 
ml-1 (Figure 3.2 d). 
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Figure 3.2. (a-c) Dose-response curves of fungal growth against azoxystrobin concentration, and 
azoxystrobin ECso values, for three R. secalis isolates, with a range of SHAM concentrations: (a) Isolate 
788; (b) K1124; (c) RS 783. Red: 0g ml"' SHAM, orange: 1.48 gg ml-1; yellow, 4.44 gg ml''; green, 13.3 µg 
ml'; blue, 40 µg ml-'; dark blue, 120 µg ml''; purple, 360 pg ml-'; grey, 1080 µg ml-'. (d) Dose-response 
curves of fungal growth against SHAM without Qol fungicide. Red: isolate 788; blue: K1124; green: 
9528.4; yellow: RS 783. (e) Comparison of azoxystrobin EC50 values for different SHAM concentrations; 
isolates as in (d). 
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Of the 2008 isolates, R. s. 2310 4.2 had azoxystrobin EC50 values of around 0.02-0.04 pg ml-' 
regardless of SHAM concentration. Isolates R. s. 2313 4.2 and R. s. 2314 4.2 did not show 
sufficiently reduced growth at the azoxystrobin concentrations tested for EC50 values to be 
calculated (data not shown). Isolate R. s. 2310 4.2 had pyraclostrobin EC50 values of around 
0.01-0.03 µg ml"' regardless of SHAM concentration (Figure 3.3a). Pyraclostrobin EC50 of 
isolate R. s. 2318 4.2 decreased from 0.145 to 0.026 µg ml"' as SHAM concentrations 
increased from 0 to 40µg ml-' (Figure 3.3b). Isolate R. s. 2314 4.2 had EC50 values of 1.5-2.5 
µg ml-1 regardless of SHAM concentration (Figure 3.3c), as did isolate R. s. 2313 4.2 with the 
exception of two anomalous values (Figure 3.3d). 
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Figure 3.3. Dose-response curves of fungal growth against pyraclostrobin concentration for four R. secalis 
isolates with a range of SHAM concentrations: (a) Dose-response curves for isolate R. s. 2310 4.2; (b) 
Dose-response curves for isolate R. s. 2318 4.2; (c) Dose-response curves for isolate R. s. 2314 4.2; (d) 
Dose-response curves for isolate R. s. 2313 4.2; with a range of SHAM concentrations: Red: 0 µg ml-1; 
orange: 0.0549 pg ml-'; yellow, 0.165 µg ml''; green, 0.494 µg ml"'; blue, 1.48 µg ml'; dark blue, 4.44 µg 
ml'; purple, 13.3 µg ml"; black, 40 µg ml-'. 
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3.3.3 Target site sequence analysis 
A 1118-base pair fragment of cytochrome b, encompassing base pairs 54-1171 of the 
genomic sequence, was amplified from the seven pre-2008 isolates. There were no 
differences in predicted amino acid sequence (Appendix 2). Of the 2008 French isolates, R. s. 
2310 4.2 and R. s. 2318 4.2 had identical predicted amino acid sequences to the pre-2008 
isolates, whereas R. s. 2313 4.2 and R. s. 2314 4.2 carried the G143A amino acid substitution 
(Figure 3.4), due to the substitution of a cytosine in place of a guanine at nucleotide position 
428 (Figure 3.5). 
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1 6U 
Syl-14 (1) MRIFKSHPLLKLVNSYIIDSPQPSNLSYLWNFGSLLAVCLAIQIVTGVTLAMHYNPSILE 
R. s. 2310 4.2 (1) ----------------------------------------------------HYNPSILE 
R. s. 2313 4.2 (1) ----------------------------------------------------HYNPSILE 
R. ß. 2314 4.2 (1) ----------------------------------------------------HYNPSILE 
R. s. 2318 4.2 (1) ----------------------------------------------------HYNPSILE 
61 120 
Syl-14 (61) AFNSIEHIMRDVNNGWLIRYLHSNTASFFFFLVYLHMGRGLYYGSYRAPRTLVWTIGTFI 
R. s. 2310 4.2 (9) AFNSIEHIMRDVNNGWLIRYLHSNTASFFFFLVYLHMGRGLYYGSYRAPRTLVWTIGTFI 
R. s. 2313 4.2 (9) AFNSIEHIMRDVNNGWLIRYLHSNTASFFFFLVYLHMGRGLYYGSYRAPRTLVWTIGTFI 
R. s. 2314 4.2 (9) AFNSIEHIMRDVNNGWLIRYLHSNTASFFFFLVYLHMGRGLYYGSYRAPRTLVWTIGTFI 
R. s. 2318 4.2 (9) AFNSIEHIMRDVNNGWLIRYLHSNTASFFFFLVYLHMGRGLYYGSYRAPRTLVWTIGTFI 
121 180 
Syl-14 (121) FILMIVTAFLGYVLPYGQMSL TVITNLMSAIPWIGQDIVEFIWGGFSVNNATLNRFF 
R. s. 2310 4.2 (69) FILMIVTAFLGYVLPYGQMSL TVITNLMSAIPWIGQDIVEFIWGGFSVNNATLNRFF 
R. s. 2313 4.2 (69) FILMIVTAFLGYVLPYGQMSL TVITNLMSAIPWIGQDIVEFIWGGFSVNNATLNRFF 
R. s. 2314 4.2 (69) FILMIVTAFLGYVLPYGQMSL TVITNLMSAIPWIGQDIVEFIWGGFSVNNATLNRFF 
R. s. 2318 4.2 (69) FILMIVTAFLGYVLPYGQMSL TVITNLMSAIPWIGQDIVEFIWGGFSVNNATLNRFF 
181 240 
Syl-14 (181) ALHFVLPFILAALVLMHLIALHDSAGSGNPLGVSGNYDRLPFAPYFLFKDLITIFLFIFV 
R. s. 2310 4.2 (129) ALHFVLPFILAALVLMHLIALHDSAGSGNPLGVSGNYDRLPFAPYFLFKDLITIFLFIFV 
R. s. 2313 4.2 (129) ALHFVLPFILAALVLMHLIALHDSAGSGNPLGVSGNYDRLPFAPYFLFKDLITIFLFIFV 
R. s. 2314 4.2 (129) ALHFVLPFILAALVLMHLIALHDSAGSGNPLGVSGNYDRLPFAPYFLFKDLITIFLFIFV 
R. s. 2318 4.2 (129) ALHFVLPFILAALVLMHLIALHDSAGSGNPLGVSGNYDRLPFAPYFLFKDLITIFLFIFV 
241 300 
Syl-14 (241) LSLFVFFMPNVLGDSENYVVANPMQTPPAIVPEWYLLPFYAILRSIPNKLLGVIAMLSAI 
R. s. 2310 4.2 (189) LSLFVFFMPNVLGDSENYVVANPMQTPP-------------------------------- 
R. s. 2313 4.2 (189) LSLFVFFMPNVLGDSENYVVANPMQTPP-------------------------------- 
R. s. 2314 4.2 (189) LSLFVFFMPNVLGDSENYVVANPMQTPP-------------------------------- 
R. s. 2318 4.2 (189) LSLFVFFMPNVLGDSENYVVANPMQTPP -------------------------------- 
301 360 
Syl-14 (301) LVILAMPFTDLSRSRGIQFRPLSKIAFYIFVANFLILMVLGAKHVESPFIEFGQISTVIY 
R. s. 2310 4.2 (217) ------------------------------------------------------------ 
R. s. 2313 4.2 (217) ------------------------------------------------------------ 
R. s. 2314 4.2 (217) ------------------------------------------------------------ 
R. s. 2318 4.2 (217) ------------------------------------------------------------ 
361 397 
Syl-14 (361) FSHFLIIVPLVSLIENSLIDLNTSIDYSSPSVLEKA- 
R. s. 2310 4.2 (217) ------------------------------------- 
R. s. 2313 4.2 (217) ------------------------------------- 
R. s. 2314 4.2 (217) ------------------------------------- 
R. s. 2318 4.2 (217) ----------------------------------- 
Figure 3.4. Translated aligned sequences of cytochrome b from R. secalis isolates Syl-14 (Torriani, 2004), 
R. s. 2310 4.2, R. s. 2318 4.2, R. s. 2313 4.2 and R. s. 2314 4.2. Position 143 is highlighted. 
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Syl-14 (1) ATGAGAATATTTAAGAGTCATCCTTTATTAAAATTGGTTAATTCCTATATAATCGATTCACCACAACCATCTAATCTAAGCTAC 
R. s. 2310 4.2 (1) ------------------------------------------------------------------------------------ 
R. s. 2313 4.2 (1) ------------------------- ---------------------------------------------------------- 
R. s. 2314 4.2 (1) ------------------------------------ ---------------- ------------ 
R. s. 2318 4.2 (1) ------------------------------------------------------------------------------------ 
Syl-14 (85) TTATGAAATTTTGGTTCTTTATTAGCCGTTTGTTTAGCTATACAAATAGTTACAGGTGTAACATTGGCTATGCATTACAACCCT 
R. s. 2310 4.2 (1) ----------------------------------------------------------------------TGCATTACAACCCT 
R. s. 2313 4.2 (1) ----------------------------------------------------------------------TGCATTACAACCCT 
R. s. 2314 4.2 (1) ----------------------------------------------------------------------TGCATTACAACCCT 
R. s. 2318 4.2 (1) ----------------------------------------------------------------------TGCATTACAACCCT 
Sy1-14 (169) AGTATATTAGAAGCGTTTAATTCCATAGAACATATTATGCGTGATGTAAATAACGGATGATTAATACGTTACTTACATAGTAAC 
R. s. 2310 4.2 (15) AGTATATTAGAAGCGTTTAATTCCATAGAACATATTATGCGTGATGTAAATAACGGATGATTAATACGTTACTTACATAGTAAC 
R. s. 2313 4.2 (15) AGTATATTAGAAGCGTTTAATTCCATAGAACATATTATGCGTGATGTAAATAACGGATGATTAATACGTTACTTACATAGTAAC 
R. s. 2314 4.2 (15) AGTATATTAGAAGCGTTTAATTCCATAGAACATATTATGCGTGATGTAAATAACGGATGATTAATACGTTACTTACATAGTAAC 
R. s. 2318 4.2 (15) AGTATATTAGAAGCGTTTAATTCCATAGAACATATTATGCGTGATGTAAATAACGGATGATTAATACGTTACTTACATAGTAAC 
Syl-14 (253) ACTGCATCTTTTTTCTTCTTCCTAGTGTATTTACACATGGGTAGAGGTTTATATTATGGGTCATACAGAGCACCTAGAACATTA 
R. s. 2310 4.2 (99) ACTGCATCTTTTTTCTTCTTCCTAGTGTATTTACACATGGGTAGAGGTTTATATTATGGGTCATACAGAGCACCTAGAACATTA 
R. s. 2313 4.2 (99) ACTGCATCTTTTTTCTTCTTCCTAGTGTATTTACACATGGGTAGAGGTTTATATTATGGGTCATACAGAGCACCTAGAACATTA 
R. s. 2314 4.2 (99) ACTGCATCTTTTTTCTTCTTCCTAGTGTATTTACACATGGGTAGAGGTTTATATTATGGGTCATACAGAGCACCTAGAACATTA 
R. s. 2318 4.2 (99) ACTGCATCTTTTTTCTTCTTCCTAGTGTATTTACACATGGGTAGAGGTTTATATTATGGGTCATACAGAGCACCTAGAACATTA 
Syl-14 (337) GTATGAACAATAGGTACATTTATATTCATATTAATGATCGTTACAGCATTCTTGGGTTATGTGCTTCCTTATGGACAGATGTCT 
R. S. 2310 4.2 (183) GTATGAACAATAGGTACATTTATATTCATATTAATGATCGTTACAGCATTCTTGGGTTATGTGCTTCCTTATGGACAGATGTCT 
R. $. 2313 4.2 (183) GTA°'?. nGTACATTTATATTCATATTAATGATCGTTACAGCATTCTTGGGTTATGTGCTTCCTTATGGACAGATGTCT 
R. s. 2314 4.2 (183) G°' ; TACATTTATATTCATATTAATGATCGTTACAGCATTCTTGGGTTATGTGCTTCCTTATGGACAGATGTCT 
R. s. 2318 4.2 (183) G1 ; TACATTTATATTCATATTAATGATCGTTACAGCATTCTTGGGTTATGTGCTTCCTTATGGACAGATGTCT 
yvy 
Syl-14 (421) TT: G l, CAGTTATAACTAATCTTATGAGTGCTATACCTTGAATAGGTCAAGACATTGTTGAGTTTATCTGAGGGGGT 
R. s. 2310 4.2 (267) TTI,. G :. CAGTTATAACTAATCTTATGAGTGCTATACCTTGAATAGGTCAAGACATTGTTGAGTTTATCTGAGGGGGT 
R. s. 2313 4.2 (267) TTAT, ýi, GCIGC: CACAGTTATAACTAATCTTATGAGTGCTATACCTTGAATAGGTCAAGACATTGTTGAGTTTATCTGAGGGGGT 
R. s. 2314 4.2 (267) TTATGAGCTGCCACAGTTATAACTAATCTTATGAGTGCTATACCTTGAATAGGTCAAGACATTGTTGAGTTTATCTGAGGGGGT 
R. s. 2318 4.2 (267) TTATGAGlTGCCACAGTTATAACTAATCTTATGAGTGCTATACCTTGAATAGGTCAAGACATTGTTGAGTTTATCTGAGGGGGT 
Syl-14 (505) TTTTCTGTTAATAATGCAACTTTAAATAGATTCTTTGCATTACATTTTGTTTTACCGTTTATATTAGCTGCATTAGTATTAATG 
R. s. 2310 4.2 (351) TTTTCTGTTAATAATGCAACTTTAAATAGATTCTTTGCATTACATTTTGTTTTACCGTTTATATTAGCTGCATTAGTATTAATG 
R. s. 2313 4.2 (351) TTTTCTGTTAATAATGCAACTTTAAATAGATTCTTTGCATTACATTTTGTTTTACCGTTTATATTAGCTGCATTAGTATTAATG 
R. s. 2314 4.2 (351) TTTTCTGTTAATAATGCAACTTTAAATAGATTCTTTGCATTACATTTTGTTTTACCGTTTATATTAGCTGCATTAGTATTAATG 
S. s. 2318 4.2 (351) TTTTCTGTTAATAATGCAACTTTAAATAGATTCTTTGCATTACATTTTGTTTTACCGTTTATATTAGCTGCATTAGTATTAATG 
Sy1-14 (589) CACTTAATAGCCTTACACGATAGTGCAGGGTCAGGTAATCCTTTAGGTGTATCAGGTAATTACGATAGATTACCTTTTGCTCCT 
R. s. 2310 4.2 (435) CACTTAATAGCCTTACACGATAGTGCAGGGTCAGGTAATCCTTTAGGTGTATCAGGTAATTACGATAGATTACCTTTTGCTCCT 
R. s. 2313 4.2 (435) CACTTAATAGCCTTACACGATAGTGCAGGGTCAGGTAATCCTTTAGGTGTATCAGGTAATTACGATAGATTACCTTTTGCTCCT 
R. s. 2314 4.2 (435) CACTTAATAGCCTTACACGATAGTGCAGGGTCAGGTAATCCTTTAGGTGTATCAGGTAATTACGATAGATTACCTTTTGCTCCT 
R. s. 2318 4.2 (435) CACTTAATAGCCTTACACGATAGTGCAGGGTCAGGTAATCCTTTAGGTGTATCAGGTAATTACGATAGATTACCTTTTGCTCCT 
Syl-14 (673) TACTTCTTATTCAAAGATTTAATAACTATCTTTTTATTTATCTTTGTATTAAGTTTATTCGTATTCTTCATGCCTAACGTATTA 
R. s. 2310 4.2 (519) TACTTCTTATTCAAAGATTTAATAACTATCTTTTTATTTATCTTTGTATTAAGTTTATTCGTATTCTTCATGCCTAACGTATTA 
S. s. 2313 4.2 (519) TACTTCTTATTCAAAGATTTAATAACTATCTTTTTATTTATCTTTGTATTAAGTTTATTCGTATTCTTCATGCCTAACGTATTA 
S. s. 2314 4.2 (519) TACTTCTTATTCAAAGATTTAATAACTATCTTTTTATTTATCTTTGTATTAAGTTTATTCGTATTCTTCATGCCTAACGTATTA 
R. s. 2318 4.2 (519) TACTTCTTATTCAAAGATTTAATAACTATCTTTTTATTTATCTTTGTATTAAGTTTATTCGTATTCTTCATGCCTAACGTATTA 
Syl-14 (757) GGTGATAGTGAAAATTACGTTGTAGCTAACCCTATGCAAACTCCACCTGCGATAGTTCCGGAGTGATATTTACTACCTTTCTAT 
R. s. 2310 4.2 (603) GGTGATAGTGAAAATTACGTTGTAGCTAACCCTATGCAAACTCCACCT------------------------------------ 
5. s. 2313 4.2 (603) GGTGATAGTGAAAATTACGTTGTAGCTAACCCTATGCAAACTCCACCT------------------------------------ 
R. s. 2314 4.2 (603) GGTGATAGTGAAAATTACGTTGTAGCTAACCCTATGCAAACTCCACCT------------------------------------ 
R. s. 2318 4.2 (603) GGTGATAGTGAAAATTACGTTGTAGCTAACCCTATGCAAACTCCACCT------------------------------------ 
Syl-14 (841) GCTATATTAAGATCTATACCTAACAAATTATTAGGTGTTATAGCTATGCTTAGTGCTATATTAGTTATATTAGCTATGCCATTT 
Syl-14 (925) ACAGATTTAAGTAGATCTAGAGGTATACAATTTAGACCTTTAAGTAAAATAGCTTTTTATATTTTTGTTGCTAATTTCTTAATA 
Syl-14 (1009) TTAATGGTGTTAGGTGCTAAACACGTTGAATCACCATTCATAGAATTTGGACAAATAAGTACCGTAATATATTTCTCACACTTT 
Syl-14 (1093) TTAATCATAGTGCCTTTGGTTTCTTTAATAGAAAACAGTTTAATAGATTTAAACACGTCAATAGACTATTCTTCGCCTTCCGTT 
Syl-14 (1177) TTAGAAAAAGCGTAA (1191) 
Figure 3.5. Aligned DNA sequences of cytochrome b from R. secalis isolates Syl-14(Torriani, 2004), R. s. 
2310 4.2, R. s. 2318 4.2, R. s. 2313 4.2 and R. s. 2314 4.2. Arrows indicate codon 143. 
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3.3.4 AOX sequence analysis 
AOX sequences for S. sclerotiorum, B. cinerea and B. graminis f. sp. hordei were found on 
GenBank. A tBLASTn search of the predicted protein sequences against the R. secalis initial 
genome contigs gave the same three significant matches for each query sequence. The three 
fragments were all on one contig and appeared to be from three exons, separated by two 
introns. Genomic and cDNA sequences from isolates K1124 and RS 783 confirmed the 
predicted introns, with no genomic sequence differences between the three isolates (Figure 
3.6). The first intron, between base pairs 251-307, is present in R. secalis and predicted in S. 
sclerotiorum, B. cinerea and B. graminis f. sp. hordei. A second predicted intron in S. 
sclerotiorum and B. cinerea is present between base pairs corresponding to 650-651 of the R. 
secalis gene, whereas a second intron in R. secalis is situated between base pairs 874-928 
(Figure 3.7). 
In a HMMER3 search of the Pfam protein families databases with the R. secalis predicted 
amino acid sequence, the Pfam A family "Alternative oxidase" as the only significant match, 
with an E-value of 3.1 e"87. All the highly conserved regions identified by Berthold et al. 
(2000) are present, except the "LET" region comprises the fungal variant "LES" (Figure 3.7). 
Analysis with MitoProt II gave 0.9903% probability of the R. secalis AOX predicted peptide 
being mitochondrially imported, with a predicted cleavage site at residue 72,11 base pairs 
downstream of the predicted site in S. sclerotiorum, B. cinerea and B. graminis f. sp. hordes 
(Figure 3.7). 
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13-13 Genomic (1)ATGTATGTCGCAAGGGTATCAACAAAGCTTCAACTCTCTAAGCAATCTGCTGCACAGCTCTCGAGAGCAGTGACTACTTGCTCCCAA 
K1124 Genomic (1)ATGTATGTCGCAAGGGTATCAACAAAGCTTCAACTCTCTAAGCAATCTGCTGCACAGCTCTCGAGAGCAGTGACTACTTGCTCCCAA 
K1124 cDNA (1)ATGTATGTCGCAAGGGTATCAACAAAGCTTCAACTCTCTAAGCAATCTGCTGCACAGCTCTCGAGAGCAGTGACTACTTGCTCCCAA 
RS 783 Genomic (1)ATGTATGTCGCAAGGGTATCAACAAAGCTTCAACTCTCTAAGCAATCTGCTGCACAGCTCTCGAGAGCAGTGACTACTTGCTCCCAA 
RS 783 cDNA (1) ATGTATGTCGCAAGGGTATCAACAAAGCTTCAACTCTCTAAGCAATCTGCTGCACAGCTCTCGAGAGCAGTGACTACTTGCTCCCAA 
13-13 Genomic (88)TGCCATGGAGGCTCAACGAACGCAGCAGGTTTTCGTTTGACAGCTGCAC)TCTACAATCGCGCCGCCAGTTCTCCACAACACCTCGA 
K1124 Genomic (88)TGCCATGGAGGCTCAACGAACGCAGCAGGTTTTCGTTTGACAGCTGCACIJTCTACAATCGCGCCGCCAGTTCTCCACAACACCTCGA 
K1124 cDNA (88)TGCCATGGAGGCTCAACGAACGCAGCAGGTTTTCGTTTGACAGCTGCAC$TCTACAATCGCGCCGCCAGTTCTCCACAACACCTCGA 
RS 783 Genomic (88)TGCCATGGAGGCTCAACGAACGCAGCAGGTTTTCGTTTGACAGCTGCAC&TCTACAATCGCGCCGCCAGTTCTCCACAACACCTCGA 
RS 783 cDNA (88)TGCCATGGAGGCTCAACGAACGCAGCAGGTTTTCGTTTGACAGCTGCACCTCTACAATCGCGCCGCCAGTTCTCCA. ". n"'^--CGA 
13-13 Genomis (175) ACACAACTACGAGATATATTCCCTTCTCCAGAACATGAGCATATCAAGAAGACCGAAGCCGCTTGGCCTCATCCI: 'GTAAGCCM 
K1124 Genomis (175) ACACAACTACGAGATATATTCCCTTCTCCAGAACATGAGCATATCAAGAAGACCGAAGCCGCTTGGCCTCATCC/. "GTAAGCC'# 
K1124 cDNA (175)ACACAACTACGAGATATATTCCCTTCTCCAGAACATGAGCATATCAAGAAGACCGAAGCCGCTTGGCCTCATCCA---- 
RS 783 Genomis (175) ACACAACTACGAGATATATTCCCTTCTCCAGAACATGAGCATATCAAGAAGACCGAAGCCGCTTGGCCTCATCC: °,! "'GTAAGCC= 
RS 783 cDNA (175) ACACAACTACGAGATATATTCCCTTCTCCAGAACATGAGCATATCAAGAAGACCGAAGCCGCTTGGCCTCATCCACC---------- 
13-13 Genomis (262) TACGATGGCGAAAAAATAAAGAATGATATCTACTACGCCCA 
K1124 Genomis (262) TACGATGGCGAAAAAATAAAGAATGATATCTACTACGCCCA 
K1124 cDNA (252) --------------------------------------------- ATACCATGGCGAAAAPATAAAGAATrATATCTACTACGCCCA 
RS 783 Genomic (262) TACGATGGCGAAAAAATAAAGAATGATATCTACTACGCCCA 
RS 783 cDNA (252)--------------------------------------------- ATACGATGGCGAAAAAATAAAGAATGATATCTACTACGCCCA 
13-13 Genomic (349) TCGAGAGCCCCAAGACTTCAGTGATAGAATAGCTCTCTTCATGGTTCGCTTACTTCGATTCGGAATGGATACAGCTACACGGTATAA 
K1124 GenomiC (349) TCGAGAGCCCCAAGACTTCAGTGATAGAATAGCTCTCTTCATGGTTCGCTTACTTCGATTCGGAATGGATACAGCTACACGGTATAA 
K1124 cDNA (294)TCGAGAGCCCCAAGACTTCAGTGATAGAATAGCTCTCTTCATGGTTCGCTTACTTCGATTCGGAATGGATACAGCTACACGGTATAA 
RS 783 Genomic (349) TCGAGAGCCCCAAGACTTCAGTGATAGAATAGCTCTCTTCATGGTTCGCTTACTTCGATTCGGAATGGATACAGCTACACGGTATAA 
RS 783 cDNA (294) TCGAGAGCCCCAAGACTTCAGTGATAGAATAGCTCTCTTCATGGTTCGCTTACTTCGATTCGGAATGGATACAGCTACACGGTATAA 
13-13 Genomis (436) GCACGACGTCGAAACGCCCAAGAAAATCGGTGACAGCAATGCTGTTACGGAAACCAAGCCTTACGCAATGTCCGAGAAGAAATGGCT 
K1124 Genomis (436) GCACGACGTCGAAACGCCCAAGAAAATCGGTGACAGCAATGCTGTTACGGAAACCAAGCCTTACGCAATGTCCGAGAAGAAATGGCT 
K1124 cDNA (381)GCACGACGTCGAAACGCCCAAGAAAATCGGTGACAGCAATGCTGTTACGGAAACCAAGCCTTACGCAATGTCCGAGAAGAAATGGCT 
RS 783 Genomic (436) GCACGACGTCGAAACGCCCAAGAAAATCGGTGACAGCAATGCTGTTACGGAAACCAAGCCTTACGCAATGTCCGAGAAGAAATGGCT 
RS 783 cDNA (381) GCACGACGTCGAAACGCCCAAGAAAATCGGTGACAGCAATGCTGTTACGGAAACCAAGCCTTACGCAATGTCCGAGAAGAAATGGCT 
13-13 Genomis (523) CATCCGAATGGTATTTCTCGAATCTGTTGCAGGTGTACCAGGGATGGTCGCTGGGATGGTTCGCCACCTTCATAGTTTGAGACGACT 
K1124 Genomis (523) CATCCGAATGGTATTTCTCGAATCTGTTGCAGGTGTACCAGGGATGGTCGCTGGGATGGTTCGCCACCTTCATAGTTTGAGACGACT 
K1124 cDNA (468) CATCCGAATGGTATTTCTCGAATCTGTTGCAGGTGTACCAGGGATGGTCGCTGGGATGGTTCGCCACCTTCATAGTTTGAGACGACT 
RS 783 Genomic (523)CATCCGAATGGTATTTCTCGAATCTGTTGCAGGTGTACCAGGGATGGTCGCTGGGATGGTTCGCCACCTTCATAGTTTGAGACGACT 
RS 783 cDNA (468)CATCCGAATGGTATTTCTCGAATCTGTTGCAGGTGTACCAGGGATGGTCGCTGGGATGGTTCGCCACCTTCATAGTTTGAGACGACT 
13-13 Genomic (610) CAAGAGAGACAATGGATGGATCGAAACACTACTGGAAGAAGCCTATAATGAGCGGATGCATCTTCTTACATTTCTCAAGATGGCAGA 
K1124 Genomis (610) CAAGAGAGACAATGGATGGATCGAAACACTACTGGAAGAAGCCTATAATGAGCGGATGCATCTTCTTACATTTCTCAAGATGGCAGA 
K1124 cDNA (555) CAAGAGAGACAATGGATGGATCGAAACACTACTGGAAGAAGCCTATAATGAGCGGATGCATCTTCTTACATTTCTCAAGATGGCAGA 
RS 783 Genomic (610) CAAGAGAGACAATGGATGGATCGAAACACTACTGGAAGAAGCCTATAATGAGCGGATGCATCTTCTTACATTTCTCAAGATGGCAGA 
RS 783 cDNA (555) CAAGAGAGACAATGGATGGATCGAAACACTACTGGAAGAAGCCTATAATGAGCGGATGCATCTTCTTACATTTCTCAAGATGGCAGA 
13-13 Genomic (697) GCCTGGCAAATTCATGAAGTTCATGATATTAGGAGCTCAGGGCGTTTTCTTCAACTCGATGTTTCTCTCCTACCTCATTTCGCCAAA 
K1124 Genomis (697)GCCTGGCAP. ATTCATGAAGTTCATGATATTAGGAGCTCAGGGCGTTTTCTTCAACTCGATGTTTCTCTCCTACCTCATTTCGCCAAA 
K1124 cDNA (642) GCCTGGCAAATTCATGAAGTTCATGATATTAGGAGCTCAGGGCGTTTTCTTCAACTCGATGTTTCTCTCCTACCTCATTTCGCCAAA 
RS 783 Genomis (697) GCCTGGCAAATTCATGAAGTTCATGATATTAGGAGCTCAGGGCGTTTTCTTCAACTCGATGTTTCTCTCCTACCTCATTTCGCCAAA 
RS 783 cDNA (642) GCCTGGCAAATTCATGAAGTTCATGATATTAGGAGCTCAGGGCGTTTTCTTCAACTCGATGTTTCTCTCCTACCTCATTTCGCCAAA 
13-13 Genomic (784) GACCTGTCACCGCTTTGTTGGCTATCTTGAGGAGGAGGCCGTCTTGACCTACTCACTTGCCATTCAAGATATTGAGGCTGGCAAGCT 
K1124 Genomis (784)GACCTGTCACCGCTTTGTTGGCTATCTTGAGGAGGAGGCCGTCTTGACCTACTCACTTGCCATTCAAGATATTGAGGCTGGCAAGCT 
K1124 cDNA (729)GACCTGTCACCGCTTTGTTGGCTATCTTGAGGAGGAGGCCGTCTTGACCTACTCACTTGCCATTCAAGATATTGAGGCTGGCAAGCT 
RS 783 Genomic (784) GACCTGTCACCGCTTTGTTGGCTATCTTGAGGAGGAGGCCGTCTTGACCTACTCACTTGCCATTCAAGATATTGAGGCTGGCAAGCT 
RS 783 cDNA (729)GACCTGTCACCGCTTTGTTGGCTATCTTGAGGAGGAGGCCGTCTTGACCTACTCACTTGCCATTCAAGATATTGAGGCTGGCAAGCT 
13-13 Genomic 
K1124 Genomic 
K1124 cDNA 
RS 783 Genomic 
RS 783 cDNA 
(871)0001 
(871)000A 
(816)000A----- 
(871)000A 
(816)000A----- 
AAATGGICTGATCCTAAATTTCAAATCCCT 
TGG, CTGATCCTAAATTTCAAAT000T 
AAATGGCCTGATCCTAAATTTCAAATCCCT 
13-13 GenomiC (958) GCGCTGGCAGTCAATTACTGGAAGATGCCTGAGGGGTCCCGAACTATGAAGGATCTCCTGCTGTACATCAGAGCAGATGAAGCCAAG 
K1124 Genomic (958)GCGCTGGCAGTCAATTACTGGAAGATGCCTGAGGGGTCCCGAACTATGAAGGATCTCCTGCTGTACATCAGAGCAGATGAAGCCAAG 
K1124 cDNA (850) GCGCTGGCAGTCAATTACTGGAAGATGCCTGAGGGGTCCCGAACTATGAAGGATCTCCTGCTGTACATCAGAGCAGATGAAGCCAAG 
RS 783 Genomis (958) GCGCTGGCAGTCAATTACTGGAAGATGCCTGAGGGGTCCCGAACTATGAAGGATCTCCTGCTGTACATCAGAGCAGATGAAGCCAAG 
RS 783 cDNA (850) GCGCTGGCAGTCAATTACTGGAAGATGCCTGAGGGGTCCCGAACTATGAAGGATCTCCTGCTGTACATCAGAGCAGATGAAGCCAAG 
13-13 Genomis (1045) CATCGCGAAGTCAACCATACACTTGGCAATCTTGACCAAAATGAAGATTCGAACCCATTCGTAAGCGAATACAAAGACACCGACCTC 
K1124 Genomis (1045) CATCGCGAAGTCAACCATACACTTGGCAATCTTGACCAAAATGAAGATTCGAACCCATTCGTAAGCGAATACAAAGACACCGACCTC 
K1124 cDNA (937) CATCGCGAAGTCAACCATACACTTGGCAATCTTGACCAAAATGAAGATTCGAACCCATTCGTAAGCGAATACAAAGACACCGACCTC 
RS 783 Genomis(1045)CATCGCGAAGTCAACCATACACTTGGCAATCTTGACCAAAATGAAGATTCGAACCCATTCGTAAGCGAATACAAAGACACCGACCTC 
RS 783 cDNA (937) CATCGCGAAGTCAACCATACACTTGGCAATCTTGACCAAAATGAAGATTCGAACCCATTCGTAAGCGAATACAAAGACACCGACCTC 
13-13 Genomic (1132) CCGCATCCAGGCAAGGGTATCGAGCATATTAAGCCGTTGGGATGGGAAAGAAAAGATGTCATTTGA 
K1124 Genomic (1132) CCGCATCCAGGCAAGGGTATCGAGCATATTAAGCCGTTGGGATGGGAAAGAAAAGATGTCATTTGA 
K1124 cDNA (1024) CCGCATCCAGGCAAGGGTATCGAGCATATTAAGCCGTTGGGATGGGAAAGAAAAGATGTCATTTGA 
RS 783 Genomis(1132) CCGCATCCAGGCAAGGGTATCGAGCATATTAAGCCGTTGGGATGGGAAAGAAAAGATGTCATTTGA 
RS 783 cDNA (1024) CCGCATCCAGGCAAGGGTATCGAGCATATTAAGCCGTTGGGATGGGAAAGAAAAGATGTCATTTGA 
Figure 3.6. Genomic sequence of AOX from R. secalis isolate 13-13, and genomic and cDNA sequences 
from isolates K1124 and RS 783. 
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Figure 3.7. Predicted amino acid sequences for AOX genes from Blumeria graminis f. sp. horde! (GenBank 
AF327336), Botrytis cinerea (Broad Institute genome, gene BC1G_05703.1), Sclerotinia sclerotiorum 
(Broad Institute genome, SS1G_02882.1) and R. secalis. Shaded residues are conserved across the four 
sequences. Highly conserved regions identified by Berthold et a/. (2000) are underlined; arrows indicate 
putative di-iron-binding sites. / indicates intron positions. Wavy underlining indicates predicted 
mitochondrial targeting regions. 
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Searches for A OX genes in a selection of fungal genomes found the sequences included in 
Figure 3.8. No AOX genes were found in the genomes of the other yeast species in the 
Genolevures database. Figure 3.8 shows the Neighbour joining tree. The 50% majority-rule 
consensus of most parsimonious trees was mostly compatible with but less resolved than the 
trees generated by other methods, with a 9-way basal polytomy in the filamentous 
ascomycetes (data not shown). Figure 3.9 shows the Maximum Likelihood phylogenetic tree. 
Bayesian analysis had reached stationarity after 500,000 generations, with the average 
standard deviation of split frequencies <0.01, the plot of log probability against generation 
time showing no apparent trend, and PRSF values in the range 1.000-1.040. The 50% 
majority-rule consensus tree of the maximum posterior probability tree set is shown in Figure 
3.10. Figure 3.11 shows the presence of AOX genes in sequenced yeast genomes, with gene 
loss and duplication events predicted based on the maximum likelihood AOX gene tree. 
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Fusarium graminearum FGSG_01342.32 
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Magnaporthe oryzae MGG_12936.62 
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Pyrenophora tritici-repentis PTRG_11607.12 
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Botrytis cinerea BC 1 G_05703.12 
Sclerotinia sclerotiorum SS 1 G_02882.12 
Figure 3.8. Neighbour-joining cladogram of coding DNA sequences of fungal AOX genes with 
Dictyostelium discoideum as an outgroup. 50% majority-rule consensus of 100 bootstrap replicates. Gene 
sources: 1. Joint Genome Initiative (http: //www. jgi. doe. gov/), 2. Broad Institute 
(http: //www. broadinstitute. org/scientific-community/data), 3. Genolevures (http: //www. genolevures. org/), 
4. GenBank (http: //www. ncbi. nlm. nih. gov/genbank/). Numbers at nodes indicate bootstrap values over 
70. 
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Figure 3.9. Maximum Likelihood phylogram of coding DNA sequences of fungal AOX genes with 
Diclyostelium discoideum as an outgroup. Gene sources: 1. Joint Genome Initiative 
(http: //www. jgi. doe. gov/), 2. Broad Institute (http: //www. broadinstitute. org/scientific-community/data), 3. 
Genolevures (http: //www. genoIevures. org/), 4. GenBank (http: //www. ncbi. nlm. nih. gov/genbank/). 
Numbers at nodes indicate bootstrap values over 70. 
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Figure 3.10. Bayesian phylogram (50% strict consensus) of coding DNA sequences of fungal AOX genes 
with Dictyoslelium discoideum as an outgroup. Gene sources: 1. Joint Genome Initiative 
(http: //www. jgi. doe. gov/), 2. Broad Institute (http: //www. broadinstitute. org/scientific-community/data), 3. 
Genolevures (http: //www. genolevures. org/), 4. GenBank (http: //www. nebi. nIm. nih. gov/genbank/). 
Numbers at nodes indicate posterior probabilities. 
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Saccharomyces paradoxus 
Saccharomyces mikatae 
Saccharomyces kudriazeviae 
Saccharomyces bayanus 
Saccharomyces servazzi 
Saccharomyces exiguus 
Saccharomyces castellii 
Kluyveromyces polyspora 
Kluyveromyces waltii 
Kluyveromyces marxianus 
Pichia angusta 
Debariomyces hansenii 
Pichia sorbitophila 
Del kera blLI eflensis 
Pichia pastoris 
Komagataella phaffü 
Figure 3.11. Saccharomycotina yeast species cladogram compiled by the Genolevures yeast genome 
consortium (Sherman el aL 2009), annotated with AOX gene presence, and predicted gene loss and 
duplication events based on the AOX gene phylogeny shown in Figure 3.8 - Figure 3.10. Shaded species 
have nuclear genomes (complete or draft) available for searching: Pale shading with strikethrough: no 
AOX genes; Mid-grey shading with single outline: one AOX gene, Dark shading with double outline: two 
AOX genes. Crosses indicate predicted gene loss events, arrows indicate predicted gene duplication 
events. 
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3.3.5 AOX expression analysis 
A OX expression three days after addition of azoxystrobin is shown in Figure 3.12. 
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Figure 3.12. AOX expression in R. secalis isolates three days after adding fungicide. Black: no fungicide; 
grey: azoxystrobin, final concentration I jig mf-'. AOX expression is calculated relative to isolate 788 with 
no fungicide. 
There was no correlation between SHAM potentiation (section 3.2.6) and constitutive AOX 
expression, with only acetone added (P=0.995) (Figure 3.13a), nor between SHAM 
potentiation and induced AOX expression, three days after adding 1 gg ml-1 azoxystrobin 
(P=0.845) (Figure 3.13b). 
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Figure 3.13. Scatter plots of SHAM potentiation (Azoxystrobin EC50 without SHAM / Azoxystrobin EC50 
with 40 µg ml"' SHAM) against AOX expression. AOX expression is calculated relative to isolate 788 with 
no fungicide. (a) Constitutive expression, without fungicide. (b) Induced expression, with 1 µg ml' 
azoxystrobin added three days before harvesting. 
AOX expression 0-4 hours after adding azoxystrobin is shown in Figure 3.14. In the first 
replicate, constitutive expression was similar for all isolates, and A OX expression increased in 
all isolates after the addition of azoxystrobin. Highest observed expression for isolates 788, R 
9528.4 and RS 783 was at 120 minutes, and highest expression for isolate K1124 was at 60 
minutes, after which transcript levels decreased again. The maximum expression level in 
isolates 788, K1124 and R 9528.4 was 5-8.5 times the reference (isolate 788 replicate I 
before adding fungicide), whereas the maximum expression for isolate RS 783 was 16.8 
times the reference. In the second replicate, induced expression levels were lower in isolates 
788, K1124 and R 9528.4, but higher in isolate RS 783. In isolate K1124, elevated 
constitutive expression was observed, after which expression decreased before a slight 
increase by 240 minutes. Expression in isolates 788 and R 9528.4 increased slowly after the 
addition of azoxystrobin throughout the time measured. Expression in isolate RS 783 
increased greatly after the addition of azoxystrobin, reaching a peak of 512 times the 
reference at 60 minutes. 
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Figure 3.14. Induced AOX expression after addition of azoxystrobin to 7-day-old cultures of four R. 
secalis isolates. (a) Biological replicate 1, (b) Biological replicate 2. Black: isolate 788; light grey: isolate 
K1124; dark grey: isolate R 9528.4; white, isolate RS 783. AOX expression is calculated relative to isolate 
788 with no fungicide for each set of biological replicates. 
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There was some apparent association between SHAM potentiation and maximum AOX 
expression (Figure 3.15). Regression analysis showed a significant positive correlation 
(p=0.027) between SHAM potentiation and Logio (Maximum AOX expression). The first 
replicate for isolate RS 783 was identified as having a high standardized residual, with the 
AOX expression lower than expected under a linear regression model. 
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Figure 3.15. Scatter plot of SHAM potentiation (Azoxystrobin EC50 without SHAM / Azoxystrobin EC50 
with 40 µg ml-' SHAM) against maximum observed AOX expression 0-4 hours after adding azoxystrobin, 
with regression line (solid) and 95% confidence limits of regression line (dashed lines). 
3.4 Discussion 
In the SHAM matrix experiments, two- to four- fold decreases in azoxystrobin sensitivity 
were measured for isolates SAC 09/943/186 and RS 219 as SHAM concentration increased 
from 0 to 40 or 44.4 µg ml-1. Isolates SAC 09/943/73, SAC 09/943/115 and F112-63 both had 
EC50 values below 0.05 µg ml-1 without SHAM, which did not decrease further as SHAM 
concentration increased to 40 or 44 µg ml-1. This is consistent with the results of McCartney 
(2006), who found that the EC50 of a less sensitive isolates decreased two- to three- fold as 
SHAM concentration increased from 0 to 55.55 µg ml-1, whereas sensitive isolates had EC50 
values below 0.1 ug ml-1 at all sub-lethal concentrations of SHAM. These results suggest that 
decreased in vitro strobilurin sensitivity in pre-2008 isolates is due to AOX activity. 
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For those isolates with azoxystrobin sensitivity affected by SHAM, EC50 values decreased as 
SHAM concentrations increased from 0 to 44.4 . ig ml-1, but at concentrations of 133 gg ml-1 
and above, SHAM itself inhibited fungal growth. This confirms that 40 . ig ml'' is a suitable 
SHAM concentration to inhibit AOX activity in R. secalis azoxystrobin sensitivity assays in 
liquid medium. For screening pre-2008 isolates, azoxystrobin sensitivity assays were carried 
out with 0 and 40 gg ml-1 SHAM. EC50 values obtained without SHAM varied considerably, 
ranging from 0.006 to 0.845 . tg ml-1. EC50 values obtained with 40 gg ml-1 SHAM were 
generally lower than those without AOX inhibition. There is still some variability, but this is 
continuous in nature and generally within a ten-fold range from 0.01 to 0.1 gg ml-1, rather 
than the large bimodal shifts seen in pathogens with target-site resistance to strobilurins (e. g. 
Sierotzki et al. 2000b). Sequencing the cytochrome b genes from a range of isolates 
confirmed the absence of target-site mutations. 
When the assay without SHAM was repeated with different cultures of the same isolate, EC5o 
values obtained varied by up to a factor of 7.6. This appeared to be linked to the presence of 
greater levels of hyphal material in the inoculum. This level of variability of EC50 values was 
not seen with SHAM-amended media, nor for isolates where EC50 was unaffected by SHAM, 
suggesting that the variability relates specifically to AOX. It is possible that AOX facilitates 
the growth of established mycelium more than that of spores, due to the reduced efficiency of 
the alternative respiratory pathway and high energy demands of spore germination. This is 
also consistent with suggestions that AOX utilisation varies with developmental stage (Wood 
and Hollomon 2003). This variability means when comparing EC50 against AOX expression, 
the same batch of inoculum, and not just the same isolate, must be used for sensitivity assays 
and RNA extraction. 
SHAM potentiation values, i. e. the EC50 without SHAM divided by the EC50 with SHAM 
(Wood and Hollomon 2003; section 3.2.6), for 40 gg ml-1 SHAM, varied from around 1 up to 
15.1, but most were in the range of 1 to 5. This is consistent with the results of McCartney 
(2006), who observed a potentiation factor of 2.5 with 55.6 µg ml-1 SHAM in a less sensitive 
isolate. However, many isolates with AOX activity indicated by SHAM potentiation also 
showed trailing growth, a low level of residual growth above the EC50 value. This is also 
absent in the presence of SHAM, implying that this, too, is a result of AOX activity. This 
could have a role in the emergence of more resistant isolates, since it would allow a low level 
107 
of fungal growth to continue in the presence of strobilurin fungicides, but only if the effect is 
seen in planta. 
No correlations between azoxystrobin log(EC50) values with or without 40 µg ml"' SHAM 
and log(EC50) values for the four triazoles tested in Chapter 4 were significant at I%. This is 
consistent with triazoles and strobilurins having different modes of action, and not showing 
cross-resistance. EC50 values for azoxystrobin with SHAM and tebuconazole were correlated 
at 5% significance, but this was a far weaker correlation than between the pairs of triazoles, 
and probably a result of separate mechanisms conferring multiple decreases in sensitivity 
between the least and most sensitive isolates. 
There was a significant positive correlation between azoxystrobin EC50 values with and 
without 40 µg ml-1 SHAM, but the relationship was only present for those isolates with the 
lowest azoxystrobin EC50 values in the absence of SHAM. Therefore slight variation in 
azoxystrobin sensitivity amongst the most sensitive isolates is not affected by SHAM at the 
concentration used, but among less sensitive isolates, further increases in azoxystrobin EC5o 
are negated by the addition of SHAM and therefore likely to be due to AOX activity. 
Of the isolates collected in France in 2008, R. s. 2310 4.2 had EC50 values within the sensitive 
range of pre-2008 isolates. Isolate R. s. 2318 4.2 had EC50 values consistent with AOX 
activity as seen in the pre-2008 isolates, with a SHAM potentiation factor of 5.58 for 
pyraclostrobin. Growth of isolates R. s. 2313 4.2 and R. s. 2314 4.2 was not sufficiently 
inhibited by azoxystrobin at the concentrations used to calculate EC50 values, so assays were 
repeated with pyraclostrobin, which has a higher intrinsic activity. Pyraclostrobin sensitivity 
of isolates R. s. 2313 4.2 and R. s. 2314 4.2 was reduced by a hundred-fold relative to sensitive 
isolates. This was far outside the range seen in the pre-2008 isolates, and closer to the 200- 
fold shift found in B. graminis f. sp. tritici isolates with the G143A substitution (Sierotski et 
al. 2000). Sequencing the cytochrome b gene from these R. secalis isolates confirmed that 
isolates R. s. 2313 4.2 and R. s. 2314 4.2 had a cytosine in place of a guanine at nucleotide 
position 428, resulting in the G143A amino acid substitution. 
However, unlike in other pathogens including B. graminis f. sp. tritici and M graminicola, in 
which the G143A mutation arose and spread, G143A has not been detected again in R. 
secalis in 2009 or 2010 (FRAC Qol Working Group 2009; FRAC QoI Working Group 2010). 
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Prior to 2008, when the G143A mutation had not been detected, it was suggested that the lack 
of G143A in R. secalis was due to low mutation rate (Gisi et al. 2002), or the structure of the 
cytochrome b gene making aG 143A mutation lethal (Grasso et al. 2006). McCartney (2006) 
noted that R. secalis cytochrome b did not contain an intron after codon 143, so G143A- 
encoding mutations would not caused a lethal loss of splicing, but Fisher et al. (2004) 
demonstrated that G143A may be detrimental to protein function in some cytochrome b 
backgrounds. The comparatively long time for G143A to be detected in R. secalis may be due 
to lower mutation rates than some other pathogens. However, this does not explain why 
having arisen, the mutation has not yet spread. This may be partly due to absence of airborne 
ascospores in R. secalis (Fountaine et al. 2010). In 2008, two field isolates carrying the 
G143A substitution were found. These isolates appear to grow normally in culture, and are 
capable of SHAM-insensitive respiration. This demonstrates that R. secalis cytochrome b 
with G143A is a functional protein, although more subtle in planta fitness costs, such that the 
mutation is only favoured under strong selection by Qol fungicides, cannot be discounted. 
However, in the case of the MBC fungicides, slow emergence and erratic early spread of 
resistant mutants was followed by spread of resistance resulting in loss of disease control 
(Cooke and Locke 2002). Therefore, resistance management for the Qol fungicides remains 
important. 
SHAM potentiation of azoxystrobin sensitivity in isolates without cytochrome b mutations 
suggested AOX activity. Searching the R. secalis genome with A OX genes of other 
leotiomycetes gave one significant match. The sequence contained two predicted introns, 
subsequently confirmed by cDNA sequences. Analysis of the predicted amino acid sequence 
with MitoProt found a potential mitochondrial targeting sequence. The predicted cleavage 
site was 11 base pairs downstream of that for other leotiomycete and most other filamentous 
ascomycete sequences. This is because MitoProt identifies the last possible cleavage site 
before other required properties of a mitochondrial targeting site are violated, and the R. 
secalis sequence contains an additional R-X-(F/I/L) motif (Gavel and von Heijne 1990) due 
to the isoleucine at residue 64. However, it also contains the predicted cleavage site present in 
the other leotiomycetes, with the R-X-(F/UL) motif present at residues 51-53. Therefore the 
exact site at which the protein is cleaved in unclear, especially since the sites in other species 
are only predictions, but the protein is likely to be mitochondrially imported. Searching the 
predicted protein against the Pfam database confirmed that it is an Alternative Oxidase. 
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Maximum likelihood and Bayesian phylogenetic trees were largely congruent, apart from 
relationships between the Pezizomycotina classes. Neighbour joining and maximum 
parsimony trees were similar but less resolved. The R. secalis A OX gene fell within the 
leotiomycete Glade, as expected. Multiple AOX genes have been reported in some species. 
Two AOX genes were reported in C. albicans, one constitutively expressed and the other 
inducible (Huh and Kang 2001). Tanton et al. (2003) reported two AOX genes in N. crassa, 
one expressed at a low level constitutively and at a higher level when induced, and the other 
not expressed under studied conditions. 
McDonald and Vanlerberghe (2006) list B. cinerea as containing two AOX genes, but the 
sequences listed were found to be two different fragments from a cDNA library, both of 
which fall within the same gene (BC 1 G_05703.1) in the B. cinerea genome. Similarly, the 
two listed sequences for Coccidioides posadasii are fragments of one gene (CPAG_01812.1 
in isolate RMSCC 3488, genome at www. broadinstitute. org). The second sequence listed for 
Podospora anserina (AF252256) was incomplete, gave no significant matches from the P. 
anserina genome (http: //podospora. igmors. u-psud. fr), and the only fungal AOX gene returned 
from a BLAST search of GenBank was from Penicillium chrysogenum. Therefore, it is not 
clear whether this represents a second AOX gene in some strains of P. anserina or a 
contaminant. 
In addition to C. albicans and N. crassa, two AOX genes were found in Candida tropicalis, 
C. parapsilosis, Yarrowia lipolytica, C. cinerea, Aspergillus clavatus, A. oryzae, A. flavus, A. 
terreus and A. niger. Phylogenetic analysis shows that these represent several relatively 
recent duplications, rather than a basal duplication followed by widespread losses. The two C. 
cinerea A OX genes group together, indicating a recent duplication within the C. cinerea 
lineage. Within the Saccharomycotina yeasts, the AOX phylogeny supports separate 
duplications in the C. tropicalis/C. albicans lineage and in the C. parapsilosis lineage, rather 
than a single duplication followed by a loss in Lodderomyces elongisporus, and a separate 
duplication in Y. lipolytica, rather than a basal duplication followed by repeated losses. 
Furthermore, the Saccharomycotina AOX genes fall as expected within the fungi, supporting 
the presence of AOX as the ancestral state, with secondary losses in the Schizosaccharomyces 
and Saccharomyces/Kluyveromyces lineages. Within the Pezizomycotina, the duplication 
leading to the second AOX gene in N. crassa appears to have originated within the 
Sordariomycetidae, but within this subclass, resolution between the M oryzae and N. crassa 
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genes is poorly supported. Therefore it is not possible to say whether the duplication took 
place within the N. crassa lineage, or in the common ancestor of N. crassa and M oryzae 
followed by a loss from M oryzae. Within Aspergillus sp., there appears to have been a 
duplication in the common ancestor followed by losses in A. fumigatus and A. nidulans, 
although the placement of the second A. clavatus gene with the Dothidiomycetes cannot be 
explained at present. There is no evidence of any AOX gene duplications ancestral to R. 
secalis, as the divergence of paralogues with different expression patterns is confined to 
within other lineages, and therefore the single AOX gene in R. secalis is descended from an 
undifferentiated A OX orthologue. 
The AOX genomic DNA sequences of the three R. secalis isolates tested were identical. 
Therefore, apparent differences in AOX activity between isolates are not due to mutations in 
coding DNA, but may be due to differences in gene expression. Initially, AOX expression 
levels were measured three days after adding the QoI fungicide azoxystrobin. Only in isolate 
R. s. 2310 4.2 was AOX expression significantly higher with azoxystrobin than in the control, 
and this isolate had a low SHAM potentiation. SHAM potentiation was not correlated with 
constitutive (p=0.995) or induced AOX expression (p=0.845) among isolates without target- 
site resistance. Kaneko and Ishii (2009) reported AOX expression in F. graminearum 
reaching a peak 60 minutes after the addition of azoxystrobin, then falling back towards the 
constitutive expression level. Therefore, the experiment was repeated with cultures harvested 
immediately before, and 30,60,120 and 240 minutes after, addition of azoxystrobin. Induced 
expression was observed within 30-120 minutes, and in isolate RS 783, the isolate showing 
the greatest upregulation, expression was decreasing again by 240 minutes. Therefore, 
induced expression of AOX in R. secalis should be measured within 1-2 hours of fungicide 
addition, as was shown by Kaneko and Ishii (2009) for F. graminearum. Yukioka et al. 
(1998) reported that AOX expression in M oryzae increased 20-60 minutes after addition of 
metominostribin, but only measured up to 60 minutes so it is not known how long the 
increased transcript levels lasted. Sierotzki et al. (2000a) report that in M. fijiensis isolates 
with a SHAM potentiation factor of 130 for azoxystrobin, AOX expression appears not to be 
inducible by trifloxystrobin. However, the trifloxystrobin was added 12 hours prior to 
harvesting the cultures, so given the current results and those of Kaneko and Ishii (2009), 
upregulation may have taken place more rapidly after QoI addition, with transcript levels 
returning to basal levels within 12 hours. 
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Constitutive AOX expression, before addition of azoxystrobin, was similar for all isolates, but 
there was variation in induced expression 30-240 minutes after addition of azoxystrobin. The 
greatest upregulation was observed in isolate RS 783, the isolate with the greatest SHAM 
potentiation in azoxystrobin sensitivity. There was a positive correlation (p=0.027) between 
Loglo(Maximum AOX expression) and SHAM potentiation. Kaneko and Ishii (2009) showed 
that greater induced AOX expression was associated with lower intrinsic azoxystrobin 
sensitivity in F. graminearum compared to M nivale. Here, it is demonstrated that in R. 
secalis, differences in induced A OX expression may be associated with intraspecific 
differences in QoI sensitivity in the absence of SHAM. 
The first biological replicate for isolate RS 783 appears anomalous, with the maximum AOX 
expression lower than expected given the SHAM potentiation value under the fitted linear 
regression model, and thirty times lower than the observed AOX expression for the second 
biological replicate. It is possible that the maximum AOX expression was between measured 
time points. The maximum observed AOX expression in the first biological replicate of 
isolate RS 783 was at 120 minutes, whereas in the second biological replicate the maximum 
observed expression was at 60 minutes. Due to the heterogeneous growth of R. secalis in 
liquid culture, it is not practicable to take representative aliquots. Consequently, a separate 
culture must be grown for each time point, limiting the number of time points for which 
measurements can be made. For future work, the use of promoter-reporter fluorescence gene 
constructs will allow repeated non-destructive measurements of expression over time. 
Furthermore, only ß-tubulin was used as an endogenous control. The use of additional 
endogenous control genes would reduce the risk that apparent changes in relative expression 
of the target gene are actually the result of confounding changes in the expression of the 
control. 
Expression analysis provides preliminary evidence for transcriptional upregulation of AOX, 
whether by increased transcription or reduced transcript degradation (Yukioka et al. 1998), in 
some R. secalis isolates. The R. secalis genome sequence upstream of the AOX coding 
sequence did not contain the induction motif identified in N. crassa (Chae et al. 2007), nor 
any of the putative transcriptional elements identified in M oryzae (Yukioka et al. 1998). 
This is not surprising, since the induction motif in N. crassa was only found within the 
Sordariales and not in M oryzae, a more distant Sordariomycete, and R. secalis as a 
Leotiomycete is more taxonomically distant from N. crassa and M oryzae than they are from 
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each other. When the R. secalis genome is released and annotated, it may be possible to 
further investigate the regulatory pathways involved in A OX upregulation in this species. 
It has been suggested that increased AOX activity may facilitate the evolution of target-site 
resistance, by enabling slow growth in the presence of Qol fungicides, under selective 
pressure for resistance and where mitochondrial mutation rates may be elevated due to high 
levels of reactive oxygen species (Avila-Adame and Köller 2003b). This could be further 
investigated by assessing in planta growth, including microscopic assessment of 
symptomless infection, of isolates with different levels of A OXupregulation or an AOX 
knockout strain, on Qol-treated plants. Alternatively, in vitro experimental evolution by serial 
transfer on Qol-amended media could be carried out, to investigate the effects of SHAM, 
flavones or AOX gene deletion on the arising of Qol-resistant strains. Since AOX over- 
expression was only observed when induced by QoIs, it was not possible to tell whether this 
upregulation was present in isolates with the G143A mutation, since it was not possible to 
achieve an inhibitory dose of fungicide for these isolates without killing all other isolates. If 
the molecular mechanisms for upregulation are identified in the future, it may be possible to 
test isolates for the corresponding genotype in order to establish whether the G143A mutation 
arose in a genetic background with AOX overexpression. 
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Chapter 4 
Triazole sensitivity in R. secalis 
4.1 Introduction 
The triazoles are demethylation inhibitor (DMI) fungicides, inhibiting lanosterol 14a- 
demethylase in ergosterol synthesis (Buchenauer 1977), resulting in ergosterol depletion and 
build-up of toxic sterol intermediates such as 14-methyl-3,6-diol (Ragsdale and Sisler 1973). 
Lanosterol 14a-demethylase is a cytochrome P450, CYP51. 
Reduced triazole sensitivity due to mutations in the target-site-encoding CYP51 genes has 
been reported in several plant and clinical pathogens, including M graminicola (Cools and 
Fraaije 2008), B. graminis f. sp. hordei (Wyand and Brown 2005) and C. albicans (Edlind 
2008). These mutations have varying, interacting, quantitative effects on triazole sensitivity, 
in contrast to the qualitative Qol resistance conferred by the G143A substitution in 
cytochrome b. Furthermore, cross-resistance patterns between azoles (triazoles and 
imidazoles) vary for different mutations. For example, in clinical C. albicans isolates, 
substitutions S405F, G464S and R467K confer similar reductions in sensitivity to fluconazole 
and ketoconazole, whereas Y132H affects ketoconazole sensitivity fourfold more than 
fluconazole sensitivity (Sanglard et al. 1998). In M graminicola, Y137F specifically affects 
triadimenol sensitivity, whereas 138 IV reduces sensitivity to tebuconazole (Cools and Fraaije 
2008). 
Some fungal species possess two paralogues of CYP51, designated CYP51A and CYP51 B 
(Mellado et al. 2001). Mutations associated with reduced triazole sensitivity in clinical 
isolates of A. fumigatus are found in the CYP51A paralogue (Diaz-Guerra et al. 2003). The 
phylogeny of CYPSI paralogues is investigated, and the nomenclature explained, in chapter 
5. 
Some fungal isolates with reduced triazole sensitivity do not possess any mutations in 
CYP51. Non-target-site mechanisms include increased efflux of the fungicide out of fungal 
cells by ABC transporter (de Waard et al. 2006) or major facilitator proteins (Tenreiro et al. 
2000). Different transporters may confer reduced sensitivity to a single compound or multiple 
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triazoles (Sanglard and Odds 2002), or to triazoles and unrelated compounds such as Qols 
(Reimann and Deising 2005). 
In some cases, reduced azole sensitivity has been linked to specific transporter-encoding 
genes, such as BcatrD in B. cinerea (Hayashi et al. 2002), or reduced intracellular azole 
accumulation has been measured directly with radio-labelled fungicides (Hayashi et al. 2001; 
Roohparvar et al. 2008). In other cases, enhanced efflux has been inferred from the 
restoration of fungicide sensitivity by the addition of putative efflux inhibitors. A range of 
drugs known to affect mammalian efflux transporters and other transmembrane protein 
targets have been tested for efflux inhibition. These include the phenothiazines, calcium- 
calmodulin antagonists in clinical use as antipsychotics, which increased triazole sensitivity 
of less-sensitive isolates of both C. albicans (Marchetti et al. 2000) and M graminicola 
(Roohparvar et al. 2008). 
Reduced triazole sensitivity has been reported in field populations of R. secalis (Jones 1990; 
Kendall et al. 1993; Cooke et al. 2004). Sensitivity shifts against triadimenol were first 
reported in a survey of UK field isolates in 1987 (Jones 1990). By 1990, triadimenol 
sensitivity had declined further, resulting in loss of field control. A correlated but smaller 
sensitivity shift was seen for propiconazole and tebuconazole, but these compounds remained 
effective in the field (Kendall et al. 1993). In 2000-2002, sensitivity shifts were seen against 
the newly-introduced epoxiconazole (Oxley 2003). In 2005-2007, further shifts in 
epoxiconazole sensitivity were reported, with some evidence of cross-resistance with the 
newer prothioconazole (Oxley et al. 2008). Current monitoring of R. secalis in the UK 
suggests some reductions in azole sensitivity, but epoxiconazole and prothioconazole still 
provide field control, albeit at higher doses, or in more of a protectant capacity in the case of 
epoxiconazole (Oxley and Burnett 2010). The mechanisms causing triazole sensitivity shifts 
in R. secalis have not yet been identified. 
This chapter describes investigations into triazole sensitivity in R. secalis and whether 
changes in sensitivity are due to mutations in CYPSI genes, or associated with efflux pump 
activity. Sensitivity to propiconazole, tebuconazole, epoxiconazole and prothioconazole was 
tested for 80 R. secalis isolates, and cross-resistance patterns investigated. Sensitivity testing 
was also carried out for an additional set of 31 isolates collected in six European countries in 
2009 by Syngenta Crop Protection, and cross-resistance patterns compared. Field isolates 
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were collected from experimental plots at Rothamsted Research in 2009 and their sensitivity 
compared to the reference and Syngenta isolate sets. The full sequence of CYP51A was found 
by genome-walking, and CYP51A and CYP51B sequences were analysed for 12 isolates with 
a range of triazole sensitivities. A CYP51A pseudogene, CYP51A-P, was also discovered and 
was sequenced for all isolates. Further sensitivity assays were carried out with the addition of 
putative efflux inhibitors to investigate the possible role of efflux pump activity in triazole 
sensitivity. 
4.2 Materials and Methods 
4.2.1 Triazole sensitivity testing 
Sensitivity testing of the isolates listed in Table 2.1 was carried out as described in section 
3.2.1, but with the fungicides and concentrations shown in Table 4.1. An additional set of 31 
isolates, collected from several sites in the Czech Republic, Germany, France, Spain, the 
United Kingdom and Ireland in 2009, provided by Syngenta Crop Protection, were also tested 
for fungicide sensitivity. 
Table 4.1. Final fungicide concentrations used in triazole sensitivity bioassays, carried out in 96-well 
microtitre plates. 
Microtitre plate 123456789 10 11 12 
column 
Fungicide Final fungicide concentration (µg ml"') (3 s. f. ) 
Epoxiconazole 0 0.00524 0.0131 0.0327 0.0819 0205 0512 128 32 8 20 50 
Prothioconazole, 
Tebuconazole, 0 0.00169 0.00508 0.0152 0.0457 0.137 0.412 124 3.70 11.1 333 100 
Propiconazole 
Tebuconazole, 
Propiconazole 0 0.00508 0.0152 0.0457 0.137 0.412 124 3.70 11.1 333 100 300 
(less sensitive 
isolates) 
Cross-resistance was assessed by testing for correlation (least squares linear regression, with 
pairwise deletions of missing values) between loglo(EC50) values for each possible pairing of 
the fungicides tested, and by Principal Componenets Analysis (PCA) using the correlation 
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matrix of logio transformed EC50s for all four fungicides, in GenStat 13 `h Edition (VSN 
International, Hertfordshire, UK). 
4.2.2 Field conditions and R. secalis isolation 
Saffron winter barley was grown in field Great Harpenden II at Rothamsted Research, 
Hertfordshire, UK, according to standard farm operations but untreated with fungicides or 
treated with two sprays at 1/3 full rate of epoxiconazole (Opus, BASF; 125g 1"1,0.33 1 ha') or 
propiconazole (Bumper 250EC, Makhteshim Agan; 250 g 1-1,0.161 ha 1) at TO and Ti. 
Infected leaves were collected three weeks after the Ti fungicide application. 
Lesions were cut from leaves, surface-sterilised for 2 minutes in 70% ethanol and 5 minutes 
in 1/10 10% sodium hypochlorite, rinsed in sterile water, dried on autoclaved tissue paper 
then placed on CDM agar containing 125 units ml-1 penicillin and 125 µg ml'' streptomycin 
(Sigma), and incubated at 18°C for seven days. Rhynchosporium secalis spores were 
harvested into sterile distilled water and streaked out onto CDM plates to obtain single-spore 
isolates. Fungicide sensitivity testing was carried out as described in section 4.2.1. PCAwas 
carried out, using the correlation matrix of loglo transformed EC50s for the four fungicides, in 
GenStat 13th Edition (VSN International, Hertfordshire, UK). 
4.2.3 Sequencing of R. secalis CYPSIA by genome-walking 
CYP5IB had been sequenced from R. secalis (Hans Cools, personal communication). A 
second CYPSJ, CYPSIA, had been found in R. secalis and a partial sequence had been 
obtained with degenerate primers (Helge Sierotzki, personal communication). The remainder 
was found by genome-walking. Genomic DNA libraries were prepared by Hans Cools, using 
the GenomeWaker universal kit (Clontech, California, USA), with restriction enzymes Dral 
(two libraries), PvuII (two libraries), EcoRV and Stuff. Three reactions in the 5' direction and 
one in the 3' direction were needed to obtain the complete coding sequence of the gene 
(Figure 4.1). For each genome-walking step, two nested PCR reactions were carried out: the 
first with API and GSP1, the second with AP2 and GSP2. Adaptor primers (API and AP2) 
were specified by the GenomeWalker Universal Kit (Clontech, California, USA). Genome- 
specific primers (GSP1 and GSP2) used in successive reactions are listed in Table 4.2, and 
were designed in Vector NTI (Invitrogen Corporation). 
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(; W3 added (; W2 added (iWI added 10') Original fragment (; W I added (3') 
196 h. p. + 516 h. p. 267 h. p. 612 h. p. 324 h. p. + 
5' 3' 
/7 
(SI' I)I GSP C2 GSP E32 C; SP AI 
(iSp GI (isP Cl GSP BI GSP A2 
Figure 4.1. Primer-binding sites and sections added to the sequence of the second CYP5I gene of R. secalis 
in successive genome walks. GSP = Gene-Specific Primer; primers listed in Table 4.2. 
Table 4.2. List of gene-specific primers used in successive genome-walking reactions to obtain the full 
sequence of R. secalis CYP51A, and primers used for the amplification and sequencing of CYP51 genes 
from R. secalis isolates 
Gene Primer name Primer sequence 
CYP51 Al: GW1 (3'), GSP 18 5'-TGGTGAAGGAGAC GCTCCGGCTCCATT-3' 
Genome A2: GWI (3'), GSP2 5'-TGATGCGCGCAGT CAAGAACGACCTCC-3' 
walking BI: GWI (5'), GSPI 5'- TTCTGAGGCAGTGG TAACCACGGAGCGAG -3' 
B2: GWI (5'), GSP2 5'- ATTGGCCGGAACC CGTGGTCGAGATCA -3' 
Cl: GW2 (5'), GSP1 5'- AGAGGGAGAGGTAG GCGATTGGGGAATGA -3' 
C2: GW2 (5'), GSP2 5'- TTCGAGTGCGCGTT GAGTGAGGCCGAA -3' 
G 1: GW3 (5'), GSPI 5'- CGTTGACATCCTGCA ATCTTCCATTGAGGA -3' 
D2: GW3 (5'), GSP2 5'- TGTGCTGGAGGAAGA GGGAGGGTGAGAGA -3' 
CYP5IA Forward I 5'-ATGCTGGGTATCTTCTCGGTGCTAG -3' 
Reverse 1 5'- GACCCTCTTTTCCCATCTAACTCTCG-3' 
Internal 5'-TGCTAACTCGGCATATCTAGCTACACC -3' 
Nested F 5'-TCCGCTATGGATTCTACACCCTCA -3' 
Nested R 5'- CCGTCTTTGGGATCTGTCCTCC-3' 
CYP51A-P Forward I 5'-AAAAGAAGAAGTCCGAACCGCCTC -3' 
Reverse 1 5'-CACCAAACGGTAAATAAGGAATCCTAATCT -3' 
CYP51 B Forward 1 5'- GGAATTTTTGAGGCTGTTACAGTCCC-3' 
Reverse 1 5'- TTCTCTCTTCTCCCACTCAACCACC-3' 
Internal 5'- CCTTCAAGACTTACGTTCCAATCATTCAG-3' 
Nested F 5'- GCGGATTGGGCGTTGTGATC-3' 
Nested R 5'-CTCAACAACCTTCGAGCTTCCATC -3' 
'GW: Genome Walk, GSP: Gene-Specific Primer 
118 
For each step, PCR reactions were set up as above using each of the six libraries as templates 
with GSP1 and AP1, followed by a nested PCR reaction using a 1/50 dilution of the first PCR 
product as template with GSP2 and AP2. The PCR programme comprised seven cycles (five 
for the nested reaction) of 25 seconds at 94°C and three minutes at 70°C (67°C for primer 
GI), followed by 32 cycles (20 for the nested reaction) of 25 seconds at 94°C and 3 minutes 
and 65°C, followed by 7 minutes at 65°C. Longest PCR products were purified using the 
Wizard SV Gel and PCR Clean-Up System (Promega, USA). Cleaned PCR products were 
ligated into the pGEM-t Easy plasmid vector (Promega, USA) using T4 DNA ligase 
(Promega, USA) according to manufacturer's instructions. JM109 competent cells were then 
transformed according to manufacturer's instructions, using blue-white screening for 
plasmids with inserts. PCR reactions were set up as described above, using 5µl of white 
transformant bacterial suspension as template, and primers AP2 and GSP2. The PCR 
programme started with 2 minutes 30 seconds at 94°C to lyse the bacterial cells; followed by 
40 cycles of 30 seconds at 94°C, 60 seconds at 52°C and 60 seconds at 72°C; followed by 5 
minutes 30 seconds at 72°C. One transformant for each PCR product was selected for 
sequencing. The bacterial suspension was added to 5m1 LB broth and incubated overnight at 
37°C with shaking. Bacterial pellets were collected from 3ml culture. Plasmid DNA was 
extracted and purified using the GeneElute (Sigma) or QIASpin (Qiagen) mini-prep kits and 
eluted into 50pl nuclease-free water, then sequenced by Eurofins MWG (Germany) and the 
sequences analysed in Vector NTI 10 (Invitrogen). 
4.2.4 Sequencing of CYPSI genes from R. secalis isolates 
The CYP51A and CYP51B genes of isolates showing a range of triazole sensitivities were 
sequenced. These were fully-sensitive isolates K 1124, FI12-63 and RS-219; intermediate 
isolates QUB 30-10, R 9528.4 and 9522.3; and less-sensitive isolates 788, SAC 1-4-8 (0003), 
GKII 18-2-3, GKII 18-3-2, SAC 09/943/14, QUB 12-3, OSA 28-2-2 and RS 783 (Figure 
4.3). 
PCR reactions were carried out using Phusion High-Fidelity DNA Polymerase (Finnzymes 
Oy, Espoo, Finland) according to manufacturer's instructions, in 30µl reactions with HF 
buffer, no DMSO, 0.5mM primers and 1.67 gg ml-1 template. The PCR programme 
comprised 2 minutes at 95°C; followed by 40 cycles of 10 seconds at 95°C, 20 seconds at 
60°C (the annealing temperature) and 50 seconds at 72°C; followed by 4 minutes 10 seconds 
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at 72°C. PCR was carried out with primers Forwards 1 and Reverse 1 shown in Table 4.2 for 
CYP5JA and CYP51B respectively. Primers were designed in Vector NTI (Invitrogen 
Corporation). PCR products were purified and sequenced by Eurofins MWG (Germany), 
with the Nested F, Nested R and Internal primers listed in Table 4.2 for CYP51A and CYPSIB 
respectively. 
CYP51A-P (see discussion, section 4.4.2) was sequenced for isolates QUB 30-10,788, QUB 
12-3, R 9528.4, GKII 18-2-3, RS 783, RSO4CH6B NB32 and RS99CH1 H1OB, in addition to 
isolates K1124, FI12-63 and RS 219 for which CYP51A-P sequences had already been 
obtained during CYP51A sequencing. cDNA sequences of CYP51B and CYP51A of isolate 
788, and CYP51A-P of isolate F112-63, were amplified from cDNA prepared as described in 
section 5.2.5. PCR reactions were carried out using Easy-A High-Fidelity PCR Cloning 
Enzyme (Stratagene, California, USA) according to manufacturer's instructions, with 2 ng µl" 
genomic or 1% cDNA template. The PCR programme comprised 2 minutes at 95°C; 
followed by 30 cycles of 40 seconds at 95°C, 30 seconds at 58°C and 2 minutes at 72°C; 
followed by 7 minutes at 72°C. PCR was carried out with primers Forward I and Reverse 1 
shown in Table 4.2 for CYP51B, CYP51A and CYP51A-P, designed in Vector NTI 
(Invitrogen Corporation). PCR products were purified, cloned and sequenced as described in 
section 4.2.3. 
4.2.5 Efflux inhibitor assay 
The assay procedure was carried out as described in section 4.2.1 for tebuconazole and 
prothioconazole and section 3.2.1 for azoxystrobin, but with a single isolate per plate. Spore 
suspensions were diluted to 5x 105 spores ml"', and 50µl was added to each well. The 
phenothiazine compounds, trifluoperazine dihidrochloride 98% (Sigma) and fluphenazine 
dihydrochloride (Sigma), were dissolved in sterile distilled water at 2.5 mg ml-1. Six serial 
dilutions were carried out at a dilution factor of 1/5, and 50µ1 was added to each well to give 
the following final concentrations: Ogg ml-1 (50µl distilled water only), 0.04 gg ml-1,0.2 µg 
ml'', 1 µg ml"', 5 pg ml-1,25 pg ml-1 125 µg ml" and 625 pg ml-1. Isolates K1124, R 9528.4, 
788 and RS 783 were tested (Table 2.1). Plates were incubated and read as described in 
section 3.2.1. 
Correlation between reduction in EC50 with 5µg ml-1 putative inhibitor, and EC50 value 
without the putative inhibitor, for each fungicide-phenothiazine combination, was tested by 
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least squares linear regression analysis in GenStat 13th Edition (VSN International, 
Hertfordshire, UK). 
4.3 Results 
4.3.1 Triazole sensitivity testing 
The full data set of triazole EC50 values is given in Appendix 3. 
Significant positive correlations (r>1, P<0.01) were found between EC50 values for all pairs 
of triazoles. Scatter plots for all pairwise comparisons are shown in Figure 4.2. 
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Figure 4.2. Scatter plots showing log(EC50) values of R. secalis isolates for each pairwise comparison of 
the four triazoles tested: (a) tebuconazole against propiconazole; (b) epoxiconazole against propiconazole; 
(c) prothioconazote against propiconazole; (d) epoxiconazole against tebuconazole; (e) prothioconazole 
against tebuconazole; (t) prothioconazole against epoxiconazole. Solid lines indicate linear regression; 
dashed lines indicate 95% confidence limits of regression line (calculated in SigmaPlot, Systat Software 
Inc. ) 
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PCA was carried out with sensitivity data for the four triazoles. The first two principal 
components encompassed 92.3% of variation (Figure 4.3a). Principal component 1 (PC 1) had 
positive latent vectors for all four variates, whereas principal component 2 (PC2) had a 
negative latent vector for prothioconazole (Table 4.3). Plotting isolates against PC1 and PC2 
(Figure 4.3b) gives separation of sensitive, intermediate and less sensitive isolates, with most 
variation in PC2 found among the less-sensitive isolates. Principal component analysis was 
repeated with the sensitive isolates excluded. Results were similar, with almost 90% of 
variation in the first two principal components, and latent vectors having the same signs and 
similar magnitudes to the full data set (data not shown). 
Table 4.3. Principal component analysis results for triazole Log(EC50) data. 
Principal component 
1234 
Percentage variation 
Latent vectors Propiconazole a 
Tebuconazole 
75.8 16.5 
0.521 0.400 
0.551 0.165 
5.94 1.77 
0.428 0.621 
0.286 -0.766 
Epoxiconazole 0.521 0.098 -0.844 0.081 
Prothioconazole 0.391 -0.896 0.152 0.145 
a Variates comprise Loglo [EC5o (µg ml- 1)] for each fungicide 
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Figure 4.3. Principal component analysis of triazole EC50 data for R. secalis isolates. (a) Cumulative 
percentage variation of principal components. (b) Principal component 2 against principal component 1. 
Red crosses indicate isolates selected for sequence analysis. 1: RS 219; 2: K1124; 3: F112-63; 4: R 9528.4; 
5: R 9522.3; 6: QUB 30-10; 7: GKII 18-3-2; 8: GKII 18-2-3; 9: 788; 10: SAC 0003 1.4.8; 11: SAC 
09/943/14; 12: QUB 12-3; 13: OSA 28-2-2; 14: RS 783. 
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Sensitivity profiles for the four triazoles tested fall into three main groups. Examples of each 
are shown in Figure 4.6. Group I in Figure 4.6, including isolates 1-3 in Figure 4.3, consists 
mainly of pre-2000 reference isolates, with propiconazole, tebuconazole and epoxiconazole 
EC50 values below 0.1 µg ml-1 and prothioconazole EC50 values between 0.1 and 0.5 . tg ml-1. 
Group II in Figure 4.6, including isolates 4-6 in Figure 4.3, have intermediate sensitivity 
levels, with propiconazole and tebuconazole EC50 values mostly between 0.1 and 1 pg ml-1 
but smaller shifts in epoxiconazole and prothioconazole sensitivity compared to the reference 
isolates. Most isolates in this group were collected in Northern Ireland in 2001. Group III in 
Figure 4.6, including isolates 7-14 in Figure 4.3, encompasses the majority of isolates from 
2001 onwards, have further reductions in sensitivity. Propiconazole EC50 values are around 
10 µg ml"1, with values for tebuconazole slightly lower. Prothioconazole EC50 values are 
around 1 µg ml-1, with values for epoxiconazole slightly lower. Within group III, the final 
three isolates in Figure 4.6, corresponding to numbered isolates 12-14 in Figure 4.3, have 
especially elevated prothioconazole EC50 values of around 10 . tg ml-1. 
PCA was repeated for the Syngenta isolate set. As for the reference isolate set, the first two 
principal components encompassed around 90% of variation, with PC 1 representing general 
positive cross-resistance, and PC2 revealing different sensitivity patterns for prothioconazole 
compared to propiconazole and tebuconazole (Table 4.4). As with the reference isolate set, 
isolates are divided into sensitive, intermediate and less-sensitive isolates along PC I, with 
PC2 variation mainly among the less-sensitive isolates (Figure 4.4). 
Table 4.4. Principal component analysis results for triazole Log(ECso) data for R. secalls isolates collected 
by Syngenta Crop Protection from six European countries in 2009. 
Principal component 
1 2 3 4 
Percentage variation 68.7 20.5 9.95 0.87 
Latent vectors Propiconazole a 0.557 -0.371 0.200 -0.715 
Tebuconazole 0.562 -0.267 0.382 0.683 
Epoxiconazole 0.506 0.105 -0.850 0.101 
Prothioconazole 0.343 0.883 0.301 -0.106 
a Variates comprise Log, o [EC50 (µg ml-')] for each fungicide 
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Figure 4.4. Principal component analysis of triazole EC50 data for R. secalis isolates collected by Syngenta 
Crop Protection from six European countries in 2009. (a) Cumulative percentage variation of principal 
components. (b) Principal component 2 against principal component 1. Initials indicate country of origin: 
CZ: Czech Republic; DE: Germany; FR: France; ES: Spain; GB: United Kingdom; IE: Ireland. 
Superimposing the biplots for the reference isolate set and the Syngenta isolate set shows that 
the sensitivity groupings match closely between the two isolate sets (Figure 4.5). The PC2 
axis is reversed for the Syngenta isolate set, as the signs of the latent vectors are arbitrary. 
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Crop Protection from six European countries in 2009 (red circles), and for the set of R. secalis isolates 
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10; 7: GKII 18-3-2; 8: GKII 18-2-3; 9: 788; 10: SAC 0003 1.4.8; 11: SAC 09/943/14; 12: QUB 12-3; 13: 
OSA 28-2-2; 14: RS 783. 
4.3.2 Rothamsted field isolates 
PC1 and PC2 were calculated from Rothamsted 2009 field isolate logio[EC50s] based on the 
coefficients obtained for the first isolate set. The 2009 isolates all fell within the lower end of 
the less-sensitive group, except one isolate which may have intermediate sensitivity (Figure 
4.5). There was no difference between isolates from plots receiving different fungicide 
treatments. 
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Figure 4.5. Principal component 2 plotted against principal component 1 for PCA of R. secalis log1olECsol 
for triazole fungicides. Crosses represent the reference set of isolates. Red symbols represent isolates 
collected from Rothamsted Research in 2009: Diamonds: Untreated; Circles: Propiconazole treated; 
Triangles: Epoxiconazole treated. 
4.3.3 CYPSI sequence analysis 
The complete CYP51A sequence was obtained. Intron positions at base pairs 173-309 and 
511-569, confirmed by cDNA sequences, were removed and the sequence translated. The 
translated sequence of isolate 788 is shown in Figure 4.7. For CYP51 B, cDNA sequences 
confirmed the presence of two introns, at base pairs 244-312 and 484-638. 
CYP51B and CYP51A sequences for the selected R. secalis isolates are shown in Appendix 
4(a) and (b). For CYP51 B, the only non-synonymous mutation resulted in a T67S substitution 
in sensitive isolate F112-63 and intermediate isolates QUB 30-10 and R9528.4 (Figure 4.6). 
For CYP51A, the only non-synonymous single nucleotide polymorphisms resulted in a P170S 
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substitution in isolate 9522.3, and an A11IV substitution in isolates SAC 09/943/14 and 
QUB 12/3 (Figure 4.6). However, substantially different CYP51A sequences were obtained 
for isolates K1124, F112-63 and RS 219. Differences included substitutions, frame-shift 
indels and premature stop-codons (Figure 4.7). 
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788 ATGCTGGGTATCTTCTCGGTGCTAGTTTCTAGCATCCGCTATGGATTCTACACCCTCACTCTCCTTATTGTCACAGTCCTGCTCAACGCTCTACACCAAC 
F112-63 ------------------------------------------------------------------------ TCAATCCTCCTCAACGCTCTACACCAAA 
101 200 
788 TCCTCCCAAAGAAGAAGTCCGAACCGCCTTTGGTATGGCATTGGATCCCATTTATCGGGAATGCCATCGAAT 
. CCTTCCTAAC 
FI12-63 TCCTCCAAAAGAAGAAGTCCGAACCGCCTCTGGTATGGCATTGGATCCCCTTTATTGGGAATGCCATCGAAT ! 'CCTTCCTAAC 
201 300 
788 CCTCTTGATCTTTTC CTCP, CCC. TTCCTCTT: G'PCCACCA(: iaCCT000-ATTA7 ACP( C,., ý ; i: ý1I (, ,.::: TGACAT ; CAACC 
FI12-63 CCTCTTGATCTTTC CTCACCCTTCCTCTTCCTCCACCACACCCCCCCATTATCAACATCACAT, CA,, TAG4CAAAAGTTACTGACATGCAACC 
301 400 
788 A7TTTTCTAGATGGCACCGACCCTCTAGCTTTCTACACAAAATGTCAACGGCAACATGGCCCGATCTTCACT°ATATTCTTTTCGGCA: -AAAAATGACTG 
FI12-63 GTTT TCTAGATGGCACCGATCCTCTAGCTTTCTACACAAAATGTCAACGGCACCATGGCCCGATCTTCACTCATATTCTTTTCGGCAGAAAAATGACTG 
401 nn *++ 500 
788 TTTATCTTGGGCTGGAAGGAAATGAGTTTATCCTCAATGGAAGATTGCAGGATGTCAACGCGGAAGATATTTATGGTCCAICTGA, 3TGT: TACi'PCTCCAT 
FI12-63 TTTATCTTGGGCTGGAAG----TGAATTTATCCTCAATGGTAGACTGCAGGATGTCAATGCAGAAGATATTTATGGTCCAC I TGAGTGTGTAITTC': CCAT 
501 600 
788 IA CCt, GAF'ü, TCGC"AA C: '. , °c ± T:,:; TG TTtiul. rc .. : PAAGTTAT000AT FI12-63 CTB, 
CýTx, 
TIGATCCCTAA CTTC Ar,. _Tr CTAAAT, AT('CC :,. ::, APAGTTATCCCAT 
601 700 
788 G2iTPI TIeG 
. 
iTATCTAGCTACACCAGTCTTCGGGCCCAACGTCATCTACGACTGCCCCAACTCCAAACTAATGGAACA 
FI12-63 GA: CAA', TCAGGGAAAGCG. ATGCTAACTCGGCA-ýTTCTAGCTACACCAGTCTTCGGGCCCAACCTCATCTACGACTGCCCCAACTCCAAACTAATGGAACA 
701 800 
788 AAAGAAATTCGTCAAGTTCGGCCTCACTCAACGCGCACTCGAACAACACGTTCCCCTCATCGAAAACGAAGTCCTCTCCTACATGGCTTCATCTCCGTCC 
FI12-63 AAAGAAATTTGTCAAG TT .. C.. C _"CF .: 
CRACSi. C ACFý'i: ý, ý 
.,., ... _..; 
"CT t. ,. C. A,; A, A. -. -" , '; GTCCTCTCCTACATGGCTTTATCTCCGTCC 
801 900 
788 TTCATTCCCCAATCGCCTACCTCTCCCTCTTCCTCCGACCAAAGCACAACCAAAATGGAACAGAAACTTCAAACAGCCATAATAGACCTGCCTCACACCA 
FI12-63 TTCATCTCCCAATCGCCTACCTCCCCCTCTTGCTCTAACCAAGGCATAACCAAAACGGAACAAAAACTTCAAACAGCCATAGTAGACCTTCCCCATACCA 
901 1000 
788 TGGCTCAGATCACAATCTTCACAGCCGGTCGCGCTCTTCAAGGCCCGGAGGTCCGCACTAAACTCACAGACGAATTCGCGGGTTTGTATGATGATCTCGA 
FI12-63 TGTCTCAGATCACAATCTTCACAGCTGGTCGCGCTCTTCAAGGCCCGGAGGACTGCAGCAAACTCACAGACTAATTCGCGGATTTGTATGATGATCTCGA 
1001 1100 
788 CCACGGGTTCCGGCCAATCAACTTCCTCGCTCCGTGGTTACCACTGCCTCAGAACTGGAGAAGGGATAAAGCACATGCAAAGATGATGAGTGTGTATATG 
FI12-63 CCACGGGTTTCGGCCAATCAACTTCCTCGCTCCGTGGCTACCGCTGCCGCAGAACTGGAGAAGAGATAAAGCACATGCAAAGATGATGAGTGTGTATATG 
1101 1200 
788 GACATCATATCACGACGACGTGAAAAGAGTGGTGGTGGAGTGGTGGGGAGAGGAATGGAAAGGGAGGAGATTGACATGATTGATAATCTCATGACTTGTG 
FI12-63 GACATCATATCACGACGATGGGAAAAGAGTGGTGGTGGGGAGGTGGGGAGAGGAATGGAGAGGGAGGAGATTGACATGATTGACAATCTCATGACTTGTG 
1201 1300 
788 TCTATAAATCCGGAGAAACGATTCCAGACAGCGAGATTGCGTGTATGATGATCACGATCCTTATGGCGGGACA--ACATTCGTCGAGCAGTTCCTCGTGC 
FI12-63 TCTATAAATCCGGAGAAACGATCCCAGATGGCGAAATTGCGTGTATGATGATCTCGATCCTTATGGCGGGAAAAAACACTCGTCCAGCAGTTCCTCGAGC 
1301 1400 
788 TGGATTATGCTCCATCTAGCCTCTCGCCCAGATCTTCAGGAGGAATTGTATCGCGAGCAACAGGATGCGAATCTCTACCTTGCCGGCAACAGAGGGCTAC 
FI12-63 TGGATTATGCTGCATCTAGCCTCTCGCCCAGATCTTCAGGAGGAATTGTATCGCGAGCAACAGGATGCGAATCCTTATCTTGCCGGCAACAAAGGACTAT 
1401 1500 
788 AATACCAGGACTTAGAGAAATTGAAGTTGTTGAGTGACGTGGTGAAGGAGACGCTCCGGCTCCATTCTAGCATCCATTCTGTGATGCGCGCAGTCAAGAA 
FI12-63 AATACCAGGACCTAGAGAAATTGACGTTGTTGGGTGACGTGGTGAAGGAGACGCTCCGGCTACATTCTAGCATCCATTCTATGATGCGCGCTATCAAGAA 
1501 1600 
788 CGACCTCCCGATTCCAGGGACACCATACGTCGTCACAACAGATAAAGTTCTGATTGCGAGTCCGCTTGTTACGCACCTCTCGCCAGAACACTTTTCAGAC 
FI12-63 CGACCTCCCGATTCCAGGGACACCATATGTTGTCACAACAGACAAAGTTCTGATCGCAAGTCCGCTTGTTACGCACCTCTCGCCAGAACACTTTTCAGAC 
1601 1700 
788 CCGGAGGAGTGGGATCCGTACCGCTGGGCTACACCGGGTGACATTGAGAAAGATGAAGAGGTGGATTATGGATATGGTGTGATTAGCAAGGGGACTAGGA 
FI12-63 CCTGAGAAACGGGATCCGTACCGTTGGGCTACCCTGGGTAACATTGAGAAAGATGAAGAGGCGGGTTATGGATATGGTGTGATTAGTAAGGAGATTAGGA 
1800 
788 GTCCGTACTTACCGTTTGGTGCGGGCAGACATCGATGCATTGGGGAGAAGTTTGCATTTGTCAATTTATTGACGATTATAGCTACGCTGGTGAGGGGATA 
FI12-63 TTCCTTATTTACCGTTTGGTGCGGGCAGACATCGGTGCATTGGGGAGAAGTTTGCATTCGTCAATTCATTGACGATTATAGCCACGCTTGTGAGGGGATA 
1801 1900 
788 TAAGTGGAGTCTTGTCCCTGGGGGAGAGGAAGGAGGACAGATCCCAAAGACGGATTATTCGAGTATGGTCTCTAGACCTATGCCGGGCTCGAGAGTTAGA 
FI12-63 TAGGTGGAGTCT ---------------------------------------------------------------------------------------- 
1901 1918 
788 TGGGAAAAGAGGGTCTAG 
FI12-63 ------------------ 
Figure 4.7. Alignment of CYP51A genomic DNA sequences from two R. secalis isolates. Introns are shown 
in grey. Vindicates the four base pair frameshift indel, * indicates the stop codon in the F112-63 sequence 
with I indicating the reading frame of each gene at that point. 
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Nucleotide sequences for CYP51A-P are given in Appendix 4(c). All sequences contained the 
4 base pair deletion at base pairs 419-422, resulting in a premature stop codon at base pairs 
482-484 (numbered according to functional CYP51A gene). cDNA sequences confirmed that 
the first intron is in the same position as in the functional CYP51A gene. The second intron 
starts two base pairs downstream but finishes in the same position as in the functional 
CYP51A gene. A third intron, with the splice site formed due to the presence of the sequence 
TAG instead of GAA at base pairs 764-766, was found at base pairs 712-766 (Figure 4.7). 
4.3.4 Efflux inhibitor assays 
Triazole EC50s over the range of phenothiazine concentrations are shown in Figure 4.8. EC50s 
for the phenothiazine compounds themselves in the absence of triazole fungicide were in the 
range 4.7-23.9 µg ml"1, so triazole EC50 values at higher phenothiazine concentrations are not 
reliable. At 5 gg ml-' phenothiazine, tebuconazole EC50s were reduced by less than 2.05-fold 
(Table 4.5). Prothioconazole EC50s were reduced by up to nine-fold, but this was not 
correlated with EC50 of the fungicide alone. Azoxystrobin EC50s were reduced by up to 4.17, 
but this was not correlated with EC50 of the fungicide alone. 
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Figure 4.8. Tebuconazole and prothioconazole ECtos of four R. secalis isolates over a range of 
concentrations of the putative efflux inhibitors fluphenazine and trifluoperazine. Black circles: isolate 
K1 124; white circles: Rs 9528.4; black triangles: 788; white triangles, RS 783. Grey shading indicates the 
range of EC50s of the putative efflux inhibitors alone for the four R. secalis isolates. 
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Table 4.5. Fungicide EC50s with and without 5 µg ml"' of the putative efflux inhibitors fluphenazine and 
trifluoperazine. 
Fungicide Putative efflux Isolate Fungicide EC50 EC5o 
inhibitor 
(µg MI-1) 
Potentiation e 
Tebuconazole Fluphenazine 
Trifluoperazine 
Prothioconazole Fluphenazine 
Trifluoperazine 
Azoxystrobin Fluphenazine 
Trifluoperazine 
0 µg m1-1 5 pg m1-1 
phenothiazine phenothiazine 
K1124 0.00969 0.0344 0.282 
RS 9528.4 0.465 0.442 1.05 
788 4.44 3.62 1.23 
RS 783 28.7 16.4 1.75 
RS 9528.4 0.583 0.284 2.05 
788 4.01 3.15 1.27 
RS 783 28.7 14.3 2.01 
KI 124 0.107 0.0227 4.73 
RS 9528.4 0.664 0.586 1.13 
788 0.518 0.998 0.519 
RS 783 10.1 1.93 5.23 
RS 9528.4 0.132 0.0147 9.00 
788 0.445 0.301 1.48 
RS 783 8.59 1.39 6.18 
RS 9528.4 0.104 0.104 1.00 
788 0.0507 0.0122 4.17 
RS 783 1.81 0.802 2.26 
RS 9528.4 0.129 0.363 0.355 
788 0.0221 0.0564 0.393 
RS 783 1.91 0.716 2.66 
a EC50 Potentiation = EC5o (0 µg ml" efflux inhibitor) / EC50 (5 µg ml" efflux inhibitor) 
4.4 Discussion 
4.4.1 Triazole sensitivity testing 
Sensitivity profiles against the four fungicides tested fall into three main groups. The first 
group, with the lowest EC50 values for all four triazoles tested, consists mainly of pre-1997 
isolates, which will be considered sensitive reference isolates for the triazoles being tested 
here, although isolates from the late 1980s onwards may come from populations that had 
already been subject to selection by triadimenol (Jones 1990). 
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The second group show some shifts in sensitivity levels, with propiconazole and 
tebuconazole EC50 values increased by around ten-fold, but smaller shifts in epoxiconazole 
and prothioconazole sensitivity relative to the reference isolates. Most isolates in this group 
were collected in Northern Ireland in 2001. Kendall et al. (1993) reported an eightfold shift in 
mean propiconazole sensitivity in field trials between 1988 and 1990, with some cross- 
resistance, but greater sensitivity, to tebuconazole. In this study, a similar shift in 
propiconazole sensitivity is apparent in this second group of isolates relative to the reference 
isolates, but with a greater shift in sensitivity to tebuconazole. 
The third group of isolates, including the majority of isolates from 2001 onwards, are further 
reduced in triazole sensitivity. Propiconazole and tebuconazole EC50 values are around 100- 
fold higher than those of the sensitive reference isolates. Prothioconazole and epoxiconazole 
EC50 values are also increased relative to the sensitive reference isolates, but generally by less 
than ten-fold. 
The decreased epoxiconazole sensitivity of isolates in group III, slightly less than ten-fold 
compared to group II, is consistent with shifts observed by Cooke et al. (2004), although 
actual sensitivity values are not comparable due to their use of MIC rather than EC50 values. 
Therefore, overall there is evidence of around a hundred-fold decrease in sensitivity to 
propiconazole and tebuconazole, around a ten-fold decrease in epoxiconazole sensitivity, and 
slightly less decline in prothioconazole sensitivity, for the majority of recent isolates 
compared to the reference isolates. Prothioconazole EC50 values appear somewhat elevated in 
vitro, compared to good control in the field (HGCA 2006), but the data still show that it is 
less affected by shifts in sensitivity than propiconazole and tebuconazole. 
EC50 values for each pairing of the triazoles tested here showed a significant positive 
correlation, suggesting positive cross-resistance between all four compounds. This is 
consistent with the results of Girling et al. (1988) and Kendall et al. (1993), with resistance 
against newer triazoles found to be correlated with, but quantitatively lower than, resistance 
to older triazoles. Multivariate analysis largely supports this conclusion. The first principal 
component has positive latent vectors for all four variants, indicating that 75.7% of variance 
can be accounted for by general positive cross-resistance to all four triazoles tested. However, 
the second principal component, accounting for a further 16.6% of variance, has a negative 
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latent vector for prothioconazole but positive latent vectors for propiconazole and 
tebuconazole. This indicates a slightly different pattern of variation in prothioconazole 
compared to the other three fungicides. It has been shown that prothioconazole interacts with 
different regions of CYP51 from other triazoles (Parker et al. 2011). However, similar latent 
vectors were obtained when the most sensitive isolates were excluded from the analysis, and 
sensitivity differences in this subset of isolates are not due to target-site alterations. 
The Syngenta isolate set had a similar pattern of triazole sensitivities, but with fewer sensitive 
isolates as they were all collected in 2009 whereas the first set included older isolates. As 
with the first isolate set, PC I, representing general positive cross-resistance and dividing 
isolates into sensitive, intermediate and less-sensitive isolates, and PC2, in which 
prothioconazole sensitivity varies differently from propiconazole and tebuconazole among 
the less-sensitive isolates, together encompass over 90% of variation. 
Isolates collected from Rothamsted field plots in 2009 fell within the lower end of the less 
sensitive group. There was no separation of isolates from plots receiving different fungicide 
treatments, suggesting that the initial population at that site was already less-sensitive and no 
further selection took place due to fungicide use within the 2008-2009 growing season. 
4.4.2 CYP51 sequence analysis 
No sequence differences detected in CYP51B, and no single-residue changes detected in 
CYP51A, correlated with differences in triazole sensitivity. Therefore, target-site resistance to 
triazoles, as found in M graminicola (Cools and Fraaije 2008) and B. graminis (Wyand and 
Brown 2005), can be ruled out for current isolates of R. secalis. 
However, CYP51A sequences obtained for isolates K1124, F112-63 and RS 219 contained 
substitutions, frame-shift indels and premature stop-codons, suggesting that the gene is non- 
functional. Therefore this appears to be a pseudogene and is referred to as CYP51A-P. 
CYP51A-P gene sequences from the selected isolates contained some sequence differences, 
but all contained a4 base pair deletion resulting in a stop codon at codon 114, and further 
premature stop codons downstream of codon 114. The presence of CYP51 paralogues in 
sensitive and other isolates, and their possible role in azole sensitivity, is investigated in 
Chapter 5. 
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4.4.3 Efflux inhibitor assays 
Since triazole sensitivity differences among intermediate and less-sensitive isolates are not 
explained by target-site sequence differences, a preliminary investigation into the possible 
role of enhanced efflux, using efflux inhibitors. However, the inhibitors used had very little 
effect on triazole sensitivity. At the highest concentration at which the efflux inhibitors 
themselves did not inhibit fungal growth, tebuconazole sensitivity was reduced around two- 
fold. This is less than the ten-fold variation seen between intermediate and less-sensitive 
isolates, and was similar for all isolates tested and not correlated with initial tebuconazole 
sensitivity. Greater reductions in prothioconazole sensitivity were seen in some isolates. The 
lowest potentiation of prothioconazole sensitivity by both phenothiazines was in isolate 788, 
which also had the highest score for Principal Component 2, indicating a lower 
prothioconazole Log[EC50] than expected from overall azole sensitivity, of the four isolates 
tested. However, these four isolates cover relatively little of the range of PC2 scores seen 
across all isolates. Therefore future tests on the effect of efflux inhibitors on prothioconazole 
sensitivity should include a selection of the isolates numbered 7-12 in Figure 4.3. However, 
potentiation in sensitivity to tebuconazole, prothioconazole or azoxystrobin was not 
correlated with initial fungicide EC50 for the isolate set tested here. 
The inhibitors tested here were phenothiazines, which have previously been found to restore 
azole sensitivity in isolates of C. albicans (Marchetti et al. 2000) and M graminicola 
(Roohparvar et al. 2008). Trifluoperazine was shown to be a non-competitive inhibitor of the 
yeast efflux pump Pdr5p (Kolaczkowski et al. 1996), although it may have different activity 
against different transporters (Wesolowska et al. 2009). McCartney (2006) reported that 
epoxiconazole and tebuconazole sensitivity in R. secalis were also unaffected by the efflux 
inhibitor ENT9811. However, efflux inhibition has been reported for a wide range of 
substances, including calcium channel blockers (Bulatova and Darwish 2008), tricyclic 
serotonin uptake inhibitors (Roohparvar et al. 2008), macrolide immunosuppressants 
(Hayashi et al. 2003), and milbemycin actinomycete metabolites (Lee et al. 2001). Therefore 
a role of efflux in reduced azole sensitivity in R. secalis cannot be categorically ruled out. 
Considering the wide range of putative efflux inhibitors, without clearly-defined structure- 
activity relationships except in some human and bacterial efflux inhibitors (Guz et al. 2000), 
it would not necessarily be possible to determine the role of efflux in sensitivity even if a 
wider range of substances were tested. Therefore, it would be preferable to measure fungicide 
accumulation directly, using [14C] radiolabelled fungicides (Hayashi et al. 2003). Fungicide 
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accumulation would also be affected by different rates of azole uptake (Mansfield et al. 
2010). Furthermore, when the R. secalis genome is released, it will be possible to search for 
predicted transporter genes, and in future microarrays or next generation sequence data may 
become available to identify genes that are upregulated in less-sensitive isolates or on 
addition of fungicides. 
However, in the absence of evidence for increased efflux, other possible mechanisms should 
be investigated. Expression levels of the triazole target-site-encoding genes CYP51A and 
CYP5JB are investigated in chapter 5. 
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Chapter 5 
CYPSJ paralogues and triazole sensitivity 
5.1 Introduction 
In the previous chapter, triazole sensitivity data were presented for R. secalis. Isolates fell 
into sensitive, intermediate and less sensitive groups, with further variation among the less- 
sensitive isolates. The target site encoding genes CYP51A and CYP51B and pseudogene 
CYP51A-P were sequenced for isolates from each sensitivity group. No point mutations 
correlated with triazole sensitivity, but in the case of the sensitive isolates, CYP51A could not 
be amplified and only CYP51A-P and CYP51B sequences were obtained. Further tests are 
needed to confirm whether CYP51A is present in these isolates. 
Multiple CYP51 genes have been identified from filamentous ascomycetes including A. 
fumigatus (Mellado et al. 2001), Fusarium spp. (Deng et al. 2007) and Magnaporthe oryzae 
(Yan et al. 2011). It is not known whether any functional divergence has taken place between 
CYP51 paralogues. In the case of A. fumigatus, CYP51 mutations and over-expression 
conferring reduced azole sensitivity have been reported in the CYP51A paralogue (Diaz- 
Guerra et al. 2003). However, knocking out A. fumigatus CYP51A increased the azole 
sensitivity of sensitive as well as less-sensitive isolates, suggesting that the presence of a 
wild-type CYP51A can confer reduced intrinsic sensitivity (Mellado et al. 2005). 
While the presence of CYP5JA may correlate with the initial shift from sensitive to 
intermediate sensitivity in R. secalis, no CYP51 mutations correlate with further sensitivity 
shifts (Section 4.3.3). Furthermore, no evidence was found of a role of enhanced efflux in 
reduced triazole sensitivity. Another possible mechanism of reduced triazole sensitivity is 
target site over-expression (Hamamoto et al. 2000). This may be due to insertions (Schnabel 
and Jones 2001; Ma et al. 2006; Ghosoph et al. 2007) or tandem repeats (Hamamoto et al. 
2000; Mellado et al. 2007) in the CYP51 promoter, mutations in transcription factors (Dunkel 
et al. 2008; Heilmann et al. 2010) or chromosome duplication (Sionov et al. 2010). These 
mechanisms all result in constitutive over-expression of CYP51, but greater induced 
expression of an ABC transporter (Luo and Schnabel 2008) and AOX (Chapter 2) in response 
to fungicide exposure have been reported in fungal isolates with reduced sensitivity to 
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triazoles and Qols, respectively. Furthermore, expression analysis of CYP5JA and CYP5JB 
may shed light on functional differences between the two paralogues. 
This chapter investigates the evolution of fungal CYP51 paralogues, and the role of the two 
R. secalis CYP51 paralogues in triazole sensitivity. Sequenced fungal genomes were searched 
for CYP51 genes, and phylogenetic analyses and selection tests were carried out. The 
designations CYP51A and CYP51B used for R. secalis CYP51 paralogues in the previous 
chapter are explained with reference to the fungal CYP51 gene tree obtained. 
A PCR-RFLP assay was designed to detect CYP51A and CYP51A-P in R. secalis isolates, and 
a Southern blot was carried out to confirm the results. A yeast expression assay was carried 
out to test whether R. secalis CYP51A encodes a lanosterol demethylase capable of 
complementing S. cerevisiae CYP51. Expression analysis was carried out for R. secalis 
CYP51A and CYP51B. Constitutive expression and induced expression in the presence of 
tebuconazole were analysed for both CYP51 paralogues. A pyrosequencing assay was 
designed to detect CYP51A in R. secalis populations, and samples from the Hoosfield spring 
barley experiment were analysed. 
5.2 Materials and Methods 
5.2.1 Analysis of CYP51 paralogues in fungal genomes 
Initially, a text search was carried out for annotated CYP51 genes in fungal genomes on the 
Broad Institute server (http: //www. broadinstitute. org/science/data). Subsequently, BLAST 
searches were carried out against each genome with S. cerevisiae CYP51, and with CYP51A 
and CYP51 C from the nearest available relative for species where these paralogues were not 
found. A preliminary amino acid alignment was constructed using the ClustaiW algorithm 
implemented in the AlignX module of Vector NTI (Invitrogen Corporation), and predicted 
introns and start and stop sites were checked manually. 
Amino acid sequences obtained from fungal genomes, plus CYP51 sequences from 
Mycobacterium tuberculosis, Trypanosoma cruzi and Homo sapiens, for which crystal 
structures have been solved, and additional outgroup sequences comprising Arabidopsis 
thaliana CYP51G1 and Mus musculus CYP51A1 and CYP7A1, were aligned using M-Coffee. 
The M-Coffee amino acid alignment was used to construct a corresponding coding nucleotide 
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alignment using PAL2NAL (Suyama et al. 2006). Rhynchosporium secalis CYP51A-P was 
then added manually according to its alignment with R. secalis CYP51A (Figure 4.7). 
Phylogenetic analyses were carried out with the full alignment, and with ambiguously- 
aligned regions excluded based on M-Coffee scores. 
Model selection was carried out in jModelTest 0.1.1, selecting models by AICc. 
Neighbour joining trees were reconstructed in MEGA5 (Tamura et al. 2011), using the 
TrN+G model for the full data set, with 100 bootstrap runs. Maximum likelihood 
phylogenetic reconstruction was carried out in PhyML (Guindon and Gascuel 2003) 
implemented through the TOPALi v2.5 platform (Milne et al. 2009), using the TVM+I+G 
model for the unambiguously aligned site set and the TrN+I+G model for the full data set, 
with 100 bootstrap runs. Nodes with under 50% bootstrap support were collapsed using the 
Phylo module of Biopython (Cock et al. 2009). Bayesian analysis was carried out in MrBayes 
(Ronquist and Huelsenbeck 2003), using the GTR+I+G model for the unambiguously aligned 
site set and the HKY+I+G model for the full data set. The mixed-chain Monte Carlo 
simulation was carried out for 1200000 generations until stationarity was reached (average 
standard deviation of split frequencies < 0.01), sampling every 100 generations, with a burn- 
in of 3000 samples. A 50% majority-rule consensus tree was calculated in PAUP* (Swofford 
1991). 
Intron sequences were too variable to align unambiguously so were not used for phylogenetic 
reconstruction, but intron presence/absence data were plotted onto the Maximum Likelihood 
tree generated from the full coding sequences for ascomycete CYP51 s. Ancestral state 
reconstructions were carried out by Maximum Parsimony in Mesquite (Maddison and 
Maddison 2010). 
Recombination detection was carried out using the DSS (Difference of Sums of Squares) 
method (McGuire and Wright 2000) in TOPALi v2.5. Selection testing was carried using the 
codon-based Z-test of selection implemented in MEGA 5 (Tamura et al. 2011). Further 
selection testing was carried out in the CodeML module of PAML 4.4 (Yang 2007), using 
branch-site new model A (model=2, NSsites=2; null model, w2=1) with the branches leading 
to the CYPSIA, B and C clades in turn set as the foreground branch, and in Diverge 2.0, using 
the Gu99 model, for each pairing of the yeast, A, B and C clades. Sequence logos for CYP51 
substrate recognition sites (Podust et al. 2001) were made using WebLogo (Crooks et al. 
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2004). Selection testing was carried out for yeast and filamentous ascomycete CYP51 clades, 
with H. sapiens CYP51 as an outgroup. Since Diverge and WebLogo require a minimum of 
four sequences per group, N. haematococca (Fusarium solani) gene eggwl. 5.6 72.1 was 
added to the alignment as a fourth CYP51 C, and the tree reconstructed in PhyML from the 
full alignment using the TrN+I+G model. 
Protein subcellular location prediction was carried out with TargetP 1.1 (Emanuelsson et al. 
2000), SignalP 3.0 (Bendtsen et al. 2004), TMHHMM (Krogh et al. 2001) and Phobius (Kall 
et al. 2004) according to the protocol described by Emanuelsson et al. (2007), with additional 
analyses in WoLF PSORT (Horton et al. 2006), Protein Prowler (Hawkins and Boden 2006) 
and MultiLoc (Hoglund et al. 2006). 
5.2.2 PCR-RFLP Assay 
To test for the presence of CYP51A genes in R. secalis isolates, a PCR-RFLP (Polymerase 
Chain Reaction - Restriction Fragment Length Polymorphism) assay was developed. PCR 
reactions were carried out using Phusion High-Fidelity DNA Polymerase (Finnzymes Oy, 
Espoo, Finland) according to manufacturer's instructions, in 30µ1 reactions with HF buffer, 
no DMSO, 0.5mM primers and 1.67 pg ml-1 template. Two reactions were carried out for 
each template to detect CYP51A and CYP51A-P, with primers Frameshift F and Stop Codon 
R for CYP51A and CYP51A-P, respectively (Table 5.1). Primers were designed manually, 
with annealing temperatures and dimer formation calculated in Vector NTI (Invitrogen 
Corporation). The PCR programme comprised 2 minutes at 95°C; 40 cycles of 10 seconds at 
95°C, 20 seconds at the annealing temperature and 50 seconds at 72°C; followed by 4 
minutes 10 seconds at 72°C. Annealing temperature was 60°C for the first cycle, reduced in 
1 °C increments per cycle to 56°C, followed by 35 cycles with an annealing temperature of 
55°C. Restriction digests were carried out using 5µl PCR product, in 10µI reactions with 
enzymes PstI, Hindill and EcoRl (Promega) according to manufacturer's instructions, 
incubating for 3 hours. Products were run on 1% agarose gel with 0.01% ethidium bromide. 
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Table 5.1. List of primers used to amplify CYPSI genes from R. secalis for PCR-RFLP analysis, Southern 
blot probe synthesis, yeast construct synthesis, expression analysis and pyrosequencing. 
Assay Gene Primer name Primer sequence 
PCR-RFLP CYP51A Frameshift F 5'- AGGAAATGAGTTTATCCTCAATGGAAGAT -3' 
Stop codon R 5'- TGAAGCCATGTAGGAGAGGACTTCGTTT -3' 
CYP51A-P Frameshift F 5'- CTGGAAGTGAATTTATCCTCAATGGTAGAC -3' 
Stop codon R 5'- TGGGTGAGGCCGAACTTGACA -3' 
Southern CYP51A Southern F 5'- TGTATGATGATCTCGACCACGGGTT -3' 
blot Reverse 10D 5'- CACCAAACGGTAAGTACGGACTCCTAG -3' 
CYP51A-P Southern F as for functional CYP51A 
Reverse 31 D 5'- CACCAAACGGTAAATAAGGAATCCTAATCT -3' 
Yeast CYP51A pYES F2 5'- GAGGTACICATGCTGGGTATCTTCTCGGTG -3' 
construct pYES R 5'- CTGAGCTICGACCCTCTTTTCCCATCTAACTCT -3' 
CYP51B 5'- GAGGTACICATGGGAATTTTTGAGGCTGTTACAGT -3' pYES F 
5'- CTGAGCTICAACCTTAACTTTTTCTCTCTTCTCCCA -3' pYES R 
5'- [Phos]GAAGACGACTGTGTACCTTGG[CJACCC 
pYES mut ACGGAAACGAATTCA -3' 
Expression CYPSIA Expression F 5'- AGGAAATGAGTTTATCCTCAATGGAAGAT -3' 
analysis Expression R 5'- TGAAGCCATGTAGGAGAGGACTTCGTTT -3' 
CYP51B Expression F 5'- ACCCCAGTCTTTGGAAAGGATGTGGT -3' 
Expression R 5'- GAGTGGTCGAATTTGTCTCGGCAA -3' 
B-tubulin Expression F 5'-GTGCAGTCACTGTTCCAGAGTTGACC -3' 
Expression R 5'-GCGGTTTGGACATTGGTGGG -3' 
Pyro- CYP51A Pyro F3 5'- CCTCTAGCTTTCTACACAAAATGTC -3' 
sequencing and Pyro R2 5'- GTTGTTCGAGTGCGCGTTG -3' 
CYP5IA-P Del Fl 5'- [Btn]TTTCGGCARAAAAATGACTGT -3' 
Del RI 5'- ACATCCTGCARTCTWCCATTGAG -3' 
Del Si 5'- TCTWCCATTGAGGATAAAYT -3' 
a [Phos]: Phosphorylated nuceleotide; [Btn]: Biotinylated nucleoide; Underlining indicates restriction 
enzyme recognition sequences, I indicates cleavage site; [C]: mismatch 
5.2.3 Southern Blot 
IOgg genomic DNA from isolates 788, K1124 and P112-63 was digested with high 
concentration restriction enzymes Hindlll, EcoRI, Pstl and EcoR V (Promega) in 2Oµ1 
reactions according to manufacturer's instructions. Products were run on a 1.2% agarose gel 
at 100V for 3 hours. The gel was washed in 0.25M hydrochloric acid for 15 minutes, rinsed 
142 
in distilled water, and blotted onto Hybond N+ membrane (GE Healthcare) with 0.4M 
sodium hydroxide for 16 hours. The membrane was washed in 2x SSC buffer (Sigma), air 
dried and stored in dry paper at room temperature. The gel was soaked in ethidium bromide 
solution for 30 minutes to ensure all DNA had been transferred. 
A PCR reaction was carried out using Phusion High-Fidelity DNA Polymerase (Finnzymes 
Oy, Espoo, Finland) according to manufacturer's instructions, in 30µl reactions with HF 
buffer, no DMSO and 0.5mM primers. Soithern Blot primers (Table 4.2) were designed 
manually, with annealing temperatures and dimer formation calculated in Vector NTI 
(Invitrogen Corporation). Template was 2.5 gl of 104 diluted plasmid containing cloned 
cDNA product of CYP51 for isolate 788 and CYP51-P for isolate F112-63, synthesised as 
described in section 4.2.4. The PCR programme comprised 2 minutes at 95°C; 40 cycles of 
10 seconds at 95°C, 20 seconds at 55°C and 50 seconds at 72°C; followed by 4 minutes 10 
seconds at 72°C. PCR products were purified using the Wizard SV Gel and PCR Clean-Up 
System (Promega, USA), and diluted to give 25ng DNA in 45µl TE buffer. The probe was 
radiolabelled with [32P] dCTP (Perkin Elmer, Waltham, Massachusetts) using the Amersham 
Rediprime II Random Prime Labelling System (GE Healthcare, Buckinghamshire) according 
to manufacturer's instructions. 
The membrane was incubated with 50m1 hybridisation buffer (7% SDS, 500mM sodium 
phosphate buffer pH 7.0) at 65°C with rotation in a hybridisation oven (Techne, Bibby 
Scientific Limited, Staffordshire), then incubated with the CYP51A (isolate 788) probe in 
hybridisation buffer with 100 µg ml-1 boiled sheared DNA at 65°C with rotation in a 
hybridisation oven for 16 hours. The membrane was washed twice in 2x SSC, 0.1% SDS 
solution preheated to 65°C, and twice in 0.1% SSC, 0.1% SDS solution preheated to 65°C, at 
65°C with rotation in a hybridisation over for 20 minutes. The membrane was sealed in a 
transparent plastic bag and placed in an autoradiogram cassette for 3 days. The autoradiogram 
was viewed with a Typhoon 8600 phosphoimager (Amersham Pharmacia Biotech, 
Buckinghamshire). The membrane was stripped by adding boiling 0.1 % SDS and leaving to 
cool to room temperature, three times, and the hybridisation repeated with CYP51A-P (isolate 
FI12-63) probe. 
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5.2.4 Yeast Complementation 
The primer binding sites and restriction sites used to make R. secalis CYP5J inserts for yeast 
constructs are shown in Figure 5.1. 
(a) Kpnl 
pYES F2 
pYES mut 
pYES R 
Sac/ 
I pYES R 
Sac! 
Figure 5.1. Primer binding sites and restriction sites for R. secalis CYP51 inserts for yeast constructs: 
(a) CYPSIA, (b) CYP51B. 
A PCR reaction was carried out with Easy-A High-Fidelity PCR Cloning Enzyme 
(Stratagene, California, USA) according to manufacturer's instructions, with primers pYES F 
and pYES R for CYP51B and pYES F2 and pYES R for CYP51A. Primers were designed 
manually, with annealing temperatures and dimer formation calculated in Vector NTI 
(Invitrogen Corporation). PCR template was a 1/10 dilution of isolate 788 cDNA, 
synthesised as described in section 5.2.5. The PCR programme comprised 2 minutes at 95°C; 
followed by 30 cycles of 40 seconds at 95°C, 30 seconds at 62°C and 2 minutes at 72°C; 
followed by 7 minutes at 72°C. PCR products were purified using the Wizard SV Gel and 
PCR Clean-Up System (Promega, USA). For CYP51A, PstI and Hindill restriction digests 
were carried out as described in section 5.2.2 to confirm that the PCR product was CYP51A 
and not CYP51A-P. 
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The CYP5JB PCR product was ligated into pGEM T-Easy plasmids, cloned in JM109 
competent cells and plasmid DNA purified as described in section 4.2.3. Site-directed 
mutagenesis to remove the internal KpnI restriction site by synonymous substitution was 
carried out with the QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies, 
California, USA), with primer CYP51 B pYES mut. Primer CYP51 B pYES mut was designed 
manually, with annealing temperature calculated in Vector NTI (Invitrogen Corporation). 
The PCR was carried out in 25µl reaction volume, with 125 ng primer, 1 gg plasmid template 
and 2.5 units Pfu polymerase. PCR cycle comprised 30 seconds at 95°C, followed by 30 
cycles of 30 seconds at 95°C, 1 minute at 55°C and 4 minutes 30 seconds at 68°C. 10 units 
DpnI was added, and incubated at 37°C for 1 hour. The product was then transformed into 
XL 1-Blue supercompetent cells. Cloned plasmids were purified using the QIASpin mini-prep 
kit (Qiagen) according to manufacturer's instructions and eluted into 50 µl distilled water. A 
KpnI restriction digest was carried out to confirm that the internal restriction site had been 
removed. 
The CYP51A purified PCR product and CYP5JB mutated plasmids were digested with KpnI 
and Sac1. This template (10 . il) was added to 2 gl KpnI, 2 gl Sacl, 2 . tl Buffer J and 1 gl BSA 
(Promega) and 3 µl distilled water, and incubated at 37°C for 3 hours. Products were run on a 
1% agarose gel, insert bands were excised, and purified using the Wizard SV Gel and PCR 
Clean-Up System (Promega). Purified inserts were inserted into pYES2-CT vector. Ligations 
were carried out with T4 ligase (Promega) with 5: 1 insert: vector, incubated at 4°C for 16 
hours. Plasmids were then cloned into XL 1-Blue supercompetent cells (Agilent) according to 
manufacturer's instructions but with the initial 1 hour incubation after heat-shocking carried 
out at 30°C rather than 37°C, and purified with the QiaSpin mini-prep kit (Qiagen). 
Purified CYPSIA, CYP51 B and empty pYES2-CT plasmids were transformed into S. 
cerevisiae strain YUG37: erg11, in which the native CYP51 is controlled by a doxycycline- 
repressible promoter. Transformation was carried out using the Sc. EasyComp 
Transformation Kit (Invitrogen) according to manufacturer's instructions. Selection plates 
comprised SD GAL+RAF agar medium, containing 2g 1"1 yeast nitrogen base without amino 
acids, 1.92 g 1"1 yeast synthetic drop-out medium supplement without uracil, 20 g 1"1 galactose 
and 20 g 1" raffinose, with or without 3 pg ml" doxycycline. 
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In order to test for CYP51 complementation, a growth assay was carried out with and without 
3 µg ml"' doxycycline. Yeast transformants were grown in SD GAL+RAF liquid medium at 
30°C in an orbital shaker for 24 hours to induce CYP51 expression. Yeast suspensions were 
diluted to 1.25 x 106 cells µl'', followed by 6 serial dilutions at 1/5 to give concentrations of 
2.5 x 105,5 x 104,1 x 104,2 x 103,4 x 102 and 8x 10' cells µl'. Five microlitre drops of 
spore suspension were placed on SD GAL+RAF plates with and without 3 . tg ml"' 
doxycycline, left to dry at room temperature, incubated at 30°C for 5 days then visually 
checked for growth. 
5.2.5 CYP51 Expression Analysis: Constitutive Expression 
Isolates QUB 30-10, QUB 12-3, F112-63, R 9528.4, GKII 18-2-3 and RS 783 were grown in 
100m1 Sabouraud liquid medium at 2.5 x 104 spores ml"' in an orbital shaker at 150 rpm at 
20°C for 10 days, at which point cultures were in the linear phase of growth as established in 
section 2.4.3. Fungal material was harvested by vacuum filtration, immediately placed into 
liquid nitrogen and stored at -80°C before freeze-drying. 
RNA extraction was carried out with TRIzol Reagent (Invitrogen, California, USA), 
according to manufacturer's instructions, using a tissue homogeniser for 2 minutes, with two 
phase separation steps using BCP (Molecular Research Center Inc., USA), and resuspending 
the pellet in 50µ1 TE. An equal volume of 8M lithium chloride was added, the mixture was 
incubated overnight at 4°C, then centrifuged at 4°C for 30 minutes and the supernatant 
discarded. The RNA pellet was washed with 70% ethanol, dried at room temperature, 
resuspended in RNase-free water and stored at -80°C. The RNA was treated with the 
TURBO DNA-free Kit (Applied Biosystems, California, USA). cDNA was synthesised with 
the Superscript III first-strand synthesis system (Invitrogen, California, USA). End-point 
PCRs were carried out with Red Hot Taq as described in section 3.2.4 with CYPSI B primers 
F1 and R1 to check for genomic contamination. 
Quantitative PCR was carried out using SYBR Green JumpStart Taq ReadyMix (Sigma), in 
25µl reactions with 0.25µM primers and 0.2% cDNA template, with the 7500 Real Time 
PCR System (Applied Biosystems). CYP51 B, CYP5JA and Q-tubulin primers Expression F 
and Expression R (Table 5.1) were used, with ß-tubulin used as the endogenous control. 
CYP51B and ß-tubulin primers were designed in Vector NTI (Invitorgen Corporation); 
CYP51A primers were designed manually, with annealing temperature and dimer formation 
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calculated in Vector NTI. The PCR cycle comprised 2 minutes at 95°C; followed by 40 
cycles of 15 seconds at 95°C, 30 seconds at 58°C and 36 seconds at 72°C at which point the 
reading was taken; followed by a dissociation cycle of 15 seconds at 95°C, 1 minute at 60°C 
and 15 seconds at 95°C. Data were analysed as described in Section 3.2.6, with fi-tubulin as 
endogenous control and isolate QUB 30-10 as calibrator sample. 
5.2.6 CYP51 Expression Analysis: Induced Expression 
Isolates QUB 30-10,788, KI 124, QUB 12-3, FI12-63, R 9528.4, GKII 18-2-3 and RS 783 
were grown as described in section 5.2.5, with two cultures of each isolate. At day 7, 
tebuconazole solution in acetone was added to one culture of each isolate to give a final 
concentration of 1 µg ml-1. An equal volume of acetone without tebuconazole was added to 
the other cultures. At day 10, cultures were harvested by vacuum filtration, immediately 
placed in liquid nitrogen and stored at -80°C before freeze-drying. RNA extraction and 
quantitative PCR was carried out as described in section 5.2.5. Two biological replicates were 
carried out. Data were analysed as described in Section 3.2.6, with ß-tubulin as endogenous 
control and isolate R9528.4 without fungicide as calibrator sample. Correlation between EC5o 
values, and gene upregulation following addition of tebuconazole, was tested by least squares 
linear regression analysis in GenStat 13th Edition (VSN International, Hertfordshire, UK). 
5.2.7 Pyrosequencing Assay 
Spring barley has been grown at Hoosfield at Rothamsted Research in Hertfordshire, UK, 
since 1852. DNA had been extracted from grain samples. Rhynchosporium secalis disease 
levels had been quantified by qPCR (Simon Atkins, unpublished data), and years with high 
levels were selected for pyrosequencing analysis. 
A PCR reaction was carried out in 25µi reactions using Red Hot Taq (ABgene) according to 
manufacturer's instructions, with 1.5mM MgC12,0.29M dNTPs, 0.2µM primers and Ing µl'1 
template. Primers used were Pyro F3 and Pyro R3 (Table 5.1), designed using 
Pyrosequencing Assay Design Software (Biotage, Uppsala, Sweden). The PCR programme 
comprised 2 minutes at 94°C; followed by 40 cycles of 30 seconds at 94°C, 1 minute at 52°C 
and 90 seconds at 72°C; followed by 5 minutes at 72°C. The products were diluted 500-fold 
in nanopure water (Sigma), and a nested PCR carried out with the same conditions as the 
initial PCR but using primers Del F1 and Del R1 (Table 5.1), designed using Pyrosequencing 
Assay Design Software (Biotage, Uppsala, Sweden), and an annealing temperature of 58°C. 
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The Pyrosequencing assay was carried out using the PyroMark system (Qiagen), according to 
manufacturer's instructions. The bead mix was made with 3µl streptavidin-coated Sepharose 
beads, 37µl binding buffer, 25µl water and l5µ1 PCR product per well. Samples were 
processed with the Q96 vacuum workstation, and annealed to primer Del Si (Table 5.1). 
Sequencing was carried out using the PSQ96 instrument (Biotage, Uppsala, Sweden), 
according to manufacturer's instructions. 
5.3 Results 
5.3.1 Analysis of CYP5J paralogues in fungal genomes 
CYP51 genes identified in genomes on the Broad Institute server are listed in Table 5.2. The 
full amino acid alignment is given in Appendix 5. For the alignment with ambiguously- 
aligned regions excluded, the TVM+I+G model was selected for phylogenetic reconstruction 
in PhyML, with GTR+I+G selected from the subset of jModeltest models available in 
MrBayes. For the full alignment of all sites, the TrN+I+G model was selected for 
phylogenetic reconstruction in PhyML, with HKY+I+G selected from the subset of 
jModeltest models available in MrBayes. All phylogenetic trees are shown in Figure 5.2. 
Figure 5.2. Phylogenetic trees of CYPS1 sequences of R. secalis and from fungal genomes on the Broad 
Institute genome server, rooted with a CYP7 outgroup. (a-d) Trees reconstructed from nucleotide 
alignments with ambiguously-aligned regions excluded based on M-Coffee alignment scores; (e-h) trees 
reconstructed from full nucleotide alignments. (a, e) Neighbour-joining phylograms: node labels indicate 
percentage bootstrap support, nodes collapsed if bootstrap support is under 50%. (b, f) 50% majority-rule 
consensus cladogram of most parsimonious trees: node labels indicate bootstrap support. (c, g) Maximum 
likelihood phylograms: node labels indicate percentage bootstrap support, nodes collapsed if bootstrap 
support is under 50%; numbers in brackets indicate omitted branch length. (d, h) 50% majority-rule 
consensus cladogram of Bayesian trees: node labels indicate percentage posterior probability. 
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01 100 100 Tnchophyton vertucosum TRV_06889 
00 F2 AspergiYus oryzae 
F2 Aspergtilus Ilavus 
Blastomyces dermatnidts BDBG_04743 1 
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Al Homo sapiens 
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0.1 
1 nchophyton tonsurans TESG 02544 2 
Tnchophyton rubrum TERG D2984.2 
Tnchophyton verrucosum TRV 06889 
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CYP7 Homo sapiens 
Al Homo sapiens 
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81 Mycobactenum tuberculosis 
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F5 Rhizopus oryzae 
Fl Rhlzopus oryzae 
F1P Rhizopus oryzae 
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Fl Schizosaccharomyces pombe 
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F3 Fusanum grarmmnearum 
F3 Fusarium oxysporum Pezizomycotina C 
F3 Fusanum verticdhoides 
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yrenophora tntkr-repentis PTRG_08691 
tagonospora nodorum SNOG_03702 1 
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otrytis cinerea BC 1 G_ 11853 1 
clerothna scierotiorum SSIG_04805 1 
1 Magnaporthe oryzae 
haetomium globosum CHGG_01652 1 
1 Neurospora crassa 
1 Fusanum graminearum 
1 Fusanum oxysporum 
1 Fusanum verticiliwides 
olletotnchum gramuncola GLRG 016121 
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00r Vertocdlum dahhae VDAG 04380 
t Verticaum albo-atrum VDBG 04839 
{ Co6etotnchum higgmsianum CH063 04981 
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Paracoccdiodes txasdiensn PAAG_00827 
Fl Histoptasma capsutatum 
1 Blastomyces dermatrtdis BDBG_01678 I 
Fl Uncmocarpus rees,, 
Fl Coccdiades s ffwtis 
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Trlchophyton equmum TEOG 02768 2 
100 Tnchophyton rutxum TERG_02984 2 
S0 Arthroderma benhamsae ARB 05314 
100 Tnchophyton venucosum TRV_06689 
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CYP7 Homo sapiens 
Et Tryparxnoma cruzi 
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GI Arab. dopsis thakana 
Al Homo sapiens 
F5 Rhizopus oryzae 
FI Rhrzopus oryzae 
F1P Rhaopus oryzae 
Fl Saccharomyces care sl. e 
F1 Candida albbcana 
Fl Candida tropicahs 
F1 Candida pwapsibsis 
Fl Lodderomyces elongisporus 
Fl Debaryomyces hanserui 
Fl Candida gu Iermondu 
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Fl Cryptococcus neolormans 
Copnnopsis cinerea GCMG 07605 
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F3 Fusanum oxysporum Pezizomycotina C 
F3 Fusanum vethcsaodea 
F1P Aspergilus teneus 
F1 AspergiNus terreus 
Fl AspergiNus ndutans 
Fl AspergiNus clavatus 
Fl Aspergifus tumrgatus 
F1 Neosartorya fischen 
Fl AspergiNus nper 
Fl AspergiNus flaws 
Fl Aspergifus oryzae 
Paracoccdades brastlrensis PAAG 00827 
Blastomyces demtatitdrs BDBG 01678 1 
Fl Hrstoptasma capsulatum 
Mrcrosporum canrc MCYG_07307 2 
Microsporum gypseum MGYG 04803.2 
Tnchophyton rubrum TERG 01703 2 
Tnchophyton equmum TEQG_00435 2 
Tnchophyton tonsurans TESG_04364 2 
Tnchophyton verrucosum TRV 00734 
Arthroderma benhamrae ARB_00950 
Fl Coccdaies imnwhs 
Fl Uncmocarpus reesu 
Rhynchosporlum socalts CYPSiB 
Botryhs cinerea BCIG 11853 1 
Scierotmra sclerotarum SSIG_04605 1 
F1 Magnaporthe oryzae 
Chaetomwm globosum CHGG 01652 1 
Fl Neurospora crassa 
CoNetotnchum graminicola GLRG_01612 1 
Coltetotnchum higginsianum CH063 04981.1 
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Fl Fusanum gramrearum 
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F7 Uncanocarpus reess 
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F2 Fusanum gramnearum 
F2 Fusanum oxysporum 
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Rhynchosporlum socalis CYP61A-p 
F2 Aspergifus ndulans 
F4 AsperguNus flaws 
F4 AspergiNus oryzae 
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F2 AsperguNus terreus 
F2 AsperguNus clavatus 
F2 AspergJNus tumigstus 
F2 Neosauorye fischen 
F2 AsperguNus Bavus 
F2 Asperguuus oryzee 
F2 Hntoptasma capsulatum 
Blastomyces dermahhdis BOBG_04743 I 
Mrcrosporum cams MCYG 07010 2 
Microsporum gypseum MGYG_07916 2 
Tnchophyton rubrum TERG_02984 2 
Tnchophyton verrucosum TRV_00734 
Arthroderma benhamrae ARB_00950 
Tnchophyton equmum TEQG 02768 2 
Trichophyton tonsurans TES( 02544 2 
Pezizomycotina B 
Pezizomycotina A 
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The presence of introns in ascomycete CYP51 genes is shown in Figure 5.3. According to 
maximum parsimony ancestral state reconstructions, an intron after alignment position 357 
(C. albicans base pair 235) was gained once with three subsequent losses. The intron after 
alignment position 566 (C. albicans position 432) was gained once with two subsequent 
losses. For the intron after position 1946 (C. albicans position 1518), two equally 
parsimonious reconstructions are possible, with one gain followed by three losses or three 
independent gains and one subsequent loss. Other introns are limited to single branches. 
Filamentous ascomycete CYP51 paralogues fall into three main clades, designated A, B and 
C (Figure 5.2). CYP51 genes are listed, along with gene names according to P450 
nomenclature (Nelson 2009), and the Glade into which they fall in phylogenetic analyses, in 
Table 5.2. 
The tree including N haematococca gene e_gwl. 5.672.1 was largely congruent with the 
maximum likelihood tree previously obtained from the full alignment, with the N 
haematococca gene falling into the CYP51 C Glade as sister group to the other Fusarium spp. 
CYP51F3 paralogues. Amino acid sequence variations between the three ascomycete CYP51 
clades and yeast CYP51 in the predicted CYP51 substrate recognition sites (Podust et al. 
2001) are shown in Figure 5.4. 
Selection testing by the codon-based Z-test found no significant evidence of positive 
selection except in some comparisons with Rhizopus oryzae CYP51 Fl p. The majority of 
pairwise comparisons showed evidence of purifying selection, even between paralogues. 
Diverge results are listed in Table 5.3. All comparisons show significant evidence of Type I 
functional divergence. The greatest coefficient of functional divergence, O,, is between yeast 
CYP51 and CYP51C; the least functional divergence is between CYPSIA and CYP51 B. 
CodeML results are listed in Table 5.4. Likelihood is significantly greater (p<0.001) for new 
Branch-site model A with free w2 than with w2=1 with the branch leading to the CYPS1A, 
CYP51B or CYP51C Glade as the foreground branch. w2 >1 was calculated as occurring at 
6.6,6.5 and 16.9% of sites on the branches leading to CYP51A, CYP51B and CYPSI C, 
respectively. 
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Yeast CYP51F1 
Fusarium spp. CYP51 F3 
Mycosphaerella graminicola CYP51 F1 
Stagonospora nodorum CYP51 F1 
Pyrenophora tritici-repentis C YP5 1 F1 
Rhynchosporium secalis CYP51F1 
Sclerotinia sclerotiorum CYP51 F1 
Botrytis cinerea CYP51 F1 
Fusarium spp. CYP51F1 
Magnaporthe grisea CYP51 F1 
Neurospora crassa CYP51 F1 
Chaetomium globosum CYP51 F1 
Verticillium dahliae C YP51 F 1' 
Colletotrichum spp. CYP51 F1 
Aspergillus spp. CYP51F1 
Paracoccidioides brasiliensis CYP51 F1 
Histoplasma capsulatum CYP51 F1 
Blastomyces dermatitidis CYP51 F12 
Uncinocarpus reesii CYP51 F1 
Coccidioides immitis CYP51 F1 
Trichophytoni Microsporum CYP51F1 
U. reesii CYP51 F2 
C. immitis CYP51F2 
P. tritici-repentis CYP51 F2 
C. higginsianum CYP51F2 
Fusarium spp. CYP51 F2 
M. grisea CYP51F2 
R. secalis CYP51 F2P 
R. secalis CYP51 F2 
Aspergillus spp. CYP51 F2 / F4 
B. dermatitidis CYP51 F2 
H. capsulatum CYP51F2 
Trichophyton/ Microsporum CYP51 F2 
Figure 5.3. Introns present in ascomycete CYPSI genes, shown on the maximum likelihood cladogram, 
with ancestral states reconstructed by maximum parsimony. Green: intron after alignment position 357; 
Red: intron after position 566; yellow: intron after position 1946; Blue: other introns, after the alignment 
position numbers indicated. Dashed lines: uncertainty due to two equally parsimonious solutions. 
1V albo-atrum excluded due to poor sequence quality at the 3' end. 
2 Intron after position 1946 was not 
predicted by GeneWise due to the absence of a guanine at the end of Exon 2, but this residue is not fully 
conserved in fungal introns, so presence or absence cannot be confirmed without transcript data. 
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Table 5.2. CYPSI genes used in this study, with gene names according to P450 nomenclature and the Glade 
into which they fall in phylogenetic analyses. Shading indicates P450 gene names not yet assigned on the 
P450 website (Nelson 2009). 
Species Locus ID P450 
nomenclature 
Fungal CYP51 
Glade 
Homo sapiens NM000780 CYP7 
BC032322 CYP51A1 
Mycobacterium BX842574 locus tag CYP51 Bl 
tuberculosis Rv0764c 
Trypansosoma cruzi AY283023 CYP51 EI 
Arabidopsis thaliana AtlgI1680 CYP51G1 
Rhizopus oryzae RO3G_11790.3 CYP51 Fl Mucoromycete 
R03G_08504.3 CYP51 Fl -p Mucoromycete 
RO3G_16595.3 CYP51 F5 Mucoromycete 
Cryptococcus CNAG_00040 CYP51 Fl Basidiomycete 
neoformans 
Puccinia graminis 1 PGTG_07202 CYP51 Fl Basidiomycete 
Puccinia trilicina 2 PTTG_05595. I CYP51 Fl Basidiomycete 
Ustilago maydis UM03662. I CYP51 Fl Basidiomycete 
Coprinopsis cinerea CC1G_07605 CYP51 Fl Basidiomycete 
CC I G_08364 Not yet Basidiomycete 
designated 
Schizosaccharomyces SPAC 13A 11.02c CYP51 Fl Taphrinomcotina 
pombe 
Candida albicans CAWG_04460 CYP51 Fl Saccharomycotina 
Candida guilliermondii PGUG_03415 CYP51 Fl Saccharomycotina 
Candida lusitaniae CLUG_04932 CYP5I Fl Saccharomycotina 
Candida parapsilosis CPAG_03310 CYP51 Fl Saccharomycotina 
Candida tropicalis CTRG_05283 CYP51 Fl Saccharomycotina 
Debaromyces hansenii DEHAOE20383g CYP51 Fl Saccharomycotina 
Lodderomyces LELG_03738 CYP51 Fl Saccharomycotina 
elongisporus 
Saccharomyces SCRG_04712.1 CYP51 Fl Saccharomycotina 
cerevisiae 
Arthroderma benhamiae ARB_00950 CYP51 FI Pezizomycotina B 
ARB_05314 CYP51 F2 Pezizomycotina A 
Aspergillus clavatus ACLA_005420 CYP51 Fl Pezizomycotina B 
ACLA_046180 CYPSI F2 Pezizomycotina A 
Aspergillus flavus AFL2G_06478 CYP51 FI Pezizomycotina B 
AFL2G_02771 CYP51 F2 Pezizomycotina A 
AFL2G_10953 CYP51 F4 Pezizomycotina A 
Aspergillusfumigatus Afu7g03740 CYP51 FI Pezizomycotina B 
Afu4g06890 CYP51 F2 Pezizomycotina A 
Aspergillus nidulans ANID_08283 CYP51 Fl Pezizomycotina B 
ANID_01901 CYP51 F2 Pezizomycotina A 
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Table 5.2 continued 
Species Locus ID P450 
nomenclature 
Fungal CYP5I 
Glade 
Aspergillus niger est_fgel_pm_C_150008 CYP5I Fl Pezizomycotina B 
est_fge 1 
_pm_C_40090 
CYP51 F2 Pezizomycotina A 
Aspergillus oryzae A0090026000842 CYP51 FI Pezizomycotina B 
A0090003000205 CYP51 F2 Pezizomycotina A 
A0090020000357 CYP51 F4 Pezizomycotina A 
Aspergillus terreus ATEG_02850 CYP51 F1 Pezizomycotina B 
ATEG_10302 CYP51 FI p Pezizomycotina B 
ATEG_05917 CYP51 F2 Pezizomycotina A 
Blastomyces BDBG_01678.1 CYP51 F1 Pezizomycotina B 
dermatitidis 
BDBG_04743.1 CYP51 F2 Pezizomycotina A 
Botrytis cinerea BCIG_11853.1 CYP51 FI Pezizomycotina B 
Chaetomium globosum CHGG_01652.1 CYP51 F1 Pezizomycotina B 
Coccidioides immitis CIMG_07469 CYP51 FI Pezizomycotina B 
CIMG_00573 CYP51 F2/ Pezizomycotina A 
CYP51 F7 
Colletotrichum GLRG_01612.1 CYP51 Fl Pezizomycotina B 
graminicola 
Colletotrichum CH063_04981.1 CYP5I FI Pezizomycotina B 
higginsianum 
CH063_09462.1 CYP51 F2 Pezizomycotina A 
Fusarium graminearum FGSG_01000 C YP51 F1 Pezizomycotina B 
FGSG_04092 CYP51 F2 Pezizomycotina A 
FGSG_11024 CYP51 F3 Pezizomycotina C 
Fusarium oxysporum FOXG_00394 CYP51 FI Pezizomycotina B 
FOXG 11545 CYP51 F2 Pezizomvcotina A 
FOXG_13138 CYP51 F3 Pezizomycotina C 
Fusarium verticillioides FVEG_01123 CYP51 Fl Pezizomycotina B 
FVEG_10277 CYP51 F2 Pezizomycotina A 
FVEG_12391 CYP51 F3 Pezizomycotina C 
Histoplasma capsulatum HCAG_04048.3 CYP51 Fl Pezizomycotina B 
(NAm 1) 
HCAG_04481.3 CYP51 F2 Pezizomycotina A 
Magnaporthe oryzae MGG_04432.6 CYP51 Fl Pezizomycotina B 
MGG_04628.6 CYP51 F2 Pezizomycotina A 
Microsporum canis MCYG_07307.2 CYP51 FI Pezizomycotina B 
MCYG_07010.2 CYP51 F2 Pezizomycotina A 
Microsporum gypseum MGYG_04803.2 CYP51 FI Pezizomycotina B 
MGYG_07916.2 CYP51 F2 Pezizomycotina A 
Mycosphaerella 110231 CYP51 Fl Pezizomycotina B 
graminicola 
Neosartorya fischeri NFIA_024690 CYP51 Fl Pezizomycotina B 
NFIA_109350 CYP51 F2 Pezizomycotina A 
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Table 5.2 continued 
Species Locus ID P450 Fungal CYP51 
nomenclature Glade 
Neurospora crassa N0002624 CYP51 Fl Pezizomycotina B 
Paracoccidioides PAAG_00827 (PbO 1) CYP51 Fl Pezizomycotina B 
brasiliensis 
Pyrenophora trilici- PTRG_08691 CYP51 FI Pezizomycotina B 
repentis 
PTRG_09430 CYP51 F2 Pezizomycotina A 
Rhynchosporium secalis CYP51 B CYP5I Fl Pezizomycotina B 
CYP5IA CYP51 F2 Pezizomycotina A 
CYP5IA-p CYPS1 F2-P Pezizomycotina A 
Sclerotinia sclerotiorum SS 1 G_04805.1 CYP51 Fl Pezizomycotina B 
Stagonospora nodorum SNOG_03702.1 CYP51 FI Pezizomycotina B 
Trichophyton equinum TEQG_00435.2 CYPS1 Fl Pezizomycotina B 
TEQG_02768.2 CYP51 F2 Pezizomycotina A 
Trichophyton rubrum TERG_0 1703.2 CYP51 FI Pezizomycotina B 
TERG_02984.2 CYP51 F2 Pezizomycotina A 
Trichophyton tonsurans TESG_04364.2 CYPS1 Fl Pezizomycotina B 
TESG_02544.2 CYP51 F2 Pezizomycotina A 
Trichophyton TRV_00734 CYP51 Fl Pezizomycotina B 
verrucosum 
TRV 06889 CYP5I F2 Pezizomycotina A 
Uncinocarpus reesii UREG_07804.1 CYP51 Fl Pezizomycotina B 
UREG_00593.1 CYP51 F7 Pezizomycotina A 
Verticillium albo-atrum VDBG_04839 CYP51 Fl Pezizomycotina B 
Verticillium dahliae VDAG_04380 CYP51 Fl Pezizomycotina B 
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Figure 5.4. Amino acid sequence logos (Crooks et al. 2004) for filamentous ascomycete CYP51 groups A, 
B and C and yeast CYP51. 
Table 5.3. Diverge results for ascomycete CYPSI clades. 
Ox (ML method) a 
LRT 9a b 
Number of sites where 
P(F1)> 50% 
Number of sites where 
P(FI)> 67% 
Yeast/C Yeast/A Yeast/B C/A C/B A/B 
0.41 +0.09 
22.3 *** 
0.29 ±0.03 
72.1 *** 
0.32 ±0.04 
74.3 *** 
0.21 ±0.06 
13.6 *** 
0.23 ±0.08 
8.2 ** 
0.16 ±0.03 
40.0 *** 
78 46 58 11 21 
20 26 34 
'Maximum likelihood estimate of 0+ standard error. Likelihood ratio test. ** significant at I%, 
*** significant at 0.1%. 'If P(FI) > 50%, sites are more likely than not to have experienced functional 
divergence; if P(FI) > 0.67, sites are twice as likely as not to have experienced functional divergence. 
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Table 5.4. CodeML results for ascomycete CYPSIs under the branch-site model. 
Foreground log Likelihood Significance ` Foreground sites with w>I 
branch 
M8a ° M8 Difference Proportion Number BEB 
A -32943.4 -32934.6 -8.8 >0.001 0.066 38 7 
B -32947.1 -32937.3 -9.8 >0.001 0.064 37 7 
C -32925.8 -32915 -10.8 >0.001 0.169 97 29 
a Model M8a: Null hypothesis with foreground o=1. Model M8: Alternative hypothesis with foreground o 
free to be > 1. ` Significance: Probability that likelihood under M8 is significantly greater than under M8a, based 
on a x12 distribution. d BEB: number of foreground sites with P ((o > 1) < 0.05 identified by Bayes Empirical 
Bayes analysis. 
DSS analysis did not reveal any significant evidence of recombination at 95% significance. 
Adjusting the probability threshold to 50% resulted in three partitions, with breakpoints at 
nucleotide alignment positions 1150 and 1805, gave three trees differing in the placement of 
some individual taxa but retaining the main A, B, C and yeast clades except the final partition 
for which the B Glade was split into two groups, as for trees generated from unambiguously 
aligned sites only, since the monophyly of the CYPSI B Glade is most strongly supported by a 
paralogue-specific region encoding the N-terminal region of the protein. 
5.3.1.1 Protein localisation prediction 
TargetP predicted most CYP51 s as localising within the secretory pathway, although some 
CYP51Bs were predicted as `other' (non-secretory, non-mitochondrial) (Table 5.5). Similar 
results were obtained by Protein Prowler. WolfPSORT also predicted locations within the 
secretory pathway (Plasma membrane, extracellular, endoplasmic reticulum or Golgi 
apparatus) for most CYP51 s, and MultiLoc predicted all CYP51 s to be located in the Plasma 
membrane, Golgi apparatus or endoplasmic reticulum (Table 5.5). The sequences were then 
analysed with SignalP. All CYP51B and CYP5IC N-terminal peptides were predicted to 
form signal anchors, whereas most CYP51 A N-terminal peptides were predicted to be 
cleaved signal peptides (Table 5.5). 
However, TMHMM predicted transmembrane helices in the N-terminal regions of all fungal 
CYP51 Is. Since SingalP predicted a signal peptide and TMHHMM predicted a 
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transmembrane helix within the same region of most proteins, Phobius (Kall et al. 2004) was 
used to distinguish between the two (Emanuelsson et al. 2007). All CYP51 N-terminal 
regions were predicted as containing a transmembrane region and not a signal peptide, except 
U maydis CYP51, Schizosaccharomyces pombe CYP51 and C. cinerea CC1G_08364, with 
predicted signal peptides upstream of the predicted transmembrane region, and P. tritici- 
repentis CYP5IA and Aspergillus niger CYP5IA, predicted as containing a signal peptide 
and not a transmembrane region (Table 5.5). The R. secalis CYP51A and CYP51B Phobius 
output plots are shown in Figure 5.5. 
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Table 5.5. Predicted subcellular localisation of fungal CYP51 peptides. 
CYP51 TargetP e Wolf 
PSORT b 
Protein 
Prowler 
MultiLoc ° SignalP TMHM 
M Helix 
Phobius 
Cyp7 Human Secretory Golgi Secretory Golgi Signal 5-24 TMH ` 
Mycobacterium Other Cyto Other Cyto Non- None None 
tuberculosis B1 secretory 
Trypanosoma Secretory Plasma Secretory Golgi Signal None Signal 
cruzi El 
Arabidopsis Secretory Cyto Secretory Golgi Non- 13-32 TMH 
thaliana GI secretory 
CYP51A1 Secretory Cyto Other Golgi Signal 4-21, Signal 
Human 28-50 +TMH 
Aspergillus 
clavatus B 
A. fumigatus B 
A. flavus B 
A. oryzae B 
A. niger B 
A. terreus B 
A. nidulans B 
A. terreus B 
Neosartorya 
fischeri 
Blastomyces 
dermatitidis 
Trichophyton 
rubrum 
Microsporum 
canis 
M. gypseum 
Trichophyton 
equinum 
T. tonsurans 
T. verrucosum 
Other ER 
Secretory Plasma 
Secretory Plasma 
Secretory Plasma 
Secretory ER 
Secretory Plasma 
Secretory Plasma 
Other ER 
Secretory Plasma 
Secretory Plasma 
Other Cyto 
Other Plasma 
Other Plasma 
Other Cyto 
Other Cyto 
Other Cyto 
Arihroderma Other Cyto 
benhamiae 
Coccidioides Secretory Extra- 
Other Golgi 
Secretory Golgi 
Secretory Plasma 
Secretory Plasma 
Secretory Plasma 
Secretory Plasma 
Secretory Plasma 
Other Golgi 
Secretory Extra- 
cellular 
Secretory Extra- 
cellular 
Secretory Extra- 
cellular 
Other Extra- 
cellular 
Other Extra- 
cellular 
Secretory Extra- 
cellular 
Secretory Extra- 
cellular 
Secretory Extra- 
cellular 
Secretory Extra- 
cellular 
Secretory Golgi 
Anchor 20-42 TMH 
Anchor 21-43 TMH 
Anchor 20-42 TMH 
Anchor 20-42 TMH 
Anchor 20-42 TMH 
Anchor 19-41 TMH 
Anchor 20-42 TMH 
Anchor 20-42 TMH 
Anchor 21-43 TMH 
Anchor 20-42 TMH 
Anchor 21-43 TMH 
Anchor 20-42 TMH 
Anchor 21-43 TMH 
Anchor 21-43 TMH 
Anchor 21-43 TMH 
Anchor 21-43 TMH 
Anchor 21-43 TMH 
Anchor 20-41 TMH 
immitis B cellular 
Uncinocarpus Secretory Extra- Secretory Golgi Anchor 20-42 TMH 
reesii B cellular 
Histoplasma Secretory Plasma Secretory Plasma Anchor 20-42 TMH 
capsulatum B 
Paracoccidioides Secretory Plasma Secretory Plasma Anchor 20-42 TMH 
brasiliensis B 
Botrytis cinerea B Other ER Other Golgi Anchor 20-42 TMH 
Sclerotinia Other Cyto Secretory Golgi Anchor 20-42 TMH 
sclerotiorum B 
Rhynchosporium Secretory Plasma Secretory Golgi Anchor 20-42 TMH 
secalis B 
Chaetomium Other MT Other Golgi Anchor 20-41 TMH 
Qlobosum B 
Table 5.5 continued 
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CYP51 TargetP a Wolf 
PSORT b 
Protein 
Prowler 
MultiLoc SignalP TMHM 
M Helix 
Phobius 
Neurospora Secretory ER Other Golgi Anchor 20-41 TMH 
crassa B 
Fusarium Other Cyto Other Golgi Anchor 20-42 TMH 
graminearum B 
F. oxysporum B Other Cyto Other Golgi Anchor 20-42 TMH 
F. verticillioides Other Cyto Other Golgi Anchor 20-42 TMH 
B 
Colletotrichum Secretory Extra- Other Extra- Anchor 20-42 TMH 
graminicola cellular cellular 
Colletotrichum Secretory ER Other Extra- Anchor 20-42 TMH 
higginsianum cellular 
Magnaporthe Other ER Other Golgi Anchor 15-37 TMH 
oryzae B 
Verticillium Other ER Other Golgi Anchor 24-46 TMH 
albo-atrum B 
V. dahliae B Other ER Other Golgi Anchor 20-41 TMH 
Pyrenophora Other Cyto Other Golgi Anchor 20-42 TMH 
tritici-repentis B 
Stagonospora Other Plasma Other Golgi Anchor 20-41 TMH 
nodorum B 
Mycosphaerella Secretory Cyto Other Extra- Anchor 20-42 TMH 
graminicola cellular 
Candida albicans Secretory Cyto- Other Golgi Non- 15-37 TMH 
nuclear secretory 
C. tropicalis Other Nuclear Other Golgi Non- 15-37 TMH 
secretory 
C. guilliermondii Secretory Golgi Other Golgi Non- 20-42 TMH 
secretory 
C. lusitaniae Secretory Plasma Secretory Golgi Signal 15-37 TMH 
Candida Secretory Mito Secretory Extra- Non- 15-37 TMH 
parapsilosis cellular secretory 
Lodderomyces Secretory ER Secretory Extra- Non- 15-37 TMH 
elongisporus cellular secretory 
Debaryomyces Secretory ER Other Extra- Non- 15-37 TMH 
hansenii cellular secretory 
Saccharomyces Secretory MT Other Golgi Non- 29-51 TMH 
cerevisiae secretory 
Schizosaccha- Secretory Plasma Secretory Extra- Signal 5-22 Signal 
romyces pombe cellular +TMH 
Coprinopsis Secretory Plasma Secretory Golgi Anchor 6-25 TMH 
cinerea FI 
C. cinerea Other Plasma Other Golgi Non- 38-60 Signal 
CC I G_08364 secretory +TMH 
Cryptococcus Secretory Cyto Secretory Golgi Non- 32-54 TMH 
neoformans secretory 
Puccinia graminis Secretory Cyto Secretory Golgi Anchor 20-39 TMH 
Ustilago maydis Secretory Plasma Other ER Signal 32-54 Signal 
+TMH 
Rhizopus oryzae Secretory ER Secretory Extra- Anchor 13-35 TMH 
F1 cellular 
Rhizopus oryzae Secretory Nuclear Secretory Extra- Anchor 12-34 TMH 
FS cellular 
F. graminearum Secretory Plasma Secretory Plasma Anchor 15-34 TMH 
C 
Table 5.5 continued 
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CYP51 TargetP a Wolf 
PSORT b 
Protein 
Prowler 
MultiLoc b SignalP TMHM 
M Helix 
Phobius 
F. oxysporum C Secretory Plasma Secretory Plasma Anchor 12-34 TMH 
F. verticillioides Secretory Plasma Secretory Golgi Anchor 12-34 TMH 
C 
C. immitis A Secretory Plasma Secretory Golgi Anchor 10-32 TMH 
U. reesii A Secretory Plasma Secretory Plasma Anchor 10-32 TMH 
P. tritici-repentis Secretory Extra- Secretory Golgi Signal 5-24 Signal 
A cellular 
F. graminearum Secretory Extra- Secretory Golgi Signal 7-29 TMH 
A cellular 
F. oxysporum A Secretory Plasma Secretory Golgi Signal 4-25 TMH 
F. verticillioides Secretory Plasma Secretory Golgi Signal 4-25 TMH 
A 
C. higginsianum Secretory Plasma Secretory Extra- Anchor 10-32 TMH 
A cellular 
M. oryzae A Secretory Plasma Secretory Golgi Signal 10-32 TMH 
R. secalis A Secretory Plasma Secretory ER Signal 13-35 TMH 
A. flavus Al Secretory Plasma Secretory Golgi Signal 7-28 TMH 
A. oryzae Al Secretory Plasma Secretory Golgi Signal 7-28 TMH 
H. capsulatum A Secretory Plasma Secretory Plasma Signal 7-24 TMH 
A. clavatus A Secretory Plasma Secretory Plasma Signal 7-29 TMH 
A. fumigatus A Secretory Extra- Secretory Golgi Signal 7-29 TMH 
cellular 
A. nidulans A Secretory Plasma Secretory Golgi Signal 7-29 TMH 
A. flavus A2 Secretory Plasma Secretory Golgi Signal 5-24 TMH 
A. oryzae A2 Secretory Plasma Secretory Golgi Signal 5-24 TMH 
A. niger A Secretory Plasma Secretory Golgi Signal 5-24 Signal 
A. terreus A Secretory Plasma Secretory Golgi Signal 4-23 TMH 
N. fischen A Secretory Extra- Secretory Extra- Signal 7-29 TMH 
cellular cellular 
B. dermatitidis A Secretory Mito Secretory Peroxi- Signal 5-24 TMH 
somal 
T. rubrum A Secretory Plasma Secretory Peroxi- Signal 5-27 TMH 
somal 
M. canis A Secretory Plasma Secretory Peroxi- Signal 5-27 TMH 
somal 
M. gypseum A Secretory Plasma Secretory Extra- Signal 5-27 TMH 
cellular 
T. equinum A Secretory Plasma Secretory Extra- Signal 5-27 TMH 
cellular 
T. tonsurans A Secretory Plasma Secretory Extra- Signal 5-27 TMH 
cellular 
T. verrucosum A Secretory Plasma Secretory Extra- Signal 5-27 TMH 
cellular 
A. benhamiaeA Secretory Plasma Secretory Extra- Signal 2-24 TMH 
cellular 
e Shaded cells indicate locations in the secretory pathway. t ER: Endoplasmic reticulum; Plasma: Plasma 
membrane; Golgi: Golgi apparatus, MT: Mitochondrial, Cyto: Cytoplasmic. ` TMH: Transmembrane helix 
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Figure 5.5. Phobius (Kalt et at 2004) output plots for (a) R. secalis CYP51A and (b) R. secalis CYP51B. 
Red: Signal peptide; Grey: Transmembrane helices; Green: Cytoplasmic; Blue: Non-cytoplasmic. 
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5.3.2 PCR-RFLP Assay 
Isolates QUB 30-10, R9528.4, R9522.3,788, SAC 1.4.8 (0003), GKII 18-2-3, QUB 12-3, 
OSA 28-2-2, GKII 18-3-2, SAC 09/943/14 and RS 783 gave PstI and Hindlll restriction 
products consistent with the functional CYP51A gene from the PCR reaction with CYP51A 
primers, and PstI and Hindlll restriction products consistent with the CYP51A pseudogene 
from the PCR reaction with CYP5JA p primers (Figure 5.6; Table 5.6). Isolates K1124, FI12- 
63 and RS 219 gave PstI and Hindlll restriction products consistent with CYP5JA p from 
PCR reactions with both primer pairs. 
Table 5.6. Restriction sites in PCR-RFLP analysis of 14 R. secalis isolates, with CYPSIA and CYPSIA p 
primers, and restriction enzymes Pst! and HindII!. 
PCR-RFLP restriction sites 
Isolate CYP51 A primers CYP51 Ap primers 
Pstl Hindlll Pstl Hindlll 
CYP51A plasmid 0 2 0 2 
CYP51A p plasmid 1 0 1 0 
RS 219 1 0 1 0 
K1124 1 0 1 0 
FI12-63 1 0 1 0 
R 9528.4 0 2 1 0 
R 9522.3 0 2 1 0 
QUB 30-10 0 2 1 0 
GKII 18-3-2 0 2 1 0 
GKII 18-2-3 0 2 1 0 
788 0 2 1 0 
SAC 1.4.8 (0003) 0 21 0 
SAC 09/943/14 0 21 0 
QUB 12-3 0 21 0 
OSA 28-2-2 0 21 0 
RS 783 0 21 0 
5.3.3 Southern Blot 
The EcoR V, PstI and Hindill digests produced two bands for isolate 788 but only one band 
for isolates F112-63 and K1124. The EcoRI digest is less clear for isolate 788. The same 
bands are visible with both probes (Figure 5.7). 
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Figure 5.6. (a) Expected PCR-RFLP product lengths for R. secalis CYPSIA genes. Solid lines indicate 
primer binding sites, dotted lines indicate restriction sites, arrows indicate amplicon and restriction 
fragment lengths. (i) CYPSIA; (ii) CYPSI p 
(b) Gel obtained from PCR-RFLP analysis of R. secalis CYP5IA and CYPSIA p plasm ids (Section 4.2.4), 
digested with Pstl and HindII!. Ladder is GeneRuler 1 kb (Fermentas). 
(c) Gel obtained from PCR-RFLP analysis of R. secalis isolates K1124, R 9528.4 and 788, amplified with 
CYP51A and CYP51A p primers, digested with (left to right for each isolate) Pstl and Hindlll. Ladder is 
GeneRuler 1 kb (Fermentas). 
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Figure 5.7. Southern blot of R. secalis genomic DNA digested with restriction enzymes EcoRV, Psil, EcoRl 
and Hindill. (a) CYPSIA probe; (b) CYPSIA-P probe. Isolate 1: F112-63; 2: K1124; 3: 788. 
Ladder (visualised on agarose gel before transfer to membrane) is GeneRuler Ikb (Fermentes). 
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5.3.4 Yeast Complementation 
Rhynchosporium secalis CYP51A complemented yeast CYP51, allowing transformants to 
grow on doxycycline-amended medium (Figure 5.8). However, R. secalis CYP51 B produced 
very slow growth in yeast on doxycycline-amended medium, insufficient for further assays to 
be carried out. 
-Dozy cý cline +Doxycy cline 
Vector onh 
R. secalis 
CYP5l. -1 
R. secalis 
CYPSI B 
Figure 5.8. Growth of Saccharomyces cerevisiae strain YUG37: erglltransformed with pYES2-CT vector 
only or pYES-CT with R. secalis CYPSIA or CYPSIB on SD +GAL+RAF agar with and without 3 µg ml-' 
doxycycline, with six inoculum concentrations of 1.25 x 106,2.5 x 105,5 x 10°, 1x 104,2 x 103 and 4x 102 
cells pf'. 
5.3.5 CYP51 Expression Analysis: Constitutive Expression 
Constitutive expression levels are shown in Figure 5.9. Isolate Fl 12-63 lacks CYP51A, so the 
calculated relative expression was very low, and the dissociation curve showed that the 
product was non-specific (Figure 5.9c). CYP51A relative expression levels for all other 
isolates fell within a factor of ten, and differences in expression level do not correlate to 
differences in sensitivity. For CYP51 B, relative expression levels for all isolates fell within a 
factor of 3, with most differences not significant at 95%. 
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Figure 5.9. Constitutive expression of (a) CYP51A and (b) CYP51B for six R. secalis isolates, as relative 
quantification calibrated to isolate QUB 30-10 with ß-lubulin as endogenous control. Error bars show 
95% confidence intervals based on the student's T distribution. (c) CYP51A qPCR dissociation curve for 
isolates QUB 30-10 (blue) and F112-63 (green). 
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5.3.6 CYP51 Expression Analysis: Induced Expression 
Induced expression levels are shown in Figure 5.10. Isolates K1124, Fl 12-63 and RS219 lack 
CYP51A, so the calculated relative expression was very low, and the dissociation curve 
showed that the product was non-specific (data not shown). In all other isolates, CYP51A 
expression increased by around 100-fold in the presence of tebuconazole, with similar 
expression levels between those isolates. Up-regulation of CYP51 B in the presence of 
tebuconazole was less than upregulation of CYP51A in all isolates, with under ten-fold 
increases in expression levels. Apart from the lack of CYP51A in sensitive isolates, there was 
no correlation between induced expression of either gene and triazole sensitivity. Fold- 
change in CYP51A expression was greater in intermediate than less-sensitive isolates (Figure 
5.11 a). There was no significant correlation between CYP51B upregulation and triazole 
sensitivity among the six isolates with CYP51A (P = 0.061, data not shown), but the 
correlation was significant for the full set of nine isolates (Figure 5.11 b). 
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Figure 5.11. Triazole sensitivity, represented by PC1 as calculated in section 4.3.1, plotted against CYPSI 
upregulation, calculated as the difference between log10IRQj with I pg ml-' tebuconazole and log, ojRQj 
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5.3.7 Pyrosequencing Assay 
Pyrosequencing results gave the percentage of DNA molecules with an insertion (CYP51A) 
or deletion (CYP51A-P) at base pair 481. Isolates with CYP51A-P only have 100% of DNA 
molecules with the deletion, whereas isolates with both CYP51A-P and CYP51A have 50% of 
DNA molecules with the deletion and 50% with the insertion (Figure 5.12). Therefore, in a 
population sample, the percentage of isolates with CYP51A is calculated as 
=x100 
D 
and the percentage of isolates with CYP51A-P only is calculated as 
D-I 
x100 D 
where I is the percentage of molecules with an insertion, and D is the percentage with a 
deletion. 
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Figure 5.12. Single isolate Pyrogram traces for (a) Isolate FI12-63, with CYP51A-P only; (b) Isolate 788, 
with CYP51A and CYP51A-P. 
The percentage of isolates containing CYP51A-P only, or CYP51A and CYP51A-P, for 
Hoosfield samples is shown in Figure 5.13. The proportion of isolates with CYP51A is low 
until 1998, after which it increases rapidly, with the majority of the population possessing 
CYP51A from 2002. 
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5.4 Discussion 
5.4.1 CYPS1 paralogues in fungal genomes 
Ascomycete CYP51 paralogues fall into three main clades. Filamentous ascomycete 
CYP51 F1 and CYP51 Fl p form the CYP51 B group; CYP51 F2, CYP51 F4 (from A. terreus 
and A. oryzae) and CYP51 F7 (from Uncinocarpus reesii and Coccidioides immitis) form the 
CYP51A group, and CYP51 F3 (from Fusarium spp. ) form the CYP51 C group. This is 
consistent with the trees presented by Liu et al. (2011) and Becher et al. (2011). The second 
paralogue in C. cinerea, currently the only known basidiomycete with multiple CYP51 s, does 
not fall into groups F I-7, and so a new name should be assigned, such as CYP51 F8. It should 
be noted that the division into CYP5JA, B and C is limited to the filamentous ascomycetes, 
with the single yeast CYP51 orthologues forming a sister group to the A+B+C Glade. As such, 
CYP51 FI is paraphyletic, with the CYP51 F1 of filamentous ascomycetes more closely 
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related to the (CYPS1 F2+F4+F7) Glade and CYP51 F3 than to the undifferentiated CYP51 Fl 
orthologues of hemiascomycetous and archiascomycetous yeasts and non-ascomycetes. The 
names CYP51 Fl -7 (Nelson 2009) provide unique and stable nomenclature for individual 
genes, whereas the designations CYP51A, CYP51B (Mellado et al. 2001) and CYP51 C (Yin 
et al. 2009) are descriptive of the phylogenetic and possibly functional divisions of 
filamentous ascomycete CYP51 paralogues. However, care must be taken to distinguish the 
A, B and C clades of ascomycete CYP51 F from the use of CYP51 A, CYP51 B and CYP51 C in 
the names of CYP51 genes from animals, bacteria and chromista, respectively. 
Phylogenetic reconstruction suggests that two CYP51 gene duplications, to give CYP51C and 
then CYP51A and CYP51B, occurred basally to the filamentous ascomycetes, followed by the 
loss of CYP51A from around half the species shown here and the loss of CYP51C from all 
lineages except Fusarium. However, protein-coding genes may carry a high chance of 
homoplasy, where sequence differences and similarities do not give a true picture of 
evolutionary history, but have been influenced by functional constraints, especially if there 
has been functional divergence between the paralogues. Therefore, the placement of CYP51 C 
as a sister group to (CYP51A + CYP51 B) may be due to functional divergence in CYP51 C 
and greater sequence conservation in CYP51 A and CYP51 B. However, the pattern of intron 
occurrence across ascomycete CYP51 s is also consistent with a basal split into A, B and C 
clades. On the phylogeny here, a most parsimonious reconstruction of intron presence does 
not require any independent gains of introns at the same position in multiple lineages, 
whereas a later duplication of Fusarium CYP51 s would require an independent gain of an 
intron after alignment position 1946. There was also no evidence of recombination in fungal 
CYP51 genes. 
There have also been some further duplications within the A group, giving rise to CYP51 F4 
in A. f avus and A. oryzae, a duplication within the B group resulting in a CYP51 B 
pseudogene in A. terreus, and one gene duplication within a Basidiomycete, C. cinerea. 
However, some of these may fall within more widespread patterns of gene duplication 
(Machida et al. 2005), so the inclusion of a CYP51 amongst the duplicated genes may not 
always have functional significance. Uncinocarpus reesii CYP51 F7 and C. immitis 
CIMG_00573 are in the CYP51A Glade, but they fall at the base of the Glade, rather than with 
the other eurotiomycetes as for CYP51B. This may also be down to long-branch attraction, 
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whereby more divergent sequences are erroneously placed outside a group of otherwise 
conserved sequences. 
The split between CYP51A and CYP51B was better-supported on trees reconstructed from the 
full sequence alignment, including ambiguously-aligned regions. This suggests that 
consistent differences between CYP51A and CYP51B include length variation, since 
ambiguously-aligned regions tend to be those containing indels. These regions include the N- 
terminal region, which protein structure models have identified as a membrane-binding helix 
(Xiao et al. 2004; Canas-Gutierrez et al. 2009). Otherwise the trees reconstructed by different 
methods are largely congruent. 
As paralogues differ in the N-terminal region, which may contain a signal protein or 
membrane anchor, subcellular localisation predictions were carried out. Protein location 
predictions predominantly identified the fungal CYP51 paralogues tested as belonging to the 
secretory pathway, which includes plasma membrane proteins, although predictions of 
location within the secretory pathway were not consistent and are generally not reliable as 
signals are poorly characterised (Emanuelsson et al. 2007). However, the N-terminal regions 
identified by TargetP (Emanuelsson et al. 2000) as secretory signals were identified by 
TMHHMM (Krogh et al. 2001) and Phobius (Kall et al. 2004) as membrane-binding regions, 
as previously reported in homology-based protein structure modelling studies (Xiao et al. 
2004). These results are consistent with all ascomycete CYP51 paralogues being plasma- 
membrane bound proteins. Predicted cytoplasmic and non-cytoplasmic regions are not 
reliable for proteins with a single membrane-spanning region (Kall et al. 2004), and the 
second transmembrane helix identified in some peptides corresponds to the first P450 
structural helix, aA' (Xiao et al. 2004; Canas-Gutierrez et al. 2009). One consistent 
difference between paralogous groups was observed at the extreme N-terminus. In CYP51B, 
the predicted transmembrane helices started at residues 19-21, with only two exceptions; in 
CYP51 A, the helices started at or before residue 10, with a single exception starting at 
residue 13; and in CYP51 C, the transmembrane helices started at residue 12 or 15. However, 
those 10-20 N-terminal residues were not recognised as signal peptides, so no differences in 
subcellular localisation of the three CYP51 paralogues are predicted at present, although in 
silico protein localisation tools only provide predictions, which may be disproved by 
experimental testing. 
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In addition to the N-terminal region, there is length variation between paralogues between 
regions aD and ß3-1, including a unique insertion of around 20 residues in R. secalis 
CYP51A; between aG and aH, with insertions in some CYP51As; between aJ and aJ', with 
insertions in CYP51 As and yeast CYP51 s; between ß2-1 and ß2-2, with insertions in 
basidiomycete CYP51 s; between aK" and aL, with insertions in basidiomycete CYP51 s and 
some CYP51Bs; and some length variability across all sequences between ß3-3 and ß4-1, and 
between 03-2 and the C-terminal. The lack of substantial length variation within any of the 
conserved structural motifs or substrate binding sites suggests overall structural conservation 
across fungal CYP51 Is. Furthermore, the lack of support for the CYP51A/CYP51 B split in 
phylogenies reconstructed from only unambiguously-aligned regions indicates a lack of 
consistent sequence differences between CYP5 1A and CYP51B within the core structural 
motifs. 
At present, the closest known relatives to R. secalis with CYP5JA are sordariomycetes 
including M oryzae, as leotiomycetes B. cinerea and S. sclerotiorum lack CYP5JA. A wider 
search of other leotiomycetes for CYP51A may identify a closer orthologue of R. secalis 
CYPSIA, which would shed more light on the evolution of the currently unique intron 
structure and the aD - ß3-1 loop insert. 
CYPSI C is consistently recovered as a separate Glade, even in phylogenies based on 
unambiguously-aligned regions, reflecting sequence differences in regions of the gene 
without length variation. Examination of amino acid sequences shows that this includes 
sequence variation within the substrate recognition sites (Podust et al. 2001), including some 
residues previously identified as conserved across all CYP51 s or phylum-specific and 
conserved within fungal CYP51s. Variation is seen in SRS (Substrate Recognition Site) 1 and 
the following a-helix C, and in SRS4 (Podust et al. 2001), generally the most conserved 
regions of CYP51 Is (Lepesheva and Waterman 2007). In particular, S312 (C. albicans residue 
number) in SRS4 has been identified as part of the fully conserved eukaryotic CYP51 
signature (Lepesheva and Waterman 2007; Lepesheva and Waterman 2011), but CYP51 C 
amino acids have a threonine in place of a serine. This suggests functional conservation 
between CYP5 IA and CYP51 B, and possible functional divergence of CYP5 1 C. 
Selection testing using the codon-based Z-test found no evidence of positive selection except 
in some comparisons with R. oryzae CYPSJFl p. This is a pseudogene in a basal fungal 
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lineage, so it is likely to be evolving neutrally but with an excess of non-synonymous 
mutations as dS is approaching saturation. The majority of pairwise comparisons of fungal 
CYP51 sequences across all sites showed evidence of purifying selection. This is to be 
expected for functional protein-coding genes, with the majority of sites conserved to retain a 
functional protein and any positive selection associated with changes in function restricted to 
a few sites (Yang 2007). Diverge (Gu and Vander Velden 2002) tests for Type I functional 
divergence, whereby some residues are less conserved in one Glade than another following 
gene duplication. CodeML (Yang 2007) tests for Type II functional divergence, whereby 
some codons experience positive selection at the point of gene duplication (Gu 1999). 
Diverge identified strong evidence for Type I functional divergence between all pairs of 
ascomycete CYP51 clades. The greatest coefficient of functional divergence is between yeast 
CYP51 s and CYP51 C; the lowest is between CYP51A and CYP51 B. In each comparison, 
many sites of apparent functional divergence, spread throughout the gene, were identified. 
Selection testing using the branch-site model in CodeML showed strong evidence of positive 
selection at some sites on the branch leading to CYP51 A, CYP51 B and CYP51 C, with a 
higher proportion of sites under positive selection on the branch leading to CYP51C. 
Twenty-nine sites with significant probability of being under positive selection on the branch 
leading to CYP51 C were identified by Bayes Empirical Bayes analysis, but this method 
works best for few sites under strong selective pressure, rather than selection across multiple 
sites (Zhang et al. 2005). Therefore there is strong evidence of Type II functional divergence 
of CYP51C at some codons but those codons cannot be reliably identified by this method. 
Overall, there is strong evidence of both Type I and Type II functional divergence between 
CYP51 paralogues: some sites have undergone positive selection when the paralogues 
diverged, and some sites are more constrained in some clades than others following 
duplication. This functional divergence appears to involve many sites spread through the 
gene, making it difficult to identify the precise sites involved, so the use of covariotide 
models (Huelsenbeck 2002) may prove informative in future analyses. 
5.4.2 CYPS1 paralogues and azole sensitivity in R. secalis 
CYP5JA and CYP51 B genes were amplified from R. secalis isolates (Chapter 4). Functional 
CYP51A genes were only obtained from isolates with intermediate and reduced sensitivity to 
triazole fungicides, whereas a CYP51A pseudogene was obtained from sensitive isolates 
(Section 4.3.3). A PCR-RFLP assay and a Southern blot were carried out to establish whether 
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the pseudogene was found only in the sensitive isolates instead of the functional gene, or 
whether it was also found in less sensitive isolates in addition to the functional gene. 
In the PCR-RFLP assay, the three fully-sensitive isolates only produced PCR products with 
restriction patterns corresponding to the CYP51A pseudogene, even with primers designed to 
preferentially amplify the functional CYP51A gene. The other isolates gave PCR products 
with restriction patterns corresponding to both CYP51A and the CYP51A pseudogene, with 
the respective primer pairs. This suggests that the functional CYP51A gene is absent from the 
fully-sensitive isolates, whereas the pseudogene is present in all isolates. Sequencing the 
genes amplified with the pseudogene-specific primers confirmed that CYP51A p is non- 
functional in all isolates (Section 4.3.3). There were some differences in the pseudogene 
sequence from isolate K1124, including an EcoRI restriction site, but the four-base-pair 
deletion and resulting premature stop codon that make CYP51A p non-functional were still 
present. Furthermore, alignment of CYP51 sequences reveals that the splicing of the third 
intron in CYP51A p removes part of helices C and D. Therefore the protein would probably 
be non-functional with or without the premature stop codon. The Southern blot confirmed 
that isolates K1124 and F112-63 contain only one CYP51A, whereas isolate 788 contains two, 
although the gene and pseudogene are too similar to be distinguished by probes of the length 
required for the labelling kit used here. 
Therefore CYPSIA p is present in all isolates, at a separate locus from CYP51A, which is 
present in isolates with intermediate and reduced sensitivity to triazole fungicides, and absent 
in sensitive isolates. It is not clear how large a region is absent in sensitive isolates. If 
CYP51A is located on a chromosome that is absent from sensitive isolates, this could be 
established by using CYP51A probes in a Southern hybridisation of a PFGE gel (von Felten et 
al. 2011). Alternatively, if a relatively short region is absent, it may be possible to design 
PCR primers for the flanking regions. Furthermore, next-generation sequencing of several 
isolates of Rhynchosporium spp. is currently underway. If this includes isolates with and 
without CYP51A, comparing the genomic sequences will reveal the portion of the genome 
that is absent in isolates lacking CYP51A. 
Constitutive expression of CYP51 B varied little between isolates, with no variation 
correlating with sensitivity differences. When measuring CYP5JA constitutive expression, 
amplification from isolate FI12-63 cDNA was very poor. This isolate lacks CYPSIA, so this 
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apparent low level of expression probably results from primer-dimer formation or non- 
specific amplification of the non-functional CYP51A. For the other isolates, CYP51A 
constitutive expression levels were slightly more variable than for CYP51 B, with around a 
ten-fold range, but again no variation correlated with sensitivity differences. Therefore 
constitutive target-site over-expression, as found in V inaequalis (Schnabel and Jones 2001) 
or P. digitatum (Hamamoto et al. 2000) does not contribute to reduced azole sensitivity in 
current isolates of R. secalis. 
Differences in induced expression of CYP51A and CYP51B between isolates did not correlate 
with reduced triazole sensitivity, apart from the low values obtained for CYP51A expression 
in isolates without CYP51A. However, in those isolates possessing a functional CYP51A 
gene, this gene was up-regulated around 100-fold in the presence of tebuconazole, in contrast 
to the far lesser (around five-fold) up-regulation of CYP51 B in all isolates. The accuracy of 
the absolute degrees of upregulation calculated here may be affected by the use of a single 
endogenous control gene, although comparisons between CYP51 A and CYP51 B would be 
unaffected so long as the same controls are used for both. This provides further evidence that 
the presence of a functional CYP51A may be related to reduced triazole sensitivity in the 
intermediate and less-sensitive isolates. The fold-change in CYP51A expression in isolates 
possessing CYP51A was negatively correlated with PC 1, a composite term calculated from 
logio [EC50]s of the four triazoles tested (section 4.3.1). The suggests that sensitivity 
differences among isolates with CYP51A are due to a mechanism independent of CYP51 
upregulation, and the fungicide concentration used had a greater effect on more sensitive 
isolates, resulting in a greater change in gene expression. Therefore, CYPSIA upregulation 
occurs as a quantitative response to the effects of tebuconazole, such as ergosterol depletion 
or accumulation of sterol intermediates, in all isolates with CYPSIA. A weaker correlation 
was seen with the fold-change in CYPSI B expression, providing further evidence that 
CYP51 B expression is less responsive to the effects of triazole fungicides. 
Heterologous expression in yeast demonstrated that R. secalis CYP51A is able to complement 
yeast CYP51. Therefore R. secalis CYP51A is a functional sterol 14a-demethylase, despite 
sequence differences including a 20-residue insertion between regions aD and 03-1 and a 
unique intron pattern. Yeast transformants expressing R. secalis CYP51B grew poorly. 
However, sensitive isolates of R. secalis can survive with CYP51B and not CYP5IA. 
Therefore, R. secalis CYP51B is able to function as sole CYP51 and the poor growth of yeast 
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transformants is probably due to issues associated with heterologous expression, such as 
different codon use preferences or post-translational processing. This adds to the evidence 
from the phylogenetic analyses and selection testing across fungal CYP51 s suggesting a lack 
of functional divergence between CYP51A and CYP51B in terms of protein structure and 
substrate, so any functional divergence is likely to be based on different transcriptional 
regulation as seen in the induced expression experiment. Divergence in regulatory control 
may be a frequent occurrence among duplicated genes in fungi (Wapinski et al. 2007), and 
differences in transcriptional control have been used to infer neo- or sub-functionalisation in 
other fungal gene families (Skamnioti et al. 2008). Therefore it appears that CYP51A and 
CYP51B can act upon the same substrate, but CYP51B is expressed at more constant levels 
whereas CYP51A is more inducible in response to the effects of DMIs. In F. graminearum, 
Becher et al. (2011) report around a 128-fold increase in CYP51A expression, compared to 
around an 8-fold increase in CYP51B expression and 3-4-fold increase in CYP51 C 
expression, on exposure to tebuconazole, whereas CYP51 B and CYP51C expression levels 
were around ten times higher than CYP51A without fungicide. 
Therefore, the presence of CYP51A in some R. secalis isolates enables greater CYP51 
expression in the presence of triazole fungicides, conferring reduced triazole sensitivity. The 
presence of CYP51A has previously been linked to inter-specific differences in intrinsic 
triazole sensitivity. In A. fumigatus, knocking out the CYP51A gene resulted in increased 
triazole sensitivity in sensitive isolates with wild-type CYP51A as well as in less-sensitive 
isolates with CYP51A mutations, suggesting that the presence of CYP51A confers lower 
intrinsic azole sensitivity (Mellado et al. 2005). Disruption of CYP51A also increased azole 
sensitivity in M oryzae and F. graminearum, whereas disruption of CYP51B did not (Liu et 
al. 2011; Yan et al. 2011). However, this is the first report of intraspecific variation in the 
presence of CYP51 paralogues. In C. glabrata (Marichal et al. 1997) and C. albicans 
(Selmecki et al. 2006), chromosome or chromosome-arm duplications encompassing CYP51 
confer reduced triazole sensitivity in some isolates. However, the chromosome arm also 
contains a gene encoding an efflux pump transcription factor, and reduced intracellular 
accumulation of azoles was measured in isolates with chromosomal duplications. Therefore, 
the resistance factors attributable to a duplicate of the existing CYP51 orthologue are 
relatively low, with MIC approximately doubled by each extra copy (Selmecki et al. 2008). 
In R. secalis, the extra copy is a diverged paralogue under different transcriptional control, 
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allowing a greater transcriptional response to triazoles, conferring a resistance factor of 
around ten against tebuconazole and propiconazole. 
When A. fumigatus CYP51A and CYP51 B were expressed in yeast, each under the control of 
the same promoter, CYP51A transformants were 16 times less sensitive to fluconazole than 
CYP51 B transformants, although sensitivity to four other clinical azoles was similar for the 
CYP51A and CYP51 B (Mellado et al. 2005). Therefore it is possible that intrinsic sequence 
differences between CYP51A and CYP51B, as well as differences in gene expression, 
contribute to the reduced triazole sensitivity of R. secalis isolates with CYP51A. Since R. 
secalis CYP51 B did not produce sufficient growth in yeast to allow fungicide sensitivity 
testing for comparison with R. secalis CYP51A, gene replacement and promoter swaps within 
R. secalis may be necessary in order to separate the effects of sequence differences or 
expression levels on triazole sensitivity. 
Pyrosequencing analysis of samples from the Hoosfield archive provides further evidence for 
the role of CYP51A in reduced triazole sensitivity in R. secalis. Levels of CYP51A increase 
from 1998 onwards, and CYP51A is found in the majority of the R. secalis population from 
2002. The first isolate found to possess CYP51A in the present study, isolate 788, dates from 
1997, and most isolates studied from after 2000 possess CYP51A. 
Previous surveys of fungicide sensitivity in R. secalis populations had reported shifts in 
sensitivity to triadimenol and then propiconazole in the early 1990s (Kendall et al. 1993), 
with a later shift in epoxiconazole sensitivity to a bimodal distribution by 2002 (Oxley et al. 
2003). Only one isolate in this study dates from before 1990, so the majority of the most 
sensitive isolates may come from a population already selected for reduced sensitivity to 
triadimenol, and the selection of CYP51A may correspond to the bimodal shift seen in 2000. 
This suggested scenario is supported by the cross-resistance between propiconazole and 
tebuconazole in isolates with CYP5JA, whereas Kendall et al. (1993) reported that isolates 
selected for decreased propiconazole were still controlled by tebuconazole, although that 
study refers to field control rather than in vitro sensitivity. Therefore, this explanation cannot 
be verified without further isolates from before 1990. It is also possible that the sensitivity 
shifts first reported in the early 1990s took place later at the Hoosfield site. Furthermore, 
CYP51A only correlates with the initial shift from sensitive to intermediate isolates seen here. 
As stated in Chapter 4, further sensitivity shifts do not correlate with any differences in 
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CYP51 sequences or expression levels, suggesting that a non-target-site mechanism is 
responsible. Knocking out CYP51A from intermediate and less-sensitive isolates would show 
whether further sensitivity shifts are independent of CYP5JA. 
CYP51A presence levels prior to 1998 were measured at 10-20% of the population. However, 
measurements of 5-9% were obtained for single isolates without CYP51A. Therefore, earlier 
years may be too close to the detection limit of the assay to be taken as conclusive evidence 
for levels of CYP51A in the pre-selection population. The presence of the highly similar 
CYP51A p in all isolates limits the sensitivity with which CYP51A may be detected, so better 
evidence for levels of CYP51A before selection may be obtained by population genetic 
methods. If CYP51A was restricted to a small part of the R. secalis population, genetic 
diversity would be lower in isolates with CYP51A than in the population as a whole. 
Following a hard selective sweep, lower diversity would be present in isolates with CYP51A 
in the absence of recombination, or linkage disequilibrium would be present following 
recombination. If a wide range of haplotypes are found at near-equilibrial frequencies in 
isolates with CYP51A, this would suggest a softer selective sweep, whereby an existing allele 
increases in frequency in an already polymorphic population. 
Rhynchosporium secalis has recently been shown to be a complex of at least three host- 
specialised lineages, referred to as R. commune on barley, R. secalis sensu stricto on rye and 
R. agropyri on couch and related grasses (Zaffarano et al. 2011). This study has shown 
variation in the occurrence of CYP51A in R. commune, with CYP51A apparently having been 
lost from the majority of isolates before being selected back to prevalence by triazole use. It 
would be interesting to investigate the occurrence of CYP51A and CYP5JA p in the other R. 
secalis s. 1. lineages and sister species R. orthosporum. This would shed more light on the the 
evolution of CYP51A in R. secalis, as it has been suggested that R. secalis s. I. lineages went 
through genetic bottlenecks during host shifts (Zaffarano et al. 2008), so if CYP51A was 
already in a minority of isolates at that point it may not have made it through the bottleneck 
in all lineages, or it may have been subsequently lost in some lineages but not others due to 
differing selective pressures or chance effects of genetic drift. Alternatively, if all other 
lineages possess a functional CYP51A, the near-loss from the barley lineage must be a very 
recent event, as the lineages were estimated as having diverged 1200-3600 years ago 
(Zaffarano et al. 2008). This would also have practical implications for the use of triazoles on 
rye, turf and forage grasses. Genome sequencing of isolates from each lineage is currently 
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underway, so when released the genomes can be searched for CYP51A, although it should be 
borne in mind that these lineages may also be polymorphic for CYP51A so its absence from 
the sequenced isolate does not necessarily indicate its absence from the lineage as a whole. If 
other lineages are found to be polymorphic for the presence of CYP51A, its presence should 
be monitored for those lineages growing on host plants on which triazoles are used. 
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Chapter 6 
General discussion 
6.1 Key findings 
6.1.1 A high-throughput fungicide sensitivity bioassay can be used for R. secalis if 
multiple readings are taken to allow for heterogeneous growth 
A high-throughput fungicide sensitivity bioassay has been developed for R. secalis. Growth 
conditions were optimised, first to produce spores for use as inoculum for the bioassay, and 
then to maximise total growth for the bioassay itself and to produce material for nucleic acid 
extraction. These different requirements for spores and biomass should be considered if 
further media and growth conditions are tested in future. 
Rhynchosporium secalis grows heterogeneously in liquid culture: its growth is filamentous 
rather than yeast-like, and too slow to cover entire wells of a 96-well microtitre plate. 
Therefore, to quantify growth by measuring optical density, it is necessary to measure 
multiple points per well. This allows the use of an automatic plate reader, which is less 
labour-intensive than measuring colony diameter, and less subjective thanjudging density of 
growth by eye. This method may be applied to other species growing heterogeneously in 
liquid culture. 
6.1.2 Qol sensitivity in R. secalis may be reduced by a target-site mutation encoding 
G143A, or by increased induced expression ofAOX, but target-site resistance has not 
yet spread 
A mutation in cytochrome b encoding the G143A substitution confers a hundred-fold 
reduction in R. secalis QoI sensitivity. However, to date, this has only been found at one site 
in France in 2008: it has not been found since, and has not been reported in the UK. 
Alternative oxidase (AOX) activity results in smaller decreases in Qol sensitivity in vitro in 
the absence of AOX inhibitors such as SHAM. For most isolates, QoI sensitivity falls within 
a tenfold range, but a further tenfold shift was seen for one isolate. For these isolates, no 
target-site mutations were found, and sensitivity shifts were mostly reversed by adding the 
AOX inhibitor SHAM. 
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Expression analysis provided preliminary evidence for AOX upregulation following the 
addition of azoxystrobin, with an apparent correlation between decreased azoxystrobin 
sensitivity in the absence of SHAM and induced A OX expression. A OX upregulation 
following Qol fungicide addition has previously been reported in M oryzae (Yukioka et al. 
1998), and greater induced A OX expression correlated with lower intrinsic QoI sensitivity in 
F. graminearum compared to M nivale (Kaneko and Ishii 2009). Here, greater induced 
expression of AOX is linked to intraspecific differences in in vitro QoI sensitivity for the first 
time. 
6.1.3 Triazole sensitivity in R. secalis has declined over the last twenty years, but 
sensitivity differences are not associated with point mutations or constitutive over- 
expression of CYPS1 
Sensitivity of R. secalis to some triazoles had decreased tenfold by 2000, with a further 
tenfold shift after that. The partial cross-resistance between triazole fungicides is well-suited 
to Principal Components Analysis. PCA revealed that the initial sensitivity shift resulted in 
positive cross-resistance to the four triazoles tested, with tenfold shifts in propiconazole and 
tebuconazole sensitivity, and correlated but quantitatively smaller shifts for epoxiconazole 
and prothioconazole. Further sensitivity shifts affect prothioconazole differently from 
propiconazole and tebuconazole, with greater shifts in prothioconazole sensitivity seen in 
isolates with the lowest overall triazole sensitivity. 
No point mutations in CYP51 were correlated with differences in triazole sensitivity. The 
three CYP51 substitutions found were each limited to 1-3 isolates not corresponding to the 
three triazole sensitivity groups. Therefore target-site resistance, as seen in species including 
M graminicola (Cools and Fraaije 2008), can be ruled out for the R. secalis isolates studied. 
Furthermore, expression analysis found no evidence of the constitutive CYP51 
overexpression caused by promoter changes in species such as P. digitatum (Hamamoto et al. 
2000) or V. inaequalis (Schnabel and Jones 2001) with reduced triazole sensitivity. 
A preliminary investigation into the possible role of enanced efflux in reduced triazole 
sensitivity did not find clear evidence of a correlation between reduced overall triazole 
sensitivity and potentiation by the putative efflux inhibitors tested. However, the effect on 
prothioconazole sensitivity should be tested for a wider range of isolates with reduced overall 
azole sensitivity, and other putative inhibitors should be tested or the intracellular 
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accumulation of radiolabelled fungicides should be measured before a wider role of efflux in 
sensitivity differences can be ruled out. 
6.1.4 Rhynchosporium secalis isolates with reduced triazole sensitivity have a second 
CYP5J paralogue 
Two CYP51 paralogues, CYP51A and CYP51 B, and a pseudogene, CYP51A p, are found in 
R. secalis. CYP51 B and CYP51 Ap were found in all isolates tested, but the functional 
CYP51A was absent from all tested isolates with the highest triazole sensitivity and present in 
all tested isolates with intermediate and reduced triazole sensitivity. Yeast complementation 
confirmed that R. secalis CYP51A is a functional sterol 14a-demethylase. Therefore the 
initial sensitivity shift against the four triazoles tested correlates with the presence of an 
additional target-site-encoding gene. Presence of CYP51A has been shown to result in 
reduced intrinsic triazole sensitivity in A. fumigatus (Mellado et al. 2005), M. oryzae (Yan et 
al. 2011) and F. graminearum (Liu et al. 2011), but this is the first report of intra-specific 
variation in the presence of CYP51A, linked to acquired triazole sensitivity differences in 
fungal populations. 
Analysis of samples from the Hoosfield spring barley archive revealed that the majority of 
the R. secalis population in that field lacked CYP51A until 1998, at which point the 
proportion of the population with CYP51A increased, forming the majority of the population 
since 2002. This correlates with the collection dates of isolates with and without CYP51A 
from other sites. 
6.1.5 The two CYP51 paralogues in R. secalis result from a gene duplication basal to the 
filamentous ascomycetes 
Phylogenetic analysis of the CYP51 paralogues from R. secalis and homologues from 
sequenced fungal genomes produced trees suggesting that the CYP51 A and CYP51 B 
paralogues result from a duplication event basal to the filamentous ascomycetes, followed by 
multiple losses of CYP51A from various fungal lineages. Rhynchosporium secalis CYP51A 
and CYP51A p diverged more recently, appearing as a sister branches. 
6.1.6 The filamentous ascomycete CYPSIA paralogue is upregulated in response to the 
effects of triazole fungicides 
CYP51A is upregulated following the addition of tebuconazole in all tested isolates with 
CYP51A; that is, isolates with intermediate and reduced triazole sensitivity. CYPSIB, present 
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in all isolates including those sensitive to triazoles, was upregulated to a far lesser degree. 
Therefore the upregulation of CYP51A appears to be at least partly responsible for the initial 
shift in triazole sensitivity in R. secalis. This resistance mechanism appears partly analogous 
to the target-site overexpression reported in species such as P. digitatum (Hamamoto et al. 
2000), or the CYP51 duplication seen in C. albicans (Selmecki et al. 2006), but all previous 
cases involve additional copies or increased transcription of an existing CYP51 gene, rather 
than a functionally-diverged paralogue. There are also intrinsic sequence differences between 
CYP51A and CYP51B, so triazole binding may differ between the paralogues. 
Greater upregulation of CYP51A than CYP51B on addition of triazoles has also been reported 
in F. graminearum (Becher et al. 2011). This suggests functional differentiation between 
CYPSIA and CYP51 B by divergence in transcriptional control. 
6.2 Practical implications for R. secalis control and resistance management 
6.2.1 QoIs 
Target site resistance to QoIs was not found in any isolates from the UK, or in any of the 70 
isolates tested except two collected by BASF in France in 2008. There have also been no 
further reported cases from industry monitoring (FRAC QoI Working Group 2010). 
Therefore Qols remain effective in the field for the control of R. secalis. 
However, the occurrence of isolates with the G143A substitution shows that it is possible for 
the G143A-encoding mutation in cytochrome b to arise in R. secalis without lethal impact on 
transcript processing or protein function. Some species contain an intron in cytochrome b that 
would not splice properly if the guanine at position 428 were replaced with a cytosine to give 
G143A (Grasso et al. 2006), but McCartney (2006) reported that this intron is not present in 
R. secalis. Deleterious effects on cytochrome b protein function have been proposed for some 
species (Fisher et al. 2004), but the occurrence of R. secalis isolates with G143A shows that 
any effects on cytochrome b function are insufficient to prevent the emergence of G143A 
under strong selective pressure. Therefore it must be assumed that the re-emergence and 
wider spread of QoI resistance remains a possibility in R. secalis, as was eventually seen with 
the MBC fungicides (Cooke and Locke 2002), and so monitoring must continue and 
resistance management guidelines should be followed. 
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AOX activity is not likely to result in control failure in the field, although further testing is 
needed to establish whether this mechanism results in any reduction in QoI sensitivity in 
planta. It has also been suggested that AOX activity may facilitate the emergence of target- 
site resistance (Avila-Adame and Kö11er 2003a), and further investigation of the mechanisms 
responsible for the increased upregulation of AOX in some R. secalis isolates may reveal 
whether G143A arose in a genetic background capable of increased AOX expression. 
However, in practical terms, it should be assumed that QoIs are a high resistance risk group 
of fungicides regardless of whether AOX can facilitate the emergence of resistance. 
6.2.2 Triazoles 
The sensitivity shifts observed for triazoles are broadly in line with previous reports (Cooke 
et al. 2004), and support current advice to UK farmers from the HGCA (Blake et al. 2011) 
and SAC (Oxley and Burnett 2010), that the newer triazoles epoxiconazole and 
prothioconazole still provide disease control, but shifts in sensitivity mean higher doses may 
be required. The range of prothioconazole sensitivities among isolates with the lowest general 
triazole sensitivity shows potential for further selection for reduced prothioconazole 
sensitivity as reported by Oxley et al. (2008), so resistance management guidance should be 
followed and prothioconazole should not be used alone (Blake et al. 2011). The incomplete 
cross-resistance between triazoles, especially between the intermediate and less-sensitive 
isolates, demonstrates the importance of chemical diversity with the triazoles. 
The mechanism responsible for these further sensitivity shifts among intermediate and less- 
sensitive isolates is still not known. Therefore, molecular diagnostics are not available and 
monitoring still requires sensitivity bioassays to be carried out. The high-throughput 
sensitivity bioassay developed in this project would be useful for such monitoring. However, 
it is possible that less selection for reduced triazole sensitivity has taken place in some areas 
outside of North-Western Europe, so isolates with CYP51A may not yet form the majority of 
the population and assays developed for the detection of CYP51A would be useful in 
sensitivity monitoring. Furthermore, triazoles can be used against R. secalis on rye and 
grasses, with propiconazole and tebuconazole currently approved for use on grasses or 
amenity grassland, and triazoles including propiconazole, tebuconazole, epoxiconazole and 
prothioconazole currently approved for use on rye, in the UK (Chemicals Regulation 
Directorate 2010). Therefore, the occurrence of CYP51A in R. secalis lineages infecting these 
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hosts should also be investigated, to assess the risk of CYP5JA-related sensitivity shifts in R. 
secalis affecting these crops. 
6.2.3 Other fungicide groups 
A shift in triazole sensitivity has taken place in R. secalis, but more slowly than in some 
pathogens such as B. graminis (Fletcher and Wolfe 1981), whereas Qol resistance has not yet 
spread in R. secalis. Along with the previously reported relatively slow spread of MBC 
resistance (Taggart et al. 1999), this supports the designation of R. secalis as a medium-risk 
pathogen (FRAC 2005). 
Of the other groups of fungicides widely used against R. secalis, the SDHIs are considered to 
be at medium to high risk of resistance development, anilinopyrimidines including cyprodinil 
are considered medium risk, morpholines medium to low risk and chlorothalonil low risk. 
Therefore, the combined pathogen and fungicide risk means resistance management is 
important for the SDHIs and cyprodinil, and this is reliant on the availability of suitable 
mixing partners including the triazoles. 
6.3 Emergence and spread of mutations conferring fungicide resistance in 
R. secalis 
Prior to the occurrence of G143A in R. secalis, there was some debate as to why target site 
resistance to Qols had not yet arisen in the species, with possible explanations including low 
mutation rates or high fitness penalties preventing the emergence of the mutation, or the 
population biology of R. secalis limiting its spread. Now G143A has been reported once 
(FRAC QoI Working Group 2008), but not found since (FRAC Qol Working Group 2010), it 
must be concluded that emergence of G143A is possible but further selection or spread is 
limited. 
Both MBC resistance and reduced triazole sensitivity have arisen and spread more slowly 
than in higher resistance risk pathogens such as B. graminis. Studies of MBC resistance in R. 
secalis found the spread of resistance to be "erratic" (HGCA 2000). When attempting to 
study the effects of fungicide treatment on levels of MBC resistance levels, treatment 
differences were masked by high levels of variability between sites and between growing 
seasons (Holloman 1997). Taggart et al. (1999) also tested initial frequency of resistant 
isolates, and found that this had a greater effect on final frequency of resistant isolates at 
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different sites than treatment during the growing season, although the effects of fungicide 
treatment were apparent within sites. 
Variation in the level of resistance in the initial R. secalis inoculum between sites and years 
suggests that the main inoculum source does not comprise widely-dispersed airborne spores. 
This is consistent with the lack of a known ascospore-producing stage in R. secalis, and the 
lack of R. secalis spores found in spore trapping experiments (Fountaine et al. 2010). 
Furthermore, fluctuations between years at a single site suggest that a large proportion of the 
initial population is brought into the site each year, as would be the expected for a primarily 
seed-borne disease, rather than persisting on site between growing seasons, for example on 
crop debris. Therefore resistance management is especially important on barley crops to be 
used for seed, and resistance monitoring in seed could prove useful. 
Similar fluctuations between years were observed for the frequency of CYPSIA in the R. 
secalis populations from the Hoosfield spring barley experiment. The proportion of isolates 
with CYP51A increases between 1995 and 1998 and between 1998 and 2002, then decreases 
again by 2005, and increases further by 2008. This also indicates that it takes more than one 
growing season for the proportion of isolates with CYP51A to increase from pre-selection 
levels to the majority of the population, which could indicate lower selective pressure, 
smaller population size or fewer generations than in pathogen-fungicide combinations for 
which selection of resistant isolates has taken place more rapidly. 
If the seed-borne nature of R. secalis is a major factor limiting the spread of new mutations, 
this would be consistent with the selection of CYP51A from a low frequency within each 
local R. secalis population, rather than a hard selective sweep of new point mutations from a 
single or few origins across the entire metapopulation. Population genetic approaches would 
shed more light on this, by investigating the occurrence of CYP51A in pre-selection 
populations, as discussed in section 6.6. 
6.4 Role of multiple CYPSI paralogues in filamentous ascomycetes 
Phylogenetic reconstruction suggests CYP51 gene duplication took place around the origin of 
the filamentous ascomycetes, with subsequent losses of CYP51A from some lineages. This 
raises two questions: why the gene duplication emerged in the first place, and why it was then 
196 
lost from some lineages and retained in others. Some recent studies have investigated the 
purpose of multiple CYP51 s through functional genetic approaches, such as assessing the 
effect of CYP51 A deletion on pathogenicity (Mellado et al. 2005; Yan et al. 2011), but 
evolutionary studies may complement this functional approach. 
Selection testing found evidence of functional divergence between all Pezizomycotina CYP51 
paralogues. However, the split between CYP51A and CYP51B was not supported when 
regions with length variation were excluded from the sequence alignment, and the substrate 
recognition sites are conserved in CYP51 A and CYP51 B. In contrast, CYP51C is consistently 
recovered as a separate Glade based on sequence variation within the core structural regions, 
including residues within substrate recognition sites SRS 1 and SRS4 which are conserved 
across other fungal CYP51s. Furthermore, R. secalis CYP51A is able to complement S. 
cerevisiae CYP51, and isolates with only CYP51B are viable but sensitive to triazoles, so both 
paralogues encode a functional sterol 14a-demethylase. However, expression analysis shows 
divergence in transcriptional regulation of R. secalis CYP51A and CYP51B, and similar 
results have been reported in F. graminearum (Becher et al. 2011). Therefore CYP51 B and 
CYP51A both catalyse the same step in sterol biosynthesis, but CYP51B is present in all 
species and expressed at a relatively constant level, whereas CYP51A is present in some 
species as an extra CYP51, the expression of which is readily inducible. 
This raises questions as to why additional induced CYP51 expression may be needed. 
Intrinsic Qol resistance is found in species such as S. tenacellus and Mycena galopoda that 
produce natural strobilurins (Kraiczy et al. 1996). Therefore, the presence of CYP51A, 
reducing intrinsic triazole sensitivity and responding transcriptionally to the effects of 
triazoles, raises the possibility that CYP51A is an adaptation to a naturally-occurring CYP51 
inhibitor, although it has been demonstrated that induction of CYP51A expression is 
proportional to the effects of the fungicide on a fungal isolate, so the transcriptional response 
is presumably induced by altered sterol content rather than direct detection of the inhibitor. 
Therefore other causes of sterol stress, such as higher requirements at particular points in the 
fungal life cycle, for example sporulation (Yan et al. 2011), could also induce CYP51 A 
expression. Further studies of expression levels of other genes in the ergosterol biosynthesis 
pathway, and of sterol composition, would reveal whether CYP51A induced expression is part 
of a general upregulation of sterol biosynthesis, or specific to that step. Microarray studies of 
F. graminearum showed some increase in expression of most ergosterol biosynthesis genes in 
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response to tebuconazole treatment, but upregulation was greatest in CYP5JA (Becher et al. 
2011). 
If CYP51A has evolved as an adaptation to natural CYP51 inhibitors, these may be defence 
compounds produced by hosts, allelopathic compounds from competing micro-organisms or 
toxins produced by the fungi themselves. The gene duplication giving rise to CYP5JA and 
CYP51 B took place around the time the Pezizomycotina diverged from the 
Saccharomycotina. It has been estimated that the crown Pezizomycotina (Lecanoromycetes, 
Sordariomycetes and Eurotiomycetes) diverged 320-400 million years ago, during the late 
Devonian or early Carboniferous period, whereas the basal pezizomycotina (crown 
Pezizomycotina plus Pezizomycetes) diverged 400-520 million years ago, during the late 
Cambrian to early Ordovician (Lucking et al. 2009). These estimates may be refined in future 
as rate models are improved and if more calibrator fossils are identified (Berbee and Taylor 
2010), but the time range for CYP51 paralogue divergence could also be narrowed by 
investigating whether basal Pezizomycotina, such as Pezizomycetes and Orbiliomycetes, 
possess a differentiated CYP51B (and possibly CYP51A) or an undifferentiated CYP51. A 
tBLASTn search of the draft genome assemblies of the Pezizomycetes Phymatotrichum 
omnivorum (University of Oklahoma Advanced Center for Genome Technology, 
http: //www. genome. ou. edu) and Tuber melanosporum (Genoscope, 
http: //www. genoscope. cns. fr) identified fragments of a single CYP51 in each species, and 
preliminary phylogenetic analyses placed these amino acid sequences together on a branch 
between the yeast and crown Pezizomycotina CYP51 Is, branching off from the crown 
Pezizomycotina prior to CYP51 paralogue divergence, but further analyses are needed once 
full sequences are available. An Orbiliomycete, Orbilia auricolor, is currently awaiting 
sequencing (Joint Genome Initiative, http: //www. jgi. doe. gov/). However, all estimates place 
the divergence of CYP51A and CYP51B long before the evolution of flowering plants or of 
mammals, so if the divergence was an adaptation to hosts, different host taxa should be 
considered. The current estimate for the divergence time of CYP51A and CYP51B 
encompasses the origin of land plants, from liverworts through to the establishment of fern 
and lycophyte forests, forming soils and altering atmospheric composition (Kenrick and 
Crane 1997). It also encompasses the origin and diversification of fish from the first 
vertebrates to the origin of amphibians (Rowe 2004), and the early origins of terrestrial 
arthropods including insects (Wheeler et al. 2004). These changes enabled fungal 
diversification into a wide range of niches, and it would be easy to be drawn into story-telling 
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as to why one of these niches required additional CYP51 s, but such suggestions would only 
be testable based on the biology of extant species. 
CYP51A was subsequently lost from several lineages, but retained in others. It could be 
hypothesised that some lineages experienced continued exposure to natural CYP51 inhibitors 
or other sterol stress and other lineages did not. This could be investigated by analysis of 
correlations between current fungal metabolites, hosts or environmental factors and presence 
of CYP51A. Any such studies should use phylogenetic comparative methods, rather than 
species-by-species comparisons, to correct for phylogenetic autocorrelation. For example, all 
Aspergillus species possess CYP51A, and share many other features due to being closely 
related. Therefore, species-by-species comparison may conclude that these features are 
correlated with presence of CYP51A, whereas phylogenetic comparative methods correct for 
shared features of species within a single lineage. 
However, even with a phylogenetic comparative approach, there is an assumption that the 
pattern of loss or retention of CYP51A is predominantly adaptive, rather than being affected 
by chance process such as genetic drift. Furthermore, current knowledge of which species 
have retained CYP51A is based largely on the single isolates used for genome sequencing, 
with a few exceptions such as A. fumigatus for which CYP51A has been sequenced from 
many isolates to study target site mutations (Diaz-Guerra et al. 2003). It has been 
demonstrated in the current study that presence of CYP51A can vary within species. Whole 
genome resequencing projects currently underway or planned for some fungal species, using 
second generation sequencing methods, will give a fuller picture of intraspecific variation. 
6.5 Constraints and contingency in molecular evolution 
An ongoing debate in evolutionary biology concerns the extent to which evolution is 
predictable. For crop protection, attempts to predict resistance have focussed on how quickly 
resistance is likely to emerge and how this may be managed (Brent and Hollomon 2007b). 
However, when evolutionary biologists discuss predictability, they are generally considering 
which adaptations will emerge: whether functional and developmental constraints result in 
convergent evolution of a limited number of adaptive solutions, or whether chance events and 
historical contingency make evolution inherently unpredictable. The evolution of fungicide 
resistance may provide some valuable insights into this debate, since similar selective 
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pressures (i. e. fungicide application) have been applied repeatedly to different populations 
and species. Therefore, repeated emergence of the same mechanism would be indicative of 
constrained, predictable evolution, whereas the occurrence of disparate adaptations to the 
same selective pressure would suggest unpredictability due to chance events or historical 
contingency. 
6.5.1 Predictability in molecular evolution: the debate so far 
While examples of morphological convergence have long been known, in recent years 
increasing attention has been paid to constraints and convergence in molecular evolution, 
such as the constraints on ß-lactamase substitutions in the evolution of antibiotic resistance 
(Weinreich et al. 2006), the concentration of mutations in restricted regions of genes and 
genomes due to constraints on other regions (Stern and Orgogozo 2009), or convergent 
recruitment of the same genes during the multiple origins of C4 photosynthesis (Christin et 
al. 2010). These examples have been countered by claims of contingency in molecular 
evolution. The evolution of citrate utilisation in one population of E. coif in the Long-Term 
Evolutionary Experiment (LTEE) was found to be dependent upon an earlier enabling 
mutation, and therefore described as historically contingent (Blount et al. 2008). While this is 
true for a literal definition of historical contingency, it must be presumed until shown 
otherwise that the rare potentiating mutation could still arise in other populations, after which 
citrate metabolism could also evolve: it is still a question of when or whether an adaptation 
might emerge, rather than alternate adaptive paths being followed. Clearer evidence of 
alternative adaptive paths was obtained when experimental evolution was carried out with 
fluctuating environmental conditions, with different populations showing different fitness 
responses interpreted as "distinct adaptive peaks", although the molecular adaptations 
responsible have not yet been reported (Cooper and Lenski 2010). 
One possible molecular mechanism for path-dependent historicity (Desjardins 2011) is sign 
epistasis. Sign epistasis is an interaction between mutations whereby a mutation is either 
beneficial or deleterious depending on the presence of another mutation, whereas negative or 
antagonistic epistasis means one mutation has a quantitatively smaller effect in the presence 
of another mutation (Khan et al. 2011). Sign epistasis has been reported between two 
mutations in an experimentally evolving yeast population (Kvitek and Sherlock 2011). Both 
mutations evolved multiple times, but were never found together, and testing in near-isogenic 
mutants confirmed that either mutation alone was beneficial but the combination was 
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deleterious. Therefore each mutation represented a separate adaptive peak, and mutants that 
first gained the less fit of the two mutations were confined to a local optimum. Another 
example of sign epistasis resulting in path-dependent evolution, contingent upon which 
mutation arises first, has recently been reported in the experimental evolution of cefotaxime 
resistance in E. coli (Salverda et al. 2011). Most lines evolved three mutations conferring the 
greatest reduction in cefoxatime sensitivity, but two lines each gained a different initial 
mutation, resulting in reduced cefoxatime sensitivity but sign epistasis with mutations from 
the global optimum set. Therefore these lines only evolved a smaller reduction in cefoxatime 
sensitivity, have become trapped at a local adaptive peak. 
It should be noted that in both of these cases, evolution was constrained, not to a single 
solution but a more complex set of possible solutions. These varying, interacting constraints 
resulted in a rugged fitness landscape, with the possibility of lineages being trapped by a local 
adaptive peak (Kvitek and Sherlock 2011). Therefore the question is not whether 
evolutionary pathways depend upon constraints or contingency, but whether the constraints 
are universal or dependent on genetic background; that is, whether the constraints are 
contingent. 
Apart from the level of contingency, the predictability of evolution also depends upon the 
role of chance. In large populations, with high mutation rates or common mutations, a 
particular mutation is almost certain to arise, and evolution is effectively deterministic. 
Smaller populations or rare mutations result in stochastic sensitivity. In a simple constraint 
dependent pathway, evolution is predictable, but where there is stochastic sensitivity this can 
only be a probabilistic rather than a deterministic prediction. In a more contingent pathway, 
evolution may still be predictable, if each step is likely to occur (Dick et al. 2009), and if the 
nature of the contingency is known. The greatest intrinsic unpredictability would result from 
a combination of stochasticity and contingency, whereby the pathway is dependent on chance 
events at preceding steps. However, even a deterministic, simply constrained pathway may be 
unpredictable in practise if the constraints are not known: for example, UV mutagenesis 
studies to identify mutations that could result in fungicide resistance often generate a wider 
range of mutants than are subsequently found in the field, due to in planta fitness costs 
associated with some mutations. 
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6.5.2 Predictability in evolution of fungicide resistance 
The evolution of Qol resistance in cytochrome b is a relatively simple constraint-dominated 
pathway. In most cases, the G143A substitution gives optimum fitness under selection by Qol 
fungicides, whereas F 129L confers a lower reduction in Qol sensitivity. However, there is 
sign epistasis between the G143A mutation and the intron at codon 143 in some fungi. 
Therefore, constraints on cytochrome b are contingent on the loss or gain of this intron, but as 
this contingent relationship is known, the evolution of Qol resistance is still predictable for a 
given lineage subject to knowing whether the intron is present. 
In the case of triazole resistance, the situation is more complicated. Mutations in CYP51 have 
different effects on fitness depending on the compounds used, and epistatic interactions with 
other CYP51 mutations (Cools et al. 2010). Therefore it would be difficult to predict which 
adaptations to selection by azole use will emerge in any given species without detailed 
knowledge of CYP51 structure and the impact of each possible mutation. Additionally, in 
some species, mutations and overexpression of CYP51A confer reduced triazole sensitivity 
(Diaz-Guerra et al. 2003), whereas in species without CYP51A this is not possible and only 
CYP51B and non-target-site mutations can occur, and so the mutations available are 
contingent upon whether CYP51A has been lost from that lineage. Furthermore, epistasis 
between mutations, coupled with selection of different mutations by different azoles, means 
the range of mutations that can emerge at a given time may be dependent on the triazoles 
used in the past. For example, in M graminicola, the S524T substitution in a wild-type 
CYP51 background appears advantageous under selection by prothioconazole, but it is not 
found in a wild-type background as other mutations had been selected by previous triazole 
use (Cools et al. 2011). The re-emergence of CYP51A in R. secalis, demonstrated in the 
present study, provides a further example of historical contingency. Phylogenetic 
reconstruction suggests a single origin of CYP51A followed by multiple losses, and it appears 
that R. secalis CYP51A was almost lost. However, before it was lost completely, a change in 
selective pressure due to azole use appears to have resulted in the re-emergence of CYP51A. 
Had it been lost completely, that particular adaptive pathway would not have been available 
in R. secalis. Therefore the adaptive pathway taken by R. secalis in response to selection by 
triazoles was contingent on chance events. 
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6.6 Future research directions 
The R. secalis genome has been sequenced, and assembly and annotation are currently 
underway before public release. Two isolates from barley, and one from each of the other two 
R. secalis host-specialised lineages and R. orthosporum, were selected for sequencing 
(Navarro-Quezada et al. 2011). 
Of the barley isolates being sequenced, one was collected before 1997 and the other is more 
recent. It is likely that the more recent isolate contains CYP51A and the older isolate does not. 
If this is the case, analysis of the sequenced genomes will reveal the size of the genomic 
region missing in isolates without CYP51A, whether it is a single gene, a region of genes or 
an entire chromosome. Whether the other lineages contain CYP5JA could reveal how 
recently R. secalis ancestors started losing that paralogue. There is evidence that host shifts 
resulted in genetic bottlenecks (Zaffarano et al. 2008), so if CYP51A was already being lost 
from the ancestral species as bottlenecks occurred, it may be absent from some lineages. 
Presence of CYP51A in other lineages would also have implications for triazole resistance 
risk of Rhynchsporium spp. on grasses and rye. However, these lineages may also be 
polymorphic for the presence of CYP51A, so the presence or absence in the sequenced isolate 
cannot be assumed to mean universal presence or absence across the lineage. 
Availability of full genome sequences, including the promoter regions of genes of interest, 
will also allow the generation of gene knockouts or reporter lines. For example, AOX 
promoter-reporter lines would allow induced expression to be monitored over a greater 
number of time points, to avoid missing maximum expression. CYP5JA knockouts would 
confirm the impact of CYP5JA on triazole sensitivity in a uniform genetic background, and 
gene replacement with CYP5JB, or recombinant constructs containing the coding sequence of 
one paralogue with the promoter of the other, would enable further investigation of the 
contribution of sequence differences and overexpression to the reduced triazole sensitivity 
conferred by CYP5JA. 
Genome sequences may also provide potential markers for population genetic studies. This 
would be especially useful for assessing pre-selection levels of CYP51A, since the accuracy 
of direct measurement from pre-selection samples is limited by the presence of the highly 
similar and more abundant CYP51A p. Diversity of genes located close to CYP51A could be 
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compared to diversity in unlinked genes, to infer whether a hard or a softer selective sweep 
has taken place. 
In addition to further scientific developments, future research directions may result from 
evolutionary developments in R. secalis. This may include re-emergence of G143A, 
sensitivity shifts against new fungicide groups such as SDHIs, or new mechanisms resulting 
in further shifts in triazole sensitivity. 
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Appendix 1. Azoxystrobin EC50s of R. secalis isolates. 
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Appendix 2. cytochrome b sequences from R. secalis isolates. 
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Appendix 3. Azoxystrobin EC50s of R. secalis isolates. 
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Appendix 4. CYPSI sequences of R. secalis isolates. (a) CYP51B translated sequences, (b) 
CYP51A translated sequences, (c) CYPSIA p sequences. 
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Appendix 5. Fungal and outgroup CYP51 sequences from Broad Institute genome sequences 
listed in Table 5.2. 
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